



Communicating health information in primary care: a 











presented to the University of Waterloo 
in fulfillment of the 
thesis requirement for the degree of 








Waterloo, Ontario, Canada, 2019 







Examining Committee Membership 
The following served on the Examining Committee for this thesis. The decision of the 
Examining Committee is by majority vote. 
 
External Examiner Dr. Jason Perepelkin 
Associate Professor 
College of Pharmacy and Nutrition 
University of Saskatchewan  
Supervisor Dr. Kelly Grindrod 
Associate Professor 
School of Pharmacy 
University of Waterloo 
Internal Member Dr. Wasem Alsabbagh 
Assistant Professor 
School of Pharmacy 
University of Waterloo 
  
Internal-external Members Dr. Catherine Burns 
Professor 
Systems Design Engineering 
University of Waterloo 
 
Dr. Elena Neiterman 
Lecturer 
School of Public Health and Health Systems 





This thesis consists of material all of which I authored or co-authored. Please see Statement 
of Contributions included in the thesis.  
 
This is a true copy of the thesis, including any required final revisions, as accepted by my 
examiners. 
 
I understand that my thesis may be made electronically available to the public. 
 
v 
Statement of Contributions 
Kate Mercer was the sole author for Chapters 1, 2, and 7 which were written under the 
supervision of Dr. Kelly Grindrod and were not written for publication. 
This thesis consists in part of four manuscripts written for publication. Exceptions to sole 
authorship of material are as follows:  
Research presented in Chapters 3 and 4:  
Dr. Kelly Grindrod and Dr. Catherine Burns were the primary co-investigators on Canadian 
Institutes of Health Research (CIHR) and TelusHealth grants which supported conducting 
this work. Dr. Lisa Guirguis, Dr. Jessie Chin, Dr. Maman Joyce Dogba, Dr. Lisa Dolovich, 
Dr. Line Guénette, Dr. France Légaré, Dr. Josephine McMurray were co-investigators on the 
grant and are co-authors on any publications relating to this work.  
This research was conducted at the University of Waterloo by Kathryn Mercer under the 
supervision of Dr. Kelly Grindrod. Dr. Kelly Grindrod, Dr. Catherine Burns, Dr. Lisa 
Guirguis, Dr. Maman Joyce Dogba, Dr. Lisa Dolovich, Dr. Line Guénette, Dr. France 
Légaré, Dr. Josephine McMurray, and Kathryn Mercer contributed to study design and 
participant recruitment. Kathryn Mercer, Khrystine Waked, Jonathan Boersma, Damla 
Kerestecioglu, and Jessie Chin conducted the one-on-one semi-structured interviews. 
Kathryn Mercer, Khrystine Waked, and Drs. Kelly Grindrod and Lisa Guirguis were the 
primary coders, contributing to coding and analysis of all interviews. Catherine Burns, Dr. 
Jessie Chin, Dr. Maman Joyce Dogba, Dr. Lisa Dolovich, Dr. Line Guénette, Laurie Jenkins, 
Dr. France Légaré, Annette McKinnon, and Dr. Josephine McMurray participated in coding 
and analysis. Kathryn Mercer wrote the draft manuscripts, which all co-authors contributed 





Chapter 3: Mercer K, Burns C, Guirguis L, Chin J, Dogba MJ, Dolovich L, Guénette L, 
Jenkins L, Légaré F, McKinnon A, McMurray J, Waked K, Grindrod KA. Exploring the role 
of teams and technology in patients’ medication decision making. J Am Pharm Assoc. 
February 2019. doi:10.1016/J.JAPH.2018.12.010 
Chapter 4: Mercer K, Burns C, Guirguis L, Chin J, Dogba MJ, Dolovich L, Guénette L, 
Jenkins L, Légaré F, McKinnon A, McMurray J, Waked K, Grindrod KA. Physician and 
Pharmacist Medication Decision-Making in the Time of Electronic Health Records: Mixed-
Methods Study. JMIR Hum Factors 2018;5(3):e24 DOI: 10.2196/humanfactors.9891  
Research presented in Chapter 5:  
This research was conducted at the University of Waterloo by Kathryn Mercer under the 
supervision of Dr. Kelly Grindrod. Kathryn Mercer designed the study with consultations 
from Drs. Elena Neiterman, Lisa Guirguis, and Kelly Grindrod, who contributed to data 
analysis. Kathryn Mercer drafted the manuscript and each author provided intellectual input 
on manuscript drafts.  
Mercer K, Neiterman E, Guirguis L, Burns C, Grindrod K. “My Pharmacist”: Creating and 
maintaining relationship between physicians and pharmacists in primary care settings This 
chapter has been accepted to Research in Social and Administrative Pharmacy. DOI: 
https://doi.org/10.1016/j.sapharm.2019.03.144 
Research presented in Chapter 6:  
This research was conducted at the University of Waterloo by Kathryn Mercer under the 
supervision of Dr. Kelly Grindrod. Kathryn Mercer designed the study and completed the 
data analysis with assistance from Dr. Kelly Grindrod. Caitlin Carter, Jackie Stapleton, and 
Jalyn Kelly contributed to designing the searches. Parvinder Sahota contributed to data 
 
vii 
collection. Kathryn Mercer drafted the manuscript and each author provided intellectual input 
on manuscript drafts. 
Mercer K, Carter C, Sahota P, Christofides E, Burns C, Grindrod K. Including the reason for 
use on prescriptions sent to pharmacists: A scoping review.  
 
As lead author of these four chapters, I was responsible for contributing to conceptualizing 
study design, carrying out data collection and analysis, and drafting and submitting 
manuscripts. My coauthors provided guidance during each step of the research and provided 





Research has yet to clearly define how health care professionals’ (HCPs) use and sharing of 
information influences how health decisions are made, both independently and 
collaboratively. Similarly, the manner in which patients use, interact with, and find health 
information is not fully, and how external influencers impact patient decision-making about 
health.  
The overall goal of this thesis is to examine how and what information is being shared among 
patients, pharmacists, and physicians and how this information is used in decision making. 
Using a variety of methodologies, this research examined five areas of communication and 
decision-making: 1) How patients, pharmacists, and physicians currently make decisions as a 
healthcare team; how this information influences shared decision-making about patients’ 
medications and health; and how this process can be improved through the use of electronic 
health records (EHRs); 2) How information is communicated among HCPs and between 
HCPs and patients; 3) What information patients seek out, collect and communicate to their 
HCPs; 4) How relationships influence professional collaboration and communication in 
healthcare; and 5) The scope of existing knowledge around including the reason for use on a 
prescription and how that influences the ways in which pharmacists make decisions. 
This thesis consists of four papers that describe two studies. Three of the papers use data 
from a qualitative examination of ethnographic observations and structured or semi-
structured interview methods to examine: 1) patients’ medication decision-making with their 
 
ix 
pharmacists and physicians; 2) pharmacist and physician medication decision-making; and 3) 
how relationships between pharmacists and physicians influence collaboration. The final 
paper is a scoping review of the literature that characterizes the current body of research on 
how including the reason for use on a prescription impacts pharmacist decision making.  
The first study examines how patients make decisions with their health care team, how 
information influences decision-making and how the process can be improved through 
EHRs. It revealed that different people play different roles when it comes to helping patients 
make decisions. The first of three papers emerging from the first study determined that while 
EHRs can support decision-making, more research is needed to further clarify perceptions of 
role and how to develop EHRs that are adaptive to varying user information needs. The 
second paper focuses on physician-pharmacists medication decision-making and examined 
how physician and pharmacist relationships influence collaboration and communication. It 
concluded that there is limited communication and collaboration between physicians and 
pharmacists around managing medications. Further, this research saw an emerging result 
about how relationships influence how and when collaboration and communication occur, 
resulting in the third paper which examined the relationships more closely. The fourth paper 
emerged from the need to better understand the current scope of research about including 
reason for use on a prescription that is sent to a pharmacist--an emerging area of interest from 
the original study. 
Taken together, the chapters provide an emerging picture of how and what information is and 
should be communicated in healthcare and the factors that influence how information is 
 
x 
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1.1 Introduction and Literature Summary 
In the modern healthcare setting, it is fundamental for healthcare providers to make decisions by 
sharing information across their healthcare team. Though historically, physicians made most of 
the decisions about people’s care without involving patients in any part of the process, and other 
caregivers had only a very minor role, the modern healthcare system is being redeveloped to 
focus on collaborative multidisciplinary care that involves the patient and other stakeholders.1,2 
As healthcare decision-making has grown to include input from practitioners other than 
physicians, the processes have become increasingly complex, and so too has the communication 
of information about care.3 Exchanging information necessitates a shared language, a 
communication channel, a system of support, and a mutual understanding of values as well as 
process. In addition, the expectations of others involved in care have also changed around factors 
such as role expectations, information sharing, and communication.4 Better ways are needed to 
facilitate this involvement, and to mitigate the challenges inherent in sharing the full range of 
information necessary to make sound decisions about health.5 To combat a fragmented system in 
Canada and internationally, evolving ways of improving information sharing include the 
introduction of new medical decision-making models and a move towards electronic health 
records (EHRs).  
 
Healthcare systems around the world are increasingly promoting the delivery of care in an 
integrated manner with multidisciplinary stakeholders working together to make health-related 
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decisions.6,7 As healthcare teams become increasingly multidisciplinary, information needs to be 
communicated to an increasing number of people who often have different information needs, 
contexts, and languages. As a foundational clinical skill for physicians and pharmacists, and 
along with a patient’s own health literacy, communication of health information plays a pivotal 
role in people’s ability to discuss their diagnosis, prognosis, and general health in meaningful 
ways.8,9 However, if there is an expectation that patients and healthcare professionals (HCPs) 
will be making the most appropriate decisions about health, the information used to make these 
decisions must be communicated between each participant in health in a way they can 
understand and use.10–12  
 
At a structural level the current systems in place do not facilitate effective information sharing 
between the various stakeholders in health. This creates downstream challenges when building 
institutional systems that facilitate sharing information. At a micro level, methods of teaching 
people how and what information must be shared are required.13,14 The traditional paternalistic 
physician-centered model of medicine, though a long established model of healthcare, is 
increasingly losing ground as an optimal way to care for patients, in large part because it does 
not offer a space for engaging patients in their own care.15 Historically, physicians were 
authorities who did not communicate with patients about either health information or their 
decision-making, and patients were intentionally not provided with information about their 
diagnosis or treatment.16  
The question is often asked, why physicians do not write… prescriptions in 
English. The answer is obvious — that if they did, the patient would often be 
less benefited than he now is. There are very few minds which have 
sufficient firmness, during the continuance of disease, to reason calmly on 
the probable effects of remedies, and to compare their wonted action… The 
only state in which the mind can rest… during severe illness, is that of 
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implicit reliance in the skill of the physician, and an entire acquiescence in 
the course adopted, without the slightest question or argument.  
Latin prescriptions. Boston Med Surg J 1833; 9:98-9916 
 
Similarly, in the paternalistic doctor-based approach to care, decision-making about medications 
and treatments was traditionally guided solely by the physician with information flowing in one 
direction, from physician to patient, without engaging other HCPs. Though fading, this 
traditional paternalistic doctor-centered belief that patients cannot and should not have access to 
any health information because they do not have the authority of a physician still lingers in 
modern healthcare interactions.  
 
However, in general, this approach has been found to no longer be effective, given the 
complexity of the healthcare systems, which have evolved through the mounting use of modern 
technology and the growing specialization of professions.17–19 Increasingly, every participant in 
healthcare follows a different modes of communicating health information, which can both 
facilitate and impede the success of sharing health-related information.20,21 Researchers are 
becoming increasingly aware of what happens when there is an over-saturation of information, as 
well as the different ways different groups of people disseminate, communicate, and use 
information.22 In healthcare, the intricacies around information sharing are demonstrated at 
micro, institutional, and structural levels. At the micro level, people need to be taught how and 
what information needs to be communicated in a way that makes sense to each group using the 
information. At the institutional level, there needs to be a way to facilitate sharing and 
communicating health information to align the languages people use to communicate and share 
information. Structurally, the healthcare systems in Canada are fragmented, and tools must be 




Availability of and access to health information is increasing, and people’s ability to find, 
prioritize, understand, and share health information (and misinformation) influences how they 
interact with and share information.23 Expectations today are that patients’ knowledge about their 
conditions is limited only by their comfort level, which carries the inherent requirement that they 
are able to understand and navigate health choices.7,15,24,25 Correspondingly HCPs are expected 
to stay on top of an over saturation of information about emerging research, best practices, new 
roles, and treatment options. Speier identified that “information overload occurs when the 
amount of input to a system exceeds its processing capacity. Decision makers have fairly limited 
cognitive processing capacity. Consequently, when information overload occurs, it is likely that 
a reduction in decision quality will occur.”26 This said, people must be allowed to control how 
much, and in what form information is delivered to them when they engage in making decisions 
about health.  
 
At some point everyone has to make a decision about their health – to seek or not seek treatment, 
to take or not take medication, to find or not find health information. Most patients will willingly 
participate in making health decisions when given the option and a platform to do so, even when 
the decisions they are making are complex and difficult.27,28 As healthcare needs increase, so too 
does the need for HCPs and patients to work together to improve continuity of care, patient 
monitoring, the identification of critical findings, and the promotion of education and learning 
opportunities. As of 2011, roughly one-third of Canadians were living with at least one 
significant chronic illness, with 12.9% of Canadians over the age of 20 living with two or more 
conditions, with the percentage rising as people age.29 The Canadian Health Measures Survey 
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identified that 41% of the participants had taken at least one prescribed medication within two 
days of being interviewed.30 The use of a prescription drug rose from 12% among 6 to 14 year 
olds to 83% of 65-79 year olds.30 In 2005, it was found that pharmacists on average dispensed 35 
prescriptions per person aged 60-79, jumping to 74 prescriptions for persons aged 80 and older.31 
Managing the use of multiple medications is complicated, requiring a high level of health 
literacy among patients, who not only need to understand diagnosis and treatment, but also must 
effectively navigate the health system.32 As well, miscommunications and misunderstandings 
among HCPs, and between HCPs and patients, result in many instances of people prescribed 
multiple medications having a higher risk of adverse drug events.33  
 
Though the future of healthcare is moving to the embrace inter-professional activity and shared 
decision-making, there are obstacles to progress in this area. This thesis explores how and when 
communication and information sharing occurs among physicians, pharmacists, and patients. As 
well, it begins to investigate how EHRs can facilitate information sharing, and the information 
participants need and value to be able to fully participate in healthcare. 
1.2 Health information seeking and sharing 
In order to make decisions about their health, people first need to access the information required 
to make these decisions. This information can come from many sources, including HCPs, family, 
friends, online and print.34 Health information-seeking behaviour refers to the different ways 
people find information related to their health and illnesses and dates back to the late 1980s when 
the theory first emerged.35 With the rapid rise of the information age and subsequent ease of 
sourcing and using health information online, finding the answer to the question of how people 
obtain health information is not easy.34–36 People will seek different types and amounts of 
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information, with significant variance depending on their personal information needs. Non-
professionals will most commonly seek out health-related information from a combination of 
sources including HCPs, family, peers, books, and the internet.35,37 Similarly, HCPs will seek out 
health information from a variety of sources including patients, peers, clinical resources and 
online, while navigating the often overwhelming amount of information they need to process in 
the course of their professional practices.38  
 
Health websites, including blogs and forums, give patients and caregivers a platform on which to 
communicate information and exchange anecdotal advice with others experiencing similar health 
issues. Studies have documented the benefit that these websites offer in terms of social and 
emotional support around many different diagnoses and experiences.39–42 While research studies 
have not been done on whether and how online sources influence decision-making, there is 
evidence that prior experience influences how people make health decisions.43,44 When 
considering non-traditional health information (online, family, and peers), it is important to be 
aware both that the narrative of other patient experiences can be very impactful, and that the 
material itself can vary greatly in its opinions, purpose and, evidence.  
 
As internet access and availability of health information has increased, patients are increasingly 
bringing online health information to their HCPs, even though HCPs are unlikely to point 
patients towards online resources.45 Hesse et al. determined that while patients are going to the 
internet to find health information, there is more trust in HCPs, which may be a result of patients 
struggling with the complexity of online health information.46 However, despite a greater trust in 
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the reliability of information from HCPs, patients continue to use online health information due 
to its convenience.47 
1.3 Communicating health information 
The communication of health information occurs by moving information between a patient, their 
physician(s), pharmacists, other HCPs, and other decision influencers (such as family and peers). 
Yet while science is able to provide increasingly precise information about health risks, benefits, 
and interventions, there is no current consensus on the most effective ways to communicate this 
information among the different people involved in a person’s health. Moreover, there is a 
notable absence of studies that systematically compare different interventions in how health 
information is communicated, most notably in how the interventions relate to and impact inter-
professional collaboration and decision-making. Better understanding how people process health 
information, which information is important to them, how perspectives changes information 
needs, and how to foster effective communication among the various participants in health, can 
help people make better healthcare decisions.  
 
Aligned with issues around the communication of health information, clarification and 
communication around role and scope of practice is necessary among HCPs and between HCPs 
and patients. For example, roughly one third of Canadian seniors take five or more medications, 
which is why pharmacists must be viewed as a key partner in their circle of care.30 As roles and 
scopes of practice change, the communication around who can and should do what as it relates to 
patient care must change as well.4,48 Research has demonstrated that clinical services provided by 
pharmacists improve patient outcomes leading pharmacists across Canada to expand their 
clinical roles to include prescribing, de-prescribing medications and vaccinations in addition to 
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their traditional dispensing roles.49 Research has validated that including pharmacists within 
primary care and emergency care is beneficial, but there has not yet been significant research to 
assess how communication between HCPs is changing, and needs to change, given this expanded 
scopes of practice.50,51 Developing a system that allows for the inclusion of pharmacists and 
other HCPs in the larger healthcare team first requires a foundational understanding of how, 
when and why HCPs and patients are communicating the information they use to make health 
decisions. 
1.4 Healthcare professional information sharing and relationships 
The traditional authoritative style of medicine, while an established and enduring aspect of 
healthcare, is increasingly losing ground as an acceptable way to care for patients in large part 
because it does not engage patients in their own care. New patient responsibilities also arise 
when care is fragmented and when healthcare technologies and practices do not (or cannot due to 
limitations stemming from privacy regulations) keep pace with the need to coordinate 
information.52,53 However, efforts are underway to address this issue and movements such as 
interprofessional shared-decision-making  have provided training and created tools aimed at 
improving patient-provider engagement.54,55 These efforts show themselves in new ways of 
improving disease self-management and encouraging incentives for behavioural change as 
researchers develop interventions which include more inclusive health behaviours as a 
collaborative goal.9,56,57 
 
Collaboration in healthcare improves patient outcomes, prevents adverse drug reactions, 
decreases mortality, optimizes medication use, and improves workflows.58–61 Inherent in building 
multidisciplinary practices that are more collaborative is understanding how inter-professional 
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relationships influence collaboration and communication. One key feature of these newer models 
is the inclusion of new ways of decision-making. Increasingly, to make healthcare decisions, 
HCPs must consider inter-professional roles as well as patient agency, engagement, and 
communication, all of which are vital to understanding how people experience and navigate their 
health from diagnosis through treatment.10,62 Yet while a movement towards a more integrated 
multidisciplinary approach to healthcare is occurring, there are still significant gaps in 
communication due to the siloed approach to health services.63,64. While inter-professional 
literature focuses on individual practitioners or ‘learning to work together’ through education, 
research is needed into teamwork and collaborative relationships in healthcare settings.  
1.5 Patient engagement, communication, and decision-making  
 One of the biggest barriers to engaging people in making health decisions is that there is no 
systematically identified range of behaviours expected of “engaged patients.” New 
pharmaceuticals and devices are making it possible for people with chronic conditions to live 
longer and better. Yet, the reality of understanding, adhering to and managing the demands of a 
large number of drug and lifestyle recommendations for chronic conditions such as diabetes, 
asthma, and HIV, as well as acute illnesses, mean that the number of healthcare decisions that 
patients are asked to make can be prodigious.12,65,66 Navigating multiple care providers, getting 
diagnostic tests, and adhering to complex treatment regimens, on top of finding the information 
necessary to make a decision about one’s health, is often initially overwhelming. For example, 
when patients are prescribed a new medication, they first need to decide to fill the medication. 
Then, once they are home, they have to adhere to drug regimens (short- and long-term), dietary 
restrictions, and rehabilitation—often on their own or with ‘touch-base’ guidance that they must 




Judith Hibbard, a leading theorist, and researcher of patient engagement, measured people’s 
attitudes about performing key behaviours that comprise engagement.69 In her 2007 study, it was 
found that while respondents in a representative sample adopted new health-related behaviours, 
they were not confident they would be able to maintain them in the face of life stress or health 
crisis.69 Hibbard presented evidence that there are four stages people go through while becoming 
able to manage their own health, including making health decisions, beginning with people not 
being aware they must play an active role in their health and end with their adopting new 
behaviours, even though this may include an awareness that they may feel unable to maintain 
these behaviours in the face of a crisis.15,69,70 These data are part of the growing body of literature 
that documents the lag between the expectations of HCPs and the actual behaviours performed 
by individuals while in their care.  
 
As a result, patients and caregivers find that they must take the initiative to coordinate and 
communicate information and services for themselves and their families—increasingly more so 
when managing multiple illnesses or chronic conditions.71–73 The consequences of non-
participation include preventable illness and suffering, suboptimal outcomes, and wasted 
resources. Research shows that when patients are actively engaged in their health, they are more 
likely to adhere to treatments, medications, and improve their overall well-being.74–76 The 
growing body of research on health decision-making, patient engagement, and adherence is 
creating strong evidence that, while there is not a single approach to interventions that meet all 
needs, those that involve collaboration among HCPs, patients, and caregivers are more 
successful.77 However, Eccles and others who have examined the difficulties of integrating 
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understanding between HCPs and patients nevertheless identify the differences between 
behaviours of patients and HCPs, and identify the benefits of a generalizable framework around 
what influences behaviour, and ultimately decisions.61,78  
 
Because all individuals have their own personal experiences and perspectives which shape how 
they think, perceive the world, and guide their beliefs, generalized frameworks for decision-
making and information sharing are necessary to provide goals and context. Considerable 
research has examined the cognitive biases that influence decision-making.79–81 To understand 
how a person makes a decision, first the perspectives of all those informing that decision must be 
understood.82 After the perspectives of all external influencers are understood, we can move to 
understand the perspectives of individuals, and explore how their experiences and perceptions 
shape relationships.82 It must be clearly understood that all decisions made related to treatment, 
healthcare, and health are motivated by a plethora of influences, many of them working at a 
subconscious level.  
1.6 Electronic health records  
At a structural level in health, a lack of a single platform that facilitates a collaborative approach 
to decision-making and information communication means that there is not an easy way for all 
involved in patient care to share information. To manage health requires HCPs and patients to be 
comfortable collecting, understanding, using, remembering and communicating a growing 
amount of health-specific knowledge. Many people are ill-equipped to do this.83 The process 
becomes increasingly difficult when navigating the questions around who needs what 
information. For example, pharmacists require information on medication reason for use, which 
is difficult to ascertain when it is not included in a prescription. EHRs are a platform for all 
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involved to access the information they require. The intent of EHRs is to support integrated 
healthcare by providing the entire medical team, ideally including the patient, with more 
information including lab tests results, radiology results, discharge summaries, and specialist 
notes.84–86 EHRs have demonstrated many benefits including fewer medication errors, broader-
based healthcare and, facilitated collaboration.85,87 
 
The idea of inter-organizational, comprehensive, and patient-centred health records began in the 
1990s in the United States, and is driven by the idea of supporting and improving healthcare.88 
While the basic idea has remained consistent, the terminology for the system has frequently 
changed: Personal Health Record (PHR), Online Health Record (OHR), Online Medical Record 
(OMR), Electronic Medical Record (EMR), and what is currently one of the more widely used 
terms, Electronic Health Record (EHR). EHRs are a networked, cross-institutional, and 
comprehensive collection of patient health data.87 EHRs can include health information relevant 
to a patient’s specific treatment as well as to their health in general. Ideally, patients have the 
ability to access, add to, and manage their own health data, making them active partners in their 
treatment and health decisions.89 
 
In primary care, better decisions can come from understanding how health data stored within 
EHRs encourages collaboration and communication among patients and their entire care team, 
and how having access to this information can ultimately improve care.54,90 Unfortunately, while 
Canada is lagging behind in the adoption of tools such as EHRs, their adoption does represent an 
opportunity to design and implement EHRs that are designed to support multidisciplinary and 




Coordinating healthcare services across providers by facilitating information sharing also 
contributes to the ability to promote optimal care through incorporating effective decision-
making tools into EHRs.91,92 Health-related decisions, both those of a patient and a practitioner 
are complex, dynamic, and variable. HCPs must make critical and non-critical decisions where 
they are tasked with making effective decisions, all too often with missing information.54 By 
making data more easily available to all those involved in a patient’s care, including HCPs, allied 
health professionals, and patients, and by providing better-organized information and more 
timely access to health data, EHRs provide a strong platform that supports health communication 
and decisions.93,94 
1.7 Decision-making in health  
 
For patients and HCPs alike, healthcare decisions differ from most daily choices in that they may 
have significant consequences and involve a complicated mix of uncertainty and trade-offs. 
Uncertainties may arise about the validity of the diagnosis, the diagnosis itself, the accuracy of 
tests, and the effects of treatments and consequences for family, friends, and work.34,36,95 With 
diverse and confounding factors such as often conflicting and difficult to understand information, 
it can be challenging for patients to comprehend all the options, let alone compare them. Health-
care decisions are complex by nature and include influences from a variety of people and places, 
including online resources, physicians, pharmacists, family members, and peers.96–98 As little as 
a century ago, a physician had only a narrow range of possible diagnoses, a small number of 
relatively simple tests, and a narrower range of treatments, many of which were ineffective. For 
example, the Merck Manual of Diagnosis and Therapy from 1899 was 192 pages, whereas the 
most recent 19th edition from 2011 runs to 3,754 pages.99,100 Our ability to understand diseases 
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and how to manage them has greatly increased, but along with increased knowledge comes 
increased complexity of health-care decisions. The 2001 Institute of Medicine report “Crossing 
the Quality Chasm” articulated the importance of making informed health decisions, particularly 
when the choices people face are complex and associated with a risk of death or major 
morbidity.101 
 
HCPs and researchers focused on supporting healthcare decision-making have identified five key 
models: paternalistic, informed, interpretive, shared, and Inter-professional Shared Decision-
Making (IP-SDM). 102–104 Despite some overlapping characteristics among the types, including 
information sharing and gradations over absolutes, the current consensus of opinion leans 
towards integrated decision models over the historic focus on physician-patient interactions with 
little or no reference to external influencers (e.g. nurses, pharmacists, family members, peers). 
The emergence of IP-SDM, which includes a broader range of participants, is changing the 
healthcare landscape. Figure 1-1 demonstrates the flow of information in the five types of 
decision-making models, which are discussed in more detail in the following sections. 
 
 
Figure 1-1 Types of Decision-Making 
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It must be clearly understood that all decisions made related to treatment, healthcare, and health 
are motivated by a plethora of influences, many of them working at a subconscious level.105,106  
1.7.1 Decision-making models and information sharing 
 
In the traditional paternalistic doctor-centered model, physicians use their skills to determine the 
patient’s medical condition and the stage of the disease and then identify the appropriate medical 
tests and/or treatments that they favour.107–109 Paternalistic decision-making is defined by a one-
way flow of information, from doctor to patient, in the best case from available evidence and 
information, and is largely influenced by physician preference. The physician presents the patient 
with information that the physician considers best, without input from the patient about their 
lives, opinions, or values. Extreme versions of the paternalistic model even go so far as to not 
give the patient an option about when the treatment will commence.104,110 The paternalist model 
assumes that the patient and the physician understand and share the same criteria for identifying 
the best treatment option and that the physician’s opinion should lead as they are the expert. The 
physician is perceived as best able to discern what is in the patient’s best interests, despite 
limited patient participation. However, Agarwal et al. have identified a recent paradigm shift in 
North American culture where autonomy is valued as much as professional expertise.111 This 
shift created tension in communication between physicians and patients and the necessity for 
new models of communication and decision-making as a foundation for a patient-centered 
approach to care.  
 
Similar to paternalistic decision-making, informed decision-making is also a one-way model, 
where information flows from the physician to the patient. According to Braddock et al. the 
majority of health decisions in the 1990s were informed.112 The end goal of an informed 
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decision-making interaction is for the patient to have all the information necessary to make a 
sound decision about the treatment they want, which the physician can then implement.113–116 
The physician thus needs to give the patient all relevant information, while being aware of other 
information a patient may have, such as that found online. Lewis and Pignone claim that the 
patients themselves tend to hold clear personal values around healthcare, and all they need to 
have in order to choose treatment are the medical facts provided by their physician.117 The 
biggest risk associated with the informed model is that its ideal of patient autonomy in practice is 
often impossible to achieve. When faced with weighty decisions and unfamiliar situations, most 
people are unsure of what they want and often prefer an expert’s opinion.69  
 
In the interpretive model, which is an offshoot of the informed model, the goal of the interactions 
between practitioner and patient is to clarify the patient’s values, thus helping elucidate what the 
patient wants.104 In this model, the patient receives all available information about their 
diagnosis, as well as risks and benefits of treatments, and going a step beyond informative, the 
practitioner helps the patient articulate their values and then determines what interventions best 
help meet these values.118  
 
While the paternalistic, interpretive, and informed models all emphasize that it is important to 
provide patients with adequate information, the shared decision-making model (SDM) seeks to 
bring mutual participation into the decision-making process, with both the practitioner and 
patient involved in the process.112,119,120 Going back more than 20 years, SDM has called for 
collaborative partnerships between patients and providers, who can then deliberate about 
treatment together.103 Studies show that communication, shared experience, and shared 
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decisions-making enhances patient satisfaction, improve adherence to treatment, and ultimately 
improve patient outcomes.121–124  
 
Weston argues that SDM forms the crux of patient-centred care, and Mulley, Trimble, and 
Elwyn also highlight “preference diagnosis” as a crucial step in recommending appropriate 
treatments to patients.114,125 In SDM, discussion allows the patient’s knowledge and preferences 
to be taken into account, along with the clinician’s expertise. With information flowing both 
ways, instead of one way, the decisions they reach are an agreement with each other, informed 
by research (see Table 1-1).  
 
Table 1-1 Different Types of Expertise 
Clinician Patient 
Diagnosis Experience of illness, current and past 
Disease Origin Personal and family values 
Prognosis Attitude to risk 
Treatment Options Attitude to side effects 
Medications Treatment preferences 
Outcomes Financial situation 
 
Research has shown that SDM tools such as decision aids increase knowledge of options, reduce 
uncertainty, help patients feel informed, and clarify patient values to the doctor.125–127 The 
potential for improved medication and treatment adherence is possible because the decision is 
made with the patient and the collaborative process can reduce the risk of decisional conflict and 
regret over time. 124,128–130 
 
While ongoing studies have found that patients prefer SDM to alternatives, it is emerging that 
actual patient behaviours demonstrate that the majority of patients still play a passive role in their 
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health decisions.9,43,130–135 Moreover, there are other influencers of treatment decisions to 
consider in addition to patients and physicians, including online health information sites, 
religion, family members, peers, and alternative medicine practitioners (such as naturopaths and 
chiropractors).7,136–138  
 
The inter-professional shared decision-making (IP-SDM) model expands the original SDM 
model beyond the traditional dyad between patients and physicians to include fostering broader 
collaboration between HCPs. 97,139–141 IP-SDM aims to be the gold standard of medication and 
treatment decision-making. According to Légaré et al., IP-SDM involves two or more health 
professionals collaborating with the patient and/or caregivers to identify the best options and 
preferences.55,77,142 A study by Zwarenstein et al. on practice-based interventions concluded that 
IP collaboration can improve both processes and outcomes in health.143 Similarly, a 2008 
Cochrane review about the effect of IP education supported this, noting that four out of six 
studies identified a positive effect on departmental culture, collaborative team behaviour, 
improved patient satisfaction, and reduced errors.3 
 
As well as including broader healthcare teams, the IP-SDM model proposes the inclusion of 
family members and caregivers and takes into account the complexity of environmental 
influences on SDM including organizational, societal, cultural, and institutional factors.97 The 
IP-SDM model has been used as a basis to develop interventions for specific decision-making 
situations including diabetes care, home care teams, inter-professional health teams, and 
healthcare chaplains.7,144,145 Bujold et al. identify the seven-steps of patient-centred IP-SDM: (1) 
choose a decision to make and explore related options; (2) exchange information; (3) clarify 
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values and preferences; (4) assess the feasibility of the decision; (5) choose the preferred 
decision option; (6) implement the decision; (7) assess the outcome.146 
 
Other goals of IP-SDM are to create more opportunities for patients to take part in decision-
making, to get their information needs met, to improve communication between patients and 
their healthcare teams, and to create consensus about a healthcare treatment.139,147 Interventions 
aimed at encouraging an IP approach to SDM can improve the quality of collaboration with the 
goal of supporting decision-making in healthcare. By bridging gaps between the various health 
disciplines, patients, and other health stakeholders such as families, IP-SDM can change the 
current siloed approach to healthcare into something more collaborative and engaging.148 
Fostering integrated decisions made with a number of different health stakeholders creates a 
better chance of improving care, patient education and understanding, continuity of care, as well 
as offering patients the increased likelihood of receiving the care and the knowledge they 
request.148  
While SDM and IP-SDM demonstrate significant advances in engagement and collaboration 
with a strong evidence background, there has been a lack of adoption into routine clinical 
practice.149 To effectively implement IP-SDM in clinical practice clinicians need to better 
understand the foundational shift of SDM, and how it affects their patients and then extend this 
knowledge to IP-SDM and further understand how this affects patients as well as 
interprofessional collaborations.145,149  
1.8 Research context 
 
The research presented in this thesis is part of a larger multi-disciplinary research project with 




● To study how integrated and shared information, including but not limited to patient 
medical histories, dispensing records, and lab values can be effectively used for “safe” 
medication therapy management. We will analyze the current state of shared medication 
and health records across patients, CBPHC settings, home-care settings, and pharmacies, 
including types of information typically exchanged, best practices and tools that support 
IP-SDM for medications. It is important to understand how to use integrated EHRs for 
collaboratively managing medications, given the current initiative for integrating medical 
records at the provincial level in Ontario.  
1.9 Research question and objectives 
There is a limited but growing body of research into how collaboration among various HCP 
impacts patient care. Research suggests that interventions to promote SDM are more effective 
when they target patients and HCPs simultaneously, but more evidence is needed to actualize 
research interventions to successful practice implementation.  
 
 This thesis used a qualitative approach to answer the overarching research question: 
● How do patients, physicians, and pharmacists understand and communicate patient-
focused medication information to make health decisions? 
 
In doing so, the research addressed five objectives: 
1. To identify how patients, pharmacists, and physicians make decisions with their healthcare 
team; how this information influences shared decision-making about patients’ medications 
and health; and how this process can be improved through use and uptake of EHRs.  
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2. To examine how information is communicated among HCPs and between HCPs and 
patients.  
3. To examine what information patients seek out, collect and communicate to their HCPs. 
4. To understand how relationships influence collaboration and communication. 
5. To understand the scope of existing knowledge around including the reason for use on a 
prescription and how that influences the ways in which pharmacists practice.  
1.10 Chapter context 
As part of building this foundational understanding, this thesis focuses on how and when 
patients, pharmacists, and physicians communicate about medication-related decisions and 
patient care. The insights gained are presented in parallel with understanding around what these 
groups want from EHRs to help them access, communicate and understand complex health 
information. 
 
This thesis first provides an overview of background information to provide context, and is 
composed of 7 chapters in total. Chapters 3, 4, and 5 consist of manuscripts accepted for 
publication, with Chapters 6 being submitted for publication, which combine to answer the 
overarching research question. While Chapters 3, 4, 5 and 6 have been written as unique 
manuscripts, it should be noted that the results and learning from each were first integrated to 
answer the initial research questions in Chapters 3 and 4, and then the emerging findings from 
Chapter 4 comprised the papers that make up Chapters 5 and 6. Chapter 2 describes the methods 
used in all the chapters. Chapters 3 and 4 are qualitative analyses of how communication 
influences decision-making, answering research objectives 1 and 2. Chapter 5 emerged from a 
secondary analysis of the data used in Chapter 4 and offers exploratory insight into how working 
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relationships influence communication and collaboration between physicians and pharmacists. 
One of the noteworthy findings of Chapter 4 is the importance pharmacists place on including a 
reason for use on, or along with, a prescription. Chapter 6 summarizes the existing scope of 
literature. Lastly, Chapter 7 concludes the findings from the manuscripts in Chapters 3, 4, 5, and 






2.1 Introduction  
It is important to clearly understand how people communicate information to make health 
decisions, as modern healthcare involves an increasing number of stakeholders who must 
communicate and coordinate with each other. Because the healthcare system is multifaceted, the 
methods used must address that complexity. The projects described in this thesis addresses the 
gap in research by exploring how people communicate health information, how the existence (or 
lack of) of relationships influences communication, and what information needs to be 
communicated for people to work collaboratively to reach health goals. This research used 
multidisciplinary mixed methods, with this thesis focusing on the qualitative research conducted. 
In addition to the four papers presented as part of this thesis, the data from this project has 
additionally resulted in further papers across other disciplines which is reflective of the overall 
multidisciplinary approach.150–154  
 
Chapters 3 and 4 consist of a qualitative thematic analysis of factors that influence decision-
making, grounded in a multidisciplinary team setting. Chapter 5 used a secondary thematic 
analysis from the data used in Chapters 3 and 4 to further explore the ways in which 
relationships influence decision-making and collaboration. Chapter 6 used scoping review 
methodology to better understand one of the findings from Chapter 4, and better understand the 
current scope of knowledge on the topic of communication, including the value of reason for use 
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on a prescription. The following sections offer details into the research design and data 
collection. 
2.2 Implementation Science, Knowledge Translation 
Knowledge-for-action theories are all focused on knowledge and change and range across many 
fields. Ottoson identifies the theories behind knowledge-for-action as: 
 
“Knowledge in some form (ideas, innovation, skills, or policy) moves in 
some direction (laterally, hierarchically, spreads, or exchanges) among 
various stakeholders (knowledge producers, end users, or intermediaries) 
and contexts (national, community, or organizational) to achieve some 
outcomes (intended benefits, unanticipated outcomes, or hijacked 
effects).”155 
 
Diffusion theory originated in communications theory, and is “the process by which an 
innovation is communicated through certain channels over time among the members of a social 
system”.156 Translation theory also originated in communication and has a focus on 
multidisciplinary multilevel knowledge for action. Knowledge utilization is the process of 
bringing an idea, technology, or practice into a clinical setting and is directly related to the 
awareness that evidence-based medicine and research do not consistently result in use and uptake 
in practice settings. Knowledge translation (KT) builds on knowledge utilization and was 
identified as both the science and art of bridging the “know-do gap” between gaining and using 
knowledge.157 The research in this study represents an exploratory approach to building 
knowledge that can be used to guide the development of tools to better support communication 
around health decisions. By integrating knowledge users (physicians, pharmacists, information 
specialists, engineers, and patients) in a collaborative approach to the research process, the goal 




The scientific study of knowledge translation is called Implementation Science, which Eccles 
and Mittman define as “the scientific study of methods to promote the systematic uptake of 
research findings and other evidence-based practices into routine practice, and, hence, to 
improve the quality and effectiveness of health services”.158 Through focusing on a scientific 
study of methods that promote research findings into practice, implementation research looks to 
improve the quality and effectiveness of both organizational and health services.158 
Implementation science also often involves multi-disciplinary research teams and requires the 
research teams to have a strong knowledge of diverse theories. 
 
Translating research into practice occurs through the diffusion of information. Historic theories 
of diffusion evolved from research that originally observed and tracked agrarian systems, into 
understanding how knowledge utilization can improve health and other social services.156 
Rogers’s five-stage decision-making process identified in the Diffusion of Innovations is integral 
to any adoption process: (1) Knowledge → (2) Persuasion → (3) Decision → (4) Implementation 
→ (5) Confirmation.156 While Rogers’s theory is focused on innovations, this thesis was aligned 
to his work in the awareness that a significant aspect of people’s adoption of anything, be it 
EHRs or the process of communicating and collaborating in care, is that each participant needs 
not just information to understand the innovation itself, but also enough information to make a 
decision to use or adopt the innovation.  
 
There has been a substantial body of research completed on EHRs, the uptake of new 
innovations, interprofessional collaboration, IP-SDM, and communicating health 
information.59,73,159 From the Diffusion of Innovations theoretical perspective, the question of 
why this information has not been fully translated into practice perhaps concludes that it is 
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because existing research has not yet provided enough information about how and why tools like 
EHRs can and should help facilitate communication and collaboration. This thesis also 
acknowledges that there is not currently a multidisciplinary theoretical framework guiding the 
overall research. While I draw upon the Diffusion of Innovations and Translation theories to 
varying degrees to guide the research, the project itself was developed to work in health, 
engineering, and business contexts At times, this has resulted in a tension between the underlying 
assumptions of each expert’s research perspective and the theories being used.  
2.3 Qualitative Research 
The research in this thesis used the qualitative approach aligned with the pragmatic worldview. 
Qualitative research is used when we need an understanding of a complex situation in a way that 
is best established by “talking directly with people, going to their homes or places of work, and 
allowing them to tell the stories unencumbered by what we expect to find”.160 Lining up with the 
theories that inform this thesis, pragmatism focuses on practical implications of research, 
emphasizing research that addresses a problem.161 Unless we more fully understand how 
decisions are made, we will not be able to sufficiently understand what influences decisions and 
ultimately understand how to improve the process. By gathering participant generated meanings 
and developing research that explores an under-researched area, the overarching project was 
designed to create information that informs healthcare reforms. The data gathered for this thesis 
was mixed-methods. This thesis specifically examines qualitative aspects of the data collected, 
with the research presented in Chapter 6 drawing elements of comparison between qualitative 




Qualitative data generates knowledge that is based on the human experience.162 When trying to 
understand health decisions, there is a need to identify how people perceive understanding and 
communicating health information. By placing our research in the context of the lived 
experiences of patients, pharmacists and physicians, we were able to understand the phenomenon 
within the context in which it was occurring. This research was guided by overarching theories, 
but did not test them. The described research was part of a larger mixed-methods study on shared 
decision-making in the context of EHRs that included observations, interviews, and talk-alouds 
with patients, physicians in primary care, and pharmacists. This thesis focuses on the qualitative, 
semi-structured interviews with physicians and pharmacists.  
2.4 Multidisciplinary Research 
Alongside the professional and research perspectives, multidisciplinary research seeks to 
decrease the historic marginalization of research participants through efforts to include, support, 
and educate patients and other stakeholders.163,164 Complexities of interacting with the healthcare 
system by nature require an approach to research that encourages working across different 
disciplines to incorporate as many of the areas both impacting and being influenced by this 
research as possible.165 Multidisciplinary research aims to bring experts from different 
disciplines and perspectives together to explore research questions from diverse outlook.164,166 
While multidisciplinary research is highly promoted in many research areas, there is confusion 
around what it means, differing interpretations around research methods, and a dearth of research 
into building a theoretical framework to guide and facilitate multidisciplinary research.164,167,168 
Conducting multidisciplinary research also allows for multiple triangulation of the data through 
the use of a variety of geographic sources, multiple coders, and a multidisciplinary team of 




Multidisciplinary investigation is a rapidly growing way to approach conducting research.170 It is 
increasingly found in many fields including health, sustainability, biotechnology, and 
engineering. The disciplines represented within health research are varied, representing an 
embedded hierarchy not only of professions but also research methodologies, something 
reflected in the broader realm of multidisciplinary research.171  
2.5 Participatory Methods  
 
Patient engagement is about meaningful collaboration. Patients become patient partners in the 
project and can be actively engaged in governance, priority setting, developing the research 
questions, and even performing certain parts of the research itself. This type of participation 
helps to ensure that the research being conducted is relevant and valuable to the patients that it 
affects. Patient partners can also collaborate with the research team to summarize or share the 
results with target audiences (especially other patients) and with policy makers or other 
decision makers who may apply the results in a health or community setting.  
Canadian Institutes of Health Research172 
 
An essential element of this view of truth is that people must be engaged in research that 
involves them. This belief aligns with the pragmatic stance of this research. Patient-engaged 
research can be generally understood “as a qualitative research inquiry in which the researcher 
and the participants collaborate at all levels in the research process (participation) to help find a 
suitable solution for a social problem that significantly affects an underserved community 
(action)’.160 Patient engagement approaches research through active engagement between the 
researchers and patients throughout, often starting during the grant writing phase and carrying on 
through the entire research project, including conducting, analyzing and disseminating research, 
as well as knowledge translation activities. Patient engagement emphasizes doing research with 
patients rather than doing research on patients, and encourages integrating patients as full team 
members. The Canadian Institutes of Health Research (CIHR) Strategy for Patient Oriented 
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Research (SPOR) was created to build capacity to engage patients as partners and improve 
patient outcomes.160 Similar initiatives exist in the United States and the United Kingdom, 
demonstrating the growing awareness of the value of including patients in the research cycle.  
 
Patient engagement in research is about supporting and strengthening the secure, trusted 
relationships that exist between patients and providers and can include grant writing, study 
design, analysis, and writing research papers. Esmail describes patient engagement in research as 
conducting research with patients instead of on them, or for them.173 CIHR defines patient 
engagement as:  
 
"Actions individuals must take to obtain the greatest benefit from 
the healthcare services available to them… Engagement is not 
synonymous with compliance. Compliance means an individual 
obeys a directive from a healthcare provider. Engagement signifies 
that a person is involved in a process which he or she harmonizes 
robust information and professional advice with his or her own 
needs, preferences and abilities in order to prevent, manage and 
cure disease.”75  
 
Conducting research that engages patients in the research process can take many forms. For 
example, while the inclusion of patients was important in developing the research described in 
this thesis, an emphasis was also placed on including all of the stakeholders in the research 
process – pharmacists, physicians, patients, and advocates. There are several approaches to 
including broader community members into the research process that emphasize doing research 
with people, instead of on people.174 Participatory Action Research (PAR) emerged from action 
research and originated in organizational development.175 PAR promotes community engaged 
research that has the end goal of action, with a focus on experimentation that is grounded in the 
social dimension – both experiential and historical.176 PAR is broad in nature and does not lend 
 
30 
itself to an easy definition, as it approaches research through the lens of human agency and 
efforts to transform the world through collective efforts.176 PAR can lead to challenges in 
defining what counts as participation, research, and action, but it ultimately emphasizes the value 
in not requiring strict definitions.176 Through stressing change, PAR highlights experiments that 
are founded in people’s lived experiences. PAR does not encourage reproducibility and promotes 
grounding research and the gaining of knowledge in human agency. 175–177  
 
Community-based participatory research (CBPR) is similar to PAR in that it also focuses on 
collaboration between the community and researchers, and tries to include multiple perspectives 
in the research process. CBPR acknowledges that there are inherent tensions due to power 
dynamics between researchers and the community.174,178 Blumenthal questioned if CBPR was 
truly possible and acknowledged the difficulties in balancing the quality and rigour of science 
with how much the project aligns with the principles of the research approach.179  
 
This project focused on a high-level approach to engaging patients as well as other stakeholders 
vested in healthcare including engineers, pharmacists, physicians, information specialists, and 
advocates in the research process, taking aspects of both CBPR and PAR research into account, 
but not falling neatly within the boundaries of either. The research team involved in the research 
project included pharmacists, physicians, and patients, where representation of the groups being 
studied throughout the design and implementation were included. The research drew from 
Chevalier and Buckle’s PAR characteristics of qualitative design research, which engaged 
patients in the research process and expanded it to include the other stakeholders. This thesis 
grounded the methodological design for the research presented as follows: i) stakeholder-focused 
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research on the questions we were seeking to address, ii) mixed methods data collection, and iii) 
multidisciplinary data analysis involving community decisions in data analysis.176 Similarly, by 
embedding elements of CBPR such as collaborative partnerships and including multiple 
perspectives throughout the research process, we were able to develop a research project with 
outcomes that are inclusive and supportive. The research presented in this thesis is inclusive of 
various stakeholder perspectives through the process, with the goal of building an understanding 
that can directly lead to the refinement or creation of tools to better support patients and 
providers in health.  
2.6 Terminology 
Terminology around multidisciplinary research is often interchangeably referred to as 
multidisciplinary, or transdisciplinary, all to refer to the practice of having diverse teams on a 
research project. For the purposes of this research project, the following definitions were agreed 
on by members of the research team during the two day meeting.  
Table 2-1 Multidisciplinary Research Definitions  
Multidisciplinary  “is a process for providing a juxtaposition of disciplines that is additive, 
not integrative; the disciplinary perspectives are not changed, only 
contrasted” 180  
Interdisciplinary “is a synthesis of two or more disciplines, establishing a new level of 
discourse and integration of knowledge.” 181 
Transdisciplinary “explains when holistic schemes that subordinate disciplines, looking at 
the dynamics of whole systems.”180 
 
2.7 Multidisciplinary Framework Method 
 
The advantage of using a multidisciplinary approach to designing this research is that it provides 
a paradigm that accounts for clinical, patient, and public involvement. Researching health 
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decisions and communication is inherently multidisciplinary, as decisions cannot be made with 
only one perspective. By designing research and using a method that supported multidisciplinary 
researchers, we were ultimately able to analyze the research with a similar mix of perspectives as 
those involved in making decisions.  
 
Bringing multidisciplinary researchers together can be a challenge. Different research paradigms, 
skills, and research perspectives often come with inherent tensions that can make collaborative 
research complicated. 182 There are several emerging methodologies to support research that 
reflect the complex nature of conducting research across disciplines, including the Framework 
Method, the Methodology for Interdisciplinary Research (MIR) framework, and the Delphi.182–
184 The Multidisciplinary Framework Method, which emerged from the Framework Method, was 
chosen to guide the analysis of the data in this thesis because it uses clear steps to follow and 
offers a supportive framework where not all members have experience with qualitative data 
analysis.  
 
Having its origins in large scale qualitative social policy research, the multidisciplinary 
framework method is becoming increasingly popular in health research.182,185 Gale et al. argue 
that the Framework Method can be used to include diverse perspectives and drive 
multidisciplinary collaboration as well as lay involvement in the research.182 By using a method 
that specifically includes lay people in the analysis, the Framework Method provides both an 
open as well as a reflexive approach to provide rigour to our analysis. The Framework Method 




2.7.1 Multidisciplinary Research Team 
Conducting multidisciplinary research results in a diversity of ideas, methods, and perspectives 
brought together to inform and analyze research. The goal of research is to generate knowledge, 
and by bringing together a group of researchers with different methodological expertise this 
project is able to effectively examine the complexities of health research from a number of 
perspectives, and for the research group as a whole to do a self-examination of their heuristics 
while analyzing data. The research team involved in this project included people representing 
health, information, business, technology, engineering, and patient partners, which reflects the 
multidisciplinary nature of this area of research (for team membership please see Appendix A), 
with the intention of representing stakeholders who make health decisions. The members of the 
research team who collectively represent the different perspectives included in the scope reflect 
best practices in multidisciplinary teams in how they reflect the different perspectives included in 
our scope.  
 
2.7.2 Multidisciplinary team two day meeting 
 
The multidisciplinary team, including engineers, clinicians, health researchers, business and 
communication researchers, patients, and a patient navigator, were involved with data analysis. 
The team met over the course of a two-day meeting, with the majority of members in attendance 
to begin to analyze and thematically code the data. The purpose of the meeting was to establish 
consistent terminology and definitions, begin to develop a multidisciplinary analysis of the data 
and attempt to merge discipline-specific understanding of the topic. The steps followed were: (1) 
interviews were transcribed verbatim; (2) core research team members read transcripts and 
listened to the audio recording to familiarize themselves with the interviews; (3) core team 
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members thematically coded the data; (4) the entire team thematically coded a subset of five 
interviews; (5) the team codes were used to develop a working analytic framework; (6) two team 
members re-coded the data; and finally (7) the data were presented to the entire team for 
discussion and refinement.  
 
2.8 Qualitative Analysis 
2.8.1 Ensuring methodological rigor 
It is essential when conducting qualitative analysis that credibility, rigour, and trustworthiness 
are demonstrated as the research often relies on researcher interpretation of the findings.186 It is 
important to ensure that as qualitative research is conducted, a critical approach be taken to make 
certain that rigour is enhanced.187 Qualitative researchers will always have bias, however, this   
thesis relied on triangulation, peer debriefing, and audit trails as three different technical checks 
to ensure quality data. Other methods to recognize researcher bias and how it may impact results, 
and confirm findings include objectivity/confirmability, reflexivity, and prolonged engagement.  
 
Findings were triangulated through confirmation with existing data, and research, as well as by 
using multiple perspectives and backgrounds to analyze the data and using different data 
collection techniques.186 All publications also included an ‘audit trail’ that included a description 
of sources, techniques of data collection and analysis, and how research decisions were made.160 
The ultimate goal was to write ‘rich descriptions’ of data which could be understood both by the 
researchers and the readers.162 By presenting the data as themes that were then presented as a 
holistic picture the goal was to reach saturation of the data, and to understand the this data, not to 
generalize the results to other settings.162 Peer debriefing, also referred to as analytic 
triangulation, was also completed by having regular discussions with qualitative researchers 
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external to the process, and the presentation of findings to interested groups.186 While 
generalizability was not the ultimate goal, by using diverse participants in the research, external 
validity was increased, and there is potential that the results are consistent in other settings.188  
 
2.9 Data Analysis 
 
Data analysis in qualitative research can be complex and, to people unfamiliar with the process, 
difficult to contextualize as qualitative research data can come from many sources.160 Thematic 
analysis is one of the most common methods used to analyze qualitative data. Using broad 
thematic analysis techniques allows for flexibility of frameworks and adaptability to different 
methods and analysis and rich description of data.160 The inductive approach to thematic analysis 
is a core characteristic of qualitative research that allows for identification, definition, and 
clarification of categories that are directed by the data.162 The inductive approach was chosen as 
it allowed the researchers to recognize emerging patterns within the data throughout the entire 
process of data analysis and was able to guide analysis within the Multidisciplinary Framework 
Method.162 By using a method of analysis that was flexible and easy to learn we were able to 
involve researchers from across different disciplines as well as actively include patient partners 
in the analysis process. 
 
While qualitative methodologies such as grounded theory also use tools like thematic analysis, 
they have different goals. The overall goal of grounded theory is to construct a theory based on 
the emerging codes, while the aim of this research is to use data to answer our pre-defined 
research questions.160 Many of our methods of analysis originated as grounded theory 
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methodologies such as using initial coding to identify key phrases.189 Our research also used 
memos, which are structured field notes used to lay out insights and observations (Appendix 
D).189 Finally, by modifying the constant comparative method to identify codes that fell outside 
of those initially identified instead of the more traditional cases that do not confirm a model.190  
 
During the two-day meeting, the research team gathered together to create the analytical 
framework. The set of codes developed were then jointly organized into the themes used for 
Chapters 3 and 4. Prior to the two-day meeting two patient and two HCP interviews were coded 
individually by each team member. During the meeting, the group used the coded interviews to 
first come to a consensus about overall codes, and agreed on overarching themes using the 
Multidisciplinary Framework Method. These final codes and themes were used to code the 
remainder of the interviews by the core research team, and after a final round of refinement the 
coded data was returned to the full team. Using a method that provided a practical way of data 
analysis allowed for all members of the research team, which included quantitative, qualitative, 
clinical, and lay members, to actively engage with the data and offer their perspective without 
having to read through the full amount of data or participate in a more technical method of 
analysis. One of the challenges inherent in multidisciplinary research is bringing together 
different research paradigms, as well as challenge beliefs inherent to one discipline of study. The 
process of decision-making about coding required all participants to be both reflective and 




2.10 Secondary analysis of data 
 Chapter 5 is based on qualitative re-analysis of the data gathered from the semi-structured 
interviews used for Chapters 3 and 4 with the specific intention of understanding how physicians 
and pharmacists feel about how they communicate.165 Secondary analysis of data is applied when 
researchers want to examine interests separate from the original analysis, analyze the original 
data further, or complete further analysis of a subset of data.191 Evolving after the initial analysis, 
this analysis utilized a Focused Ethnographic approach that used the interviews and observations 
to focus a re-analysis of the data on the relationships between physician and pharmacist cultures 
inherent to the larger Canadian health environment.160  
 
Secondary thematic analysis of the data was carried out because, during the initial coding guided 
by the original research question, questions were generated that the data regarding relationships 
between pharmacists and physicians could answer. After re-examining the original data and 
codes, the data was then re-analyzed under the lens of the following research question: How do 
relationships between physicians and pharmacists influence collaboration and communication? 
Similarly to our original research analysis, which used methods from grounded theory, 
theoretical sampling was used to seek out further data to expand a developing category was 
used.189,192 
 
2.11 Project Overview 
2.11.1 Recruitment 
Between October 2015 – April 2016, a diverse sample of physicians, pharmacists, and patients 
were recruited across Canada in Ontario (Toronto, Kitchener-Waterloo, North Ontario), Nova 
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Scotia (Halifax), Alberta (Calgary and Edmonton), and Quebec (Montreal and Quebec). 
Diversity was achieved as much as possible with different perspectives and geographical 
locations given the limitations of recruitment. The four provinces were chosen as each has a 
different EHR system and offer diverse cross-Canada insight into patient and HCP experience. 
Further, recruiting participants from across Canada increased the generalizability of the results. 
Inclusion criteria for patients were that patients were taking at least one medication, and 
regularly saw their doctor. Patients were also recruited through personal, academic, and 
professional connections. 
 
2.11.2 Ethics Clearance 
Ethics clearance for this research was granted by the University of Waterloo (ORE#: 20940), 
Wilfrid Laurier University (WLU: 4637), Dalhousie University (REB#: 2015-3716), and 
University of Alberta (Pro00061862). All participants signed informed consent prior to 
interviews. All participant information is kept in a secure location.  
 
2.11.3 Key informant interviews  
Between October 2015 and April 2016, interviews were conducted across Canada with 
Pharmacists (25), Family Physicians (9), and Patients (30). Observations were completed by the 
research team and participants were given the choice of where they would like the interview to 




2.11.4 Patient Interviews 
An ethnographic approach to data collection was used for interviews with patients. Demographic 
information was gathered, and the Agency for Healthcare Research and Quality’s Short 
Assessment of Health Literacy-English (SAHL-E) was administered. This was followed by a 
semi-structured interview, which was conducted by a member of the research team. Patients 
were given a list of Likert scale questions aimed at understanding their trust of their various 
healthcare providers (General Practitioners, Nurse Practitioners, Specialists, and Pharmacists). 
For data analysis, all audio recordings were transcribed and thematically coded. 
 
Assessing participants’ health literacy helped contextualize participants’ comfort with health 
information without relying on self-assessment. Health literacy assessment is well established, 
with many potential tools measuring print, oral, and online information-seeking, capacity for 
understanding health information, and both communicative and functional health literacy.193 
SAHL-E was chosen as it was free, and was quick and easy to administer.  
 
Interviews (Appendix E) were conducted according to a semi-structured interview schedule, 
which specified topics to be covered during each interview, with additional probing questions to 
elicit opinions regarding patients’ experiences in shared decision-making with their HCP, as well 
as insight into their thoughts about the potential benefits and risks of EHRs. Initial topics 
addressed included clinical experiences, factors influencing the decision to take, or not take, 
medication or treatment, the role of themselves or other people in that decision, who the people 
are who help them make decisions, and a request for recent examples of situations they deemed 
relevant. The structure of the listed initial questions was not rigidly followed, with participants 
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being invited to add any relevant examples, situations, thoughts, or opinions they had as the 
interview progressed. Throughout patient interviews, probing questions were added in order to 
glean insight into newly emerging themes, so they could be adequately addressed in subsequent 
interviews. At the end of the interviews, participants were invited to add anything they thought 
might be relevant, or to make a statement about what had previously been discussed.  
 
Interviews were conducted at the participant’s home, at the School of Pharmacy, or at a location 
of the participant’s choosing, one-on-one with the interviewer(s). Interviews were recorded using 
a digital recorder, and the duration of each interview was usually under one hour. Interviews 
were transcribed verbatim from the audio recordings, and after transcription was complete, 
transcripts were reviewed to ensure that complete participant anonymity was maintained.  
 
2.11.5 Pharmacist and Physician Interviews 
The research team used a purposive sampling approach to identify a broad spectrum of practice 
sites. Recruitment outreach was conducted using posters, social media, and snowball sampling 
from contacts of the researcher team. Pharmacists and family physicians practicing in Ontario, 
Alberta, Quebec, and Nova Scotia were all recruited using the same outreach methods. 
 
Interviews with HCPs consisted of two parts: (1) medication-focused decision-making, and (2) 
interviewees’ opinions of EHRs. HCPs were interviewed where they practiced, either in the 
pharmacy or the physician’s office. Interviews focused on how the pharmacist or physician 
presented information to patients, how collaboration was approached during care, specifically 
with relation to medication prescribing or problem solving, how they currently interact with 
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EHRs or EMRs used in their practice, and finally potential areas for developing new EHRs. The 
interview guide is available in Appendix C.  
 
Interviews were conducted in community pharmacies and primary care clinics, using the 
included provinces to represent different levels of primary care integration and adoption of 
electronic health records (See Table 4-1 in Chapter 4 for more details). 
2.11.6 Think-Aloud Protocol. 
Think-aloud, sometimes referred to as talk-aloud is a protocol where participants think aloud as 
they perform a specific task.194 As participants go about a task, they say whatever comes to mind 
including what they are looking at, completing, thinking, distracted by, and/or feeling.195 By 
verbalizing their task, with the ultimate goal of making the thought process as explicit as 
possible, the researcher is able to get insight into the participant’s full process, rather than only 
seeing the final outcome.194 Physicians and pharmacists were asked to complete this protocol as 
they completed a task related to medication management, which was audio-recorded, transcribed 
verbatim, and analysed with the semi-structured interview data.   
2.12 Scoping Review Methodology 
The breadth of information available on the inclusion of reason for use with a diagnosis 
intersects with many disciplines and spans across a number of emerging fields of research. 
Conducting a scoping review over a systematic review was chosen because scoping reviews do 
not assess the quality of existing literature, but rather are intended to identify gaps in current 
literature, and inform where more research may be necessary.196 To better understand the current 
scope of knowledge, a scoping review, following the methodology of Arksey and O’Malley and 
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Levac, Colquhoun, and O’Brien, was chosen as the way to best synthesize the available 
information.196,197  
 
Arksey and O’Malley recommend six stages, including the option of consultation, which was 
later described by Levac, Colquhoun, and O’Brien as essential to validate the findings. 196,197 
Stage one of a scoping review identifies the research question; stage two identifies relevant 
studies; stage three describes the process of study selection; stage four charts the data; stage five 
collates, summarizes, and reports the results.  
 
As the scoping review was conducted, the authors began to understand that it offered significant 
insights into the process of searching for information in a multidisciplinary paradigm. The 
challenges were not only in understanding the different terminologies, frameworks, and 
methodologies reflected in the searching but in building a narrative around how to communicate 
the value of the results within a discipline-specific focus. The methods used for this review are 
reflective of the potential for developing future methodologies for searching in multidisciplinary 
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Objectives: We know little about how electronic health records (EHRs) should be designed to 
help patients, pharmacists, and physicians participate in interprofessional shared decision-
making (IP-SDM) We used a qualitative approach to understand better how patients make 
decisions with their health care team and, how this information influences decision making about 
their medications, and finally how this process can be improved through the use of EHRs. 
  
Design: Participants from four regions across Canada took part in a semi-structured interview 
and completed a brief demographic survey. The interview transcripts were thematically analyzed 
using the Multidisciplinary Framework Method. 
 
Settings and Participants: 30 Participants aged 18 and older with at least one chronic illness were 
recruited from across Canada. We interviewed participants in their homes, at the School of 
Pharmacy, or another location of their choosing. 
 
Results: We identified four main themes: (1) Complexity of patient decision-making: who, 
where, what, when, why; (2) Relationships with Physicians and Pharmacists: Who do I trust for 
what?; (3) Accessing health information for decision making: How much and from where?; (4) 
Patients’ methods of managing information for health decision-making. Across the themes, 
participants appreciated expert advice from professionals and wanted to be informed about all 
options, despite concerns about limited knowledge. EHRs were perceived as a potential solution 




Conclusions: Patients make decisions with their healthcare providers as well as with family and 
friends. The pharmacist and physicians play different roles in helping patients make decisions. 
We found that making EHRs accessible not only to healthcare providers but also patients can 
provide a cohesive and clear context for making medication-related decisions. EHRs may 
facilitate clear communication, foster inter-professional understanding, and improve patient 
access to their health information. Future research should examine how to develop EHRs that are 
adaptive to user needs and desires.  
 
Key Points:  
Background: 
 This project was completed by a multi-disciplinary research team from across Canada 
that included engineers, clinicians, healthcare researchers, business and communication 
researchers, patients, and a patient navigator. Patient partners were involved throughout 
the research process.  
 To best navigate health decisions, patients need to be active participants in managing and 
understanding their health.  
 Weighing costs, benefits, preferences, and an abundance of information contribute to 
patients’ lack of confidence about making the ‘right’ decision, perpetuating a cycle of 
limited agency, and low adherence to treatment regimes.  




 For patients, the type and amount of information desired changes if a health situation is 




 Patients value their relationship with their physician more than their relationship with a 
pharmacist. Pharmacists are viewed as a reliable source of information whatever their 
relationship with the patient.  
 In addition to providing information for healthcare providers, EHRs should be accessible 
to patients and designed to help them navigate medication decision-making with their 




A good relationship between patients and their healthcare providers (HCPs) is essential for 
patient well-being. In the modern healthcare system, multi-setting electronic health records 
(EHRs), which refers to a digital version of a patients paper chart, available to authorized users, 
across multiple sites have emerged as a powerful tool to improve communication between HCPs 
and patients.54,198 Nevertheless, the challenge across North America has been to incorporate 
EHRs in patient-centered care at all touch points, including visits with the physician, pharmacist, 
and emergent care. There has been increasing evidence that EHRs can successfully improve care 
coordination by improving communication and collaboration among HCPs.199,200 However, it is 
still unknown how this can translate into both improved communication and collaboration among 
HCPs and improved communication and collaboration between HCPs teams and patients and 
their caregivers-families. While there is a strong awareness of what patient-centered care is, there 
is no standard approach to patient-centered communication and how EHRs can support it.201,202  
 
One patient-centered communication approach for medication decisions is shared decision-
making (SDM). SDM is defined as “an interpersonal, interdependent process in which the health 
care provider and the patient relate to and influence each other as they collaborate in making 
decisions about the patient’s health care.”203 While SDM supports patient-centered care, there is 
limited understanding of how to adapt EHRs to support SDM.  
 
Pharmacist involvement in SDM falls under the auspices of interprofessional shared decision-
making (IP-SDM)—an expansion of the physician-patient decision-making dyad. In IP-SDM, 
multiple HCPs and the patient contribute to the shared decision.97,204,205 IP-SDM is particularly 
complex when it involves pharmacists, who are not typically co-located with physicians and are 
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thus perceived to be outside the immediate circle of care.206 Electronic health records (EHRs) 
have the potential to provide a platform for improved communications and understanding 
between HCPs and patients, emphasizing the importance of information continuity in primary 
care, and ultimately facilitating IP-SDM related to medications or treatments.54,148,198 To 
accomplish this, EHRs must evolve from being a resource for HCPs to one that supports all 
members of the decision-making team.  
 
At present, research suggests that patients typically rely on the expertise of one trusted HCP to 
make important decisions, especially when the situation is emergent or ambiguous (e.g., having 
surgery or starting a new medication).207,208 For individuals living with chronic illness, those 
decisions are spread across multiple HCPs and time and are complicated by frequent diagnostic 
and monitoring tests, and complex treatment regimens.114,209,210 Thus, to design EHRs that can 
help patients navigate the spectrum of complex care decisions, we must have a clear 
understanding of the types of relationships patients have with different HCPs, and the types of 
information both patients and HCPs need to share decisions. 
3.3 Objectives 
Patients who have difficulty managing their care experience more preventable illness and 
suffering, suboptimal outcomes and can be more reluctant to participate actively in their care 
decisions.9,135 There is potential for both EHRs and IP-SDM to support patients, and medications 
can serve as an exemplar of that potential.120 Therefore we sought to describe patient 
perspectives on how people make medication decisions, what information is needed and desired 







We used a qualitative approach that included a short demographic survey, a one-hour semi-
structured interview and photographic field notes recording how participants currently organize 
their health information.186 This project was part of a larger mixed methods study to analyze the 
state of IP-SDM and EHRs among patients, primary care clinics, and pharmacies.147 This 
research received ethics approvals from the University of Waterloo, the University of Alberta, 
Wilfrid Laurier University, Université Laval, the University of Toronto, and Dalhousie 
University.  
 
Recruitment & Participants 
Participants were recruited from four Canadian provinces: Alberta, Ontario, Quebec, and Nova 
Scotia.1 We recruited a purposive sample of patients who were over age 18 and lived with at 
least one chronic illness. Participants were excluded if they were unable to speak English or 
French or unable to provide consent. We recruited through community-based advertising posters, 
online promotion in social media, and snowball sampling. Local and regional patient support 
groups were contacted to invite their members to participate.  
 
Data Collection 
                                                 
1 Alberta & Nova Scotia HCPs had access to EHRs at the time of the study. In Ontario, HCPs in some health regions 




Semi-structured 60 minute, in-person interviews were conducted and audio recorded by four 
trained members of the research team then transcribed verbatim. Interviews occurred where the 
participant felt most comfortable including their home, local university, or at another location of 
the participants choosing. All members conducted interviews in Ontario (KM, KG, JB, KW), 
with one research assistant conducting interviews in Nova Scotia (JB) and one research assistant 
conducting interviews in Quebec and Alberta (KW). French interviews were conducted by a 
bilingual member of the research team (KW) using a French version of the interview guide and 
were professionally translated.  
 
The core research team (KM, KG, CB, LG) developed the interview protocol using a reflective 
case study by Dogba et.al. on the emerging paradigm of IP-SDM.205 The interview protocol 
included open-ended questions and probes to help elaborate or clarify participants’ answers as 
necessary.  
 
Interviews gathered information on three areas (Appendix E): (1) how participants make 
decisions about medications (e.g. “What is the most important thing on your mind when you’re 
making the choice to take, or to not take that medication”), (2) how decisions are made with 
different professions (IP-SDM) (e.g. “Have you ever disagreed with your doctor about a 
suggested treatment?), and (3) participant understanding and perceptions of EHRs (e.g. Have you 
heard of electronic health records?). We recognized that most participants would have little to no 
familiarity with IP-SDM, so the interview protocol was designed to ask about elements of IP-
SDM. The interviews focused on patient perceptions of how they communicate and interact with 
HCPs involved in their care, from the initial interaction through to diagnosis and medication 
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prescribing, dispensing and refilling. Participants were asked to discuss their knowledge of 
health records and what potential they envision for EHRs. Field notes were taken during and 
after the interview to record the environment, external influencers, distractions, and photographs 
of how the medications were stored. 211,212 Participant data were anonymized in the transcripts. 
 
Data Analysis 
Data were stored and organized using NVIVO 11 software and analyzed using emergent 
coding.213 Analysis involved the entire multidisciplinary team, including engineers, clinicians, 
health researchers, business and communication researchers, patients, and a patient navigator. A 
modified version of the Multidisciplinary Framework Method was used 182 according to the 
following process: (1) interviews were transcribed verbatim; (2) the core research team read 
interview transcripts and listened to the recordings; (3) Two team members (KM, KW) initially 
thematically coded the data; (4) Together the research team (KM, KW, KG, CB, LG, JM, LG, 
FL, AM, JC, MD, LD) thematically coded two patient interviews which allowed us to expand the 
coding framework to include a multidisciplinary, patient engaged perspective; (5) These team 
codes were used to develop a working analytic framework; (6) two team members re-coded all 
data including patient interviews (KM, KW); (7) the coded data was returned to the team for 
discussion and refinement. Any disagreements were resolved through discussion. Collected field 
notes were not included in the thematic analysis, however, we did use field-note photographs to 





We conducted semi-structured interviews with 30 participants between 30 and 85 years of age 
(mean, 61 years), and 73% were women (Table 3-1). Participants had received a diagnosis of at 
least one chronic illness, including osteoporosis, hypertension, Crohn’s disease, and cancer. We 
identified forty participants, with seven being lost to follow-up and three withdrawals due to 
changes in illness status, resulting in 30 interviews. None currently or had previously worked in 
the healthcare system. Participants managed an average of four prescriptions (range: 2-13). Over 
the previous three months, participants averaged two visits to their family physician, three visits 
to a pharmacist, and two visits to a specialist.  
Table 3-1 - Participant Demographics 
Total participants in study 30 
 Average age 60.5 
 Gender  
 Male 8 
 Female 22 
Average number of self-reported chronic medical conditions 2 
Highest level of education attained  
 High school 6 
 College diploma 7 
 Bachelor’s degree 11 
 Master’s degree 4 
 PhD  2 
Average number of prescriptions medicines taken regularly 4.3 
Average number of supplements taken regularly 2.7 
Average number of visits to family physician in past 3 months 2.1 
Average number of visits to pharmacist in past 3 months 3.1 
Average number of visits to specialist physician in past 3 months 2.4 
Average number of different pharmacies visited in past 3 months 1.1 
 
Using multidisciplinary coding, the codes were arranged into four main themes: (1) Complexity 
of patient decision-making: who, where, what, when, why; (2) Relationships with physicians and 
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pharmacists: Who do I trust for what?; (3) Accessing health information for decision-making: 
How much and from where?; (4) Patients’ ways of managing information for health decision-
making. (Table 3-2). Ideas about EHRs and IP-SDM cross through all four themes.  
Table 3-2 Themes related to how patients make medication related decisions. 
Theme Description Relevance to EHRs 
 
Complexity of patient 
decision making: who, 
where, what, when, why  
The context significantly influences 
health decisions. Emergent situations 
are approached differently than 
chronic health conditions, and the 
different contexts includes past 
experiences, physical location, and 
availability of health information.  
EHRs can help people 
make decisions by 
providing access to their 
health information, and 
give an understanding of 





Pharmacists: Who do I 
trust for what? 
  
Patients describe how interactions 
with HCPs influence their health 
decisions. Participants described the 
nature of the relationship with 
different HCPs (physicians vs. 
pharmacist) and how this influences 
health decision making. Family, 
friends and HCPs all influence 




different people for 
different types of health 
information. Designing 
EHRs to account for 
different relationships 
influencing health 
decisions can allow for 
greater awareness of the 
different roles people 
play in decisions.  
 
Accessing health 
information for decision 
making: How much and 
from where? 
 
Even though there may be similarity 
in experience, patient diversity leads 
patients to feel hesitant about 
making decisions ‘out of their 
experience’. Patients require 
information to make health 
decisions, most of which is not 
easily available to them. The amount 
of information desired varies on a 
case-by-case basis, often dependent 
on if patient is in a crisis situation. 
Most critically, patients are often 
getting information outside of 
traditional contexts (i.e from a HCP) 
The amount of 
information a patient 
wants changes based on 
chronic and acute health 
situations. EHRs would 
benefit from being able 
to provide different 
amounts of information 






3.5.1 Complexity of patient decision-making: who, where, what, when, why 
The context in which a person arrives at a decision is impacted by the type of health decision 
they are making (e.g., emergent or ongoing), past experiences whether positive or negative, 
external (e.g., HCP, friend) and internal (e.g., family values, past experiences) influencers, and 
information patients can access (e.g., patient portals, HCP, personal documentation, online).  
 
“During an appointment [with my family physician] it's really hard [to 
decide about a medication]. I need time to think about it so I talk to my 
pharmacist, I go on the internet, I talk to friends, and I really check it out 
before I make a decision. I trust my doctor, but I still want to know more 
about the drug” Female, 77, 1016 
 
Previous experience with complications from treatments or errors in medications, even if a single 
instance, shapes how participants approach decision-making. These lived experiences did not 
have to pertain to the same medication, treatment, or decision process to influence the context in 
which participants make future decisions. 
 
which means that there is potential 
for misaligned information between 
patients and HCPs. 
 
Patient’s ways of 
managing information for 
health decision making  
Patients shared strategies on 
managing and sharing health 
information. Current EHRs did not 
appear to support required 
communication.  
 
Participants expressed a 
desire for EHRs to 
transmit health 
information between 
their various HCPs, 
lessening their perceived 





“For my complaint I had to order my own chart, and I was shocked to 
death. I found oh, three or four other errors. I lost trust in the system. I have 
to go be going by something life threatening or I won't go to a hospital, 
period.” Male, 54, 1021 
 
Participants noted that they negotiate interactions with their various HCPs differently and were 
influenced by HCPs, family, and peers in different ways depending on the acuity of the health 
issue. In crisis situations, participants expressed a desire for an expert (i.e., an oncologist for a 
new cancer diagnosis) to define treatment decisions and to not overwhelm them with too much 
information. In these cases, participants describe a mentality of immediate survival, rather than 
wanting to gather more information and discuss options.  
 
“It was mostly [the doctors] giving me information because when you are 
first diagnosed [with cancer], you are just blown away and you just want to 
start and do something and they are mainly giving me information and 
telling me how it's going to go.” Female, 57, 1004 
 
Despite an initial preference for an HCP to make a decision in an acute situation, as time passed 
and the health situation changed to chronic, participants shift their preference to start gathering 
information from other sources.  
 
“[Understanding medications post heart attack is] a learning process. I 
think any patient has to have a certain trust in the professionals. As the 
month's pass, you say, well wait a second now, is this necessary? Is there a 
supplement, a natural blood thinner that you could take rather than say, the 
rat poison they give you?” Male, 70, 1013 
 
For chronic conditions, participants rarely describe having made a decision about their health in 
one location or at one time. While participants had little experience with EHRs, they envisioned 
EHRs would help them make decisions by providing access to their health information, an 
 
56 
understanding of why their physicians make recommendations, and improved information flow 
between HCPs. 
 
“I'd like to see the data. For example, at least once a year, my annual, I'll 
go off and do blood work. All of the data that comes from that I'd love to see 
because I think it would help inform how I behave or how I think about 
myself.” Male, 63, 1030  
 
3.5.2 Relationships with Physicians and Pharmacists: Who do I trust for what? 
 
We observed that participant perceptions about how they interact with their HCPs significantly 
influenced their engagement in the decision-making processes. This includes how they describe 
how they negotiate the responsibility for making medication related decisions with their HCP, 
and the type of relationships the patients’ have with the physician and/or pharmacist.  
 
Participants aligned feeling comfortable with their family physician with the quality of care they 
received. 
 
“[With my family physician] generally it is the comfort from the initial 
meeting. If you are able to talk to each other and then they express a good 
competency of everything going on, then I make that good connection.” 
Male, 54, 1021 
 
When participants discussed what they like about their physician, and what made them trust the 
physician, they most often brought up how a physician learned about them, their family, and 
their values. Participants who perceived a physician’s lack of caring also had lower levels of trust 




“[My family physician] never asks about me. Never. You know, what was 
your job? How are you coping with the death of your husband? He had my 
husband as a patient too. What about your children? Nothing. He never asks 
me anything. As someone looking after my medication I trust him, but not as 
someone looking out for me” Female, 77, 1016 
 
Participants perceived that pharmacists influence decision-making in a way that was different 
from family physicians. For example, several participants reported having more trust in their 
pharmacist’s knowledge of drug information than in their physician’s knowledge. None of the 
participants felt it was necessary to have a relationship with a pharmacist to be able to access the 
pharmacists’ knowledge.  
 
“Pharmacists I tend to trust more than the doctor, as far as pills go. Now as 
far as giving me something for the heart attack, they're pretty well locked 
into [the prescription] ... Compared to my family physician, I would far 
more trust a pharmacist being aware of what drugs interact with what 
drugs.” Male, 70, 1013 
 
Most participants were not aware of any relationship between their pharmacist and their family 
physician. From the participant’s perspective, the only connection between the physician and the 
pharmacist is the patient and the prescription.  
 
“As individuals, I don’t think the pharmacist and doctor interact. What I 
have noticed with my doctor is, years ago, you would go into the office, 
they'd write out the prescription, they'd hand it to you. You had the 
responsibility of taking it to the pharmacist to fill it. That's the only 





3.5.3 Accessing health information for decision-making: How much and from where? 
 
Participants consistently reported that gathering information from others who had been through a 
similar experience helped to alleviate stress. Participants who were part of a cancer support 
group spoke at length about how they actively sought information about treatment and other 
options from their cancer support group, as did another who participated in a support group for 
people living with fibromyalgia. 
 
“I have some friends who are very interested in health. Some who are very 
interested in alternative medicine. I talk to them about my problem and 
come up with a decision that is based speaking to them, my physician, and 
online information. For better or worse.” Female, 69, 1006  
 
By comparison, another participant only wanted to know minimal information. Later, he 
discussed how he only spoke to his physician to get information.  
 
“I like the basic information and any potential side effects or harm that 
might cause or drug interactions. Other than that it gets almost confusing 
and complicated” Male, 54, 1021 
 
Participants expressed concern about how health information in an EHR, was interpreted by 
other patients. Although most participants expressed confidence in their own ability to 
understand health information, they were also concerned that other patients would be 
overwhelmed or not understand how to interpret health information.  
 
“I think if we're going to give access to patients, we have to educate them. 
They have to know what they're looking for. Normal is simple, what do we 
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do with abnormal? There has to be a lot of education around it.” Female, 
42, 1017 
 
While many of the participants stated they had heard of EHRs, the difference between EHRs and 
EMRs was not well understood.  
“All [my oncologist] had to do was put in an access number, go online and 
she had my whole history of tests and results and everything and whatever. I 
think I would like to have that access. If doctors know about it, why on earth 
shouldn't we, as the patients, get to know about it?” 
Female, Female, 74, 1003 
 
All of the participants interviewed identified a desire for an easier way to access health 
information, for both themselves and their HCPs. When prompted, participants thought EHRs 
had great potential.  
 
3.5.4 Patient’s methods of managing information for health decision-making 
 
Participants have diverse experiences of receiving information, searching for additional 
information, and understanding their HCPs opinions about what information was valued. 
Participants want information because, in most cases, they did not feel like an expert, and found 
it difficult to be confident in making correct decisions. As a way of coping with overwhelming 
information and concerns about incomplete health records, many participants developed 
independent ways of organizing their health information. 
 
“I have my own copies of everything. When I went to my breast cancer 
oncologist for the first time, I made a summary of all of my treatment, so 
that she could see exactly what I've been through. If I'm doing it myself, I 
 
60 
feel like I'm including all the important things that they need to know.” 
Female, 57, 1007 
 
How participants organize their health information changed depending on their priorities. One 
participant who had an emergent situation after a heart attack, spoke about keeping careful notes 
on their health interactions. Yet, during the home visit, all of their health and wellness objects 
(such as medications) randomly scattered in a drawer (Fig. 3-1). This speaks to the gaps in 
current tools available to assist patients and their caregivers with collection and management of 
health information. We keep isolated personal records of health interactions as there is no 
central, accessible digital record of care, and no reliable, affordable, universal system for 
managing in-home dispensing. 
 
Figure 3-1 - Medication organization 
Participants wanted access to EHRs to help transmit information among HCPs and to be aware 
of who had access to which information. In many examples, participants felt that transmission of 
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health information between HCPs was delayed and that they were the one responsible for 
communicating health information to ensure timely access. During the interviews, participants 
commonly describe a process of moving from the physician’s office to a pharmacy to their home 
or another social location and discussing options with different people in these places. 
Participants describe an ideal world where the EHR would move information between HCPs.  
 
“I would love to have access to my electronic health records because I know 
when I went to my osteoporosis specialist after I had cancer, I told her I had 
cancer. It was news to her and she wanted to find out what the results 
were.” Female, 74, 1003 
 
In our observations, patient-generated records included artifacts such as printouts of Wikipedia 
pages and medication information sheets from the pharmacy, typically organized into binders 




Figure 3-2 Health information binder 
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In many cases when we asked participants about what drugs they were taking, they showed us a 
printed list of medications from their pharmacist. Of note in provinces that had EHRs available 
to both the physician and pharmacist, participants still describe a lack of communication and 
understanding between their physicians and pharmacists. This list only provides basic 
information about a prescription – the date dispensed, how many refills, and the drug name and 
dose. Patient-generated notations can be problematic, as illustrated by Fig. 3-3 where a 
participant highlighted Tecta (a proton pump inhibitor for stomach acid) as medication for 
cholesterol, and hydromorphone (an opioid with some antitussive properties) as a treatment for 
phlegm.  
 
Figure 3-3 Pharmacy print out of medication list 
3.6 Discussion 
We examined patient perspectives on how they make medication decisions, what information is 
needed and desired, and the ways EHRs might support patients in shared medication decision-
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makings with HCPs. During the interviews, it became clear that even when participants were in a 
location that had EHRs, they did not have personal experiences with using or interacting with an 
EHR. This paper draws on participant perspectives on medication decision-making to provide 
insight into what should be included in the design of future EHRs so they and useful for SDM.  
 
We observed that medication decisions are complex and that, from the patients’ perspective, the 
decisions often occur without a formal connection between the physician and pharmacist. There 
are also two aspects to decision-making: (1) type of decision being made, and (2) sources of 
information. The decisions being made can range from ‘do I take a medication?’ to ‘who do I 
listen to?’ Our results show the potential that exploring including a platform for aggregating 
health information from traditional and non-traditional sources and thusly fostering a patient’s 
ability to work with different HCPs, EHRs can be used to foster IP-SDM.214 This study identifies 
1) what information patients are missing and (2) how EHRs could be designed as a mode of 
delivery for SDM tools and thusly improving patient information access. 
 
Research is emerging on how to best incorporate IP-SDM into EHRs.93,159,214,215 If information 
access is grounded in a single shared EHR, all who are involved in decision-making have a 
common platform to share information in a meaningful way. Lenert et al. have developed a 
model to incorporate SDM into EHRs.159 The model emphasizes that EHRs need to 
accommodate the preferences and communication styles of patients and HCPs as they relate to 
IP-SDM.93 However, this model needs to expand to include other HCPs, especially for patients 




When making a decision, the amount of information that our patient participants wanted varied 
based on the nature of the situation -emergent or chronic. Our research expands on the idea that 
patients are more involved in SDM when they are offered a choice rather than a 
recommendation.135,216 We also identified that patients can shift between preferring different 
decision styles depending on the circumstances. For example, participants who were in 
emergency health situations mentioned wanting to be told what to do. By comparison, once 
participants had lived with a chronic illness, they preferred to lead or share in decision-making 
rather than to receiving a recommendation. As such, the usefulness of an EHR for patients will 
likely also change over the course of an illness as well. 
 
Participants show diverse ways of organizing their health information independently of formal 
medical records. The concept of a patient maintained ‘shadow records’ highlights three aspects 
of how people use, organize, and create health information. First, it shows that the participants’ 
desire to have access to their own records motivates them to create their own information 
management systems. Second, there is a lack of awareness of how they can share this 
information with their HCPs. Third patients believe that information which may be valuable in 
decision-making is missing from their formal health record. Patient portals and personal health 
records have helped patients see what information their HCPs have access to, and what is 
missing from their record.217,218  
 
Relationships are also an important component of IP-SDM.219 Similar to other studies, we found 
that patients deeply value the relationship they have with their primary care physician but did 
find they may not see value in a comparable relationship with their pharmacist.220 Furthermore, it 
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was clear that participants were aware that their pharmacist and physician did not work together 
as a team. Thus, future EHR design needs to consider how to convey the role each HCP has 
played in a patient decision to start or modify treatment. By increasing transparency and 
providing a platform, EHRs have the potential to improve access to information for patients and 
HCPs.37,221 Understanding the complexities of the IP-SDM process shows the potential for to 
support patients in sharing medication related decisions. 
 
The main limitation of this study is that the national focus required the use of multiple 
interviewers. Despite training to ensure consistent approaches to participant interviews, 
unintended variance in interview style may have influenced participant response data. Further, 
the interviews were conducted prior to the launch of patient access to EHRs in two of the four 
provinces included in this study. As such, most interviewees did not have personal experience 
with an EHR. Those who were aware of EHRs, or identified as having used an EHR did not have 
substantial experiences interacting with them and were not aware of the full potential or purpose 
of them. This also meant that participants were not constrained by preconceptions of what an 
EHR looks like, leading many to describe a vision of an EHRs that was more consistent with 
their needs and desires. Finally, as with any qualitative study, the results should not be 
considered to be generalizable to all patients in all situations. Rather, the strength of our 
methodological approach was that it aimed to gather the perspectives of a diverse group of 
patients and to analyze the data with a multidisciplinary team. As such, our research provides 
insight into the design of EHRs that can support patients, physicians, and pharmacists in making 





We found that patients make decisions both with their HCPs and outside the healthcare setting 
with family and friends. We also identified that pharmacists and physicians have different roles 
in helping patients make decisions about medications. EHRs have the potential to facilitate clear 
communication, foster inter-professional understanding, and improve patient access to their 
health information. EHR designers need to account for these different types of users.  
 
Further qualitative research to understand the roles of other allied HCPs and caregivers. Future 
research examining how to develop EHRs that are adaptive to user needs and desires and that 
lower barriers to SDM can provide context for medication decision-making. 
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Background: Primary care needs to be patient-centred, integrated, and interprofessional to help 
patients with complex needs manage the burden of medication-related problems. Considering the 
growing problem of polypharmacy, there is increasing attention on how and when medication-
related decisions should be coordinated across multi-disciplinary care teams. Improved 
knowledge on how integrated electronic health records can support interprofessional shared 
decision-making for medication therapy management is necessary to continue to improve patient 
care. 
 
Objective: This objective of this study was to examine how physicians and pharmacists 
understand and communicate patient-focused medication information with each other and how 
this knowledge can influence the design of electronic health records.  
 
Methods: This study is part of a broader cross-Canada study between patients and health care 
providers around how medication-related decisions are made and communicated. We visited 
community pharmacies, team-based primary care clinics, and independent-practice family 
physician clinics throughout Ontario, Nova Scotia, Alberta, and Quebec. Research assistants 
conducted semi-structured interviews with physician and pharmacists. A modified version of the 
Multidisciplinary Framework Method was used to analyze the data. 
 
Results: Data was collected at 19 pharmacies and 9 medical clinics and we identified six main 
themes from 34 healthcare professionals. First, Interprofessional Shared Decision Making was 
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not occurring and clinicians made decision based on their understanding of the patient. 
Physicians and pharmacist reported indirect Communication, incomplete Information specifically 
missing insight into indication and adherence, and misaligned Processes of Care that were 
further compounded by electronic health records that are not designed to facilitate collaboration. 
Scope of Practice examined professional and workplace boundaries for pharmacists and 
physicians that were internally and externally imposed. Physicians decided on the degree of the 
Physician/Pharmacist Relationship, often predicated by co-location.  
Conclusion: When managing medications, there was limited communication and collaboration 
between primary care providers and pharmacists. Pharmacists were missing key information 
around reason for use, and physicians required accurate information around adherence. EHRs are 
a potential tool to help clinicians communicate information to resolve this issue. EHRs need to 
be designed to facilitate interprofessional medication management, so that pharmacists and 
physicians move beyond task-based work toward a collaborative approach. 
 
Acknowledgements: Our thanks go to Christian Chabot for his support and input throughout the 
project, and Jonathan Boersema for assisting with data collection. 
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In clinical settings, medication-related decisions are often passed verbally among patients, 
doctors, nurses and pharmacists, and the message can become distorted. Too often, however, 
critical information is not shared, even when an electronic health record (EHR) is used, and the 
decision to prescribe or not prescribe, to take or not take a medication is made with missing or 
distorted information.222–225 Health systems now promote an ethos of partnership, where 
providers and patients navigate complex relationships and interactions. The shift from a patient-
physician decision-making dyad, to a network of providers, introduces more complexity into 
what are often byzantine processes that precede health decisions. Nevertheless, patients often 
rely on a trusted HCP’s expertise to make important decisions where the situation is emergent or 
ambiguous (e.g., having surgery or starting a new medication).207,208 Research has not yet 
empirically characterized how current communication between healthcare practitioners affects 
care, and specifically how EHRs can strengthen communication by making information easier to 
access.198  
A medication decision involves at minimum a patient, a prescriber, and a pharmacist, and all 
parties are engaged in a process of shared decision making (SDM).226,227 SDM is based on a 
model of communication where healthcare professionals (HCP) and a patient both contribute to 
clinical decisions in unique ways. 210,228 The HCP shares information about the benefits and risks 
of different treatment options; the patient describes their preferences and values as they relate to 
their treatment options. Inter-professional shared decision-making (IP-SDM) involves multiple 
HCPs is emerging as a response to care increasingly being delivered by inter-professional teams 
to collaboratively work with a patient to decide on the best course of action.204 A systematic 
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review of the adoption of shared decision making by HCPs concluded that while it is unclear if 
interventions that promote the adoption of SDM are effective, interventions that target patients 
and HCPs simultaneously are more effective than ones that only target one group.55 The 
evolution of IP-SDM is challenging our beliefs about how and when HCPs actively 
communicate with each other and with patients, and the role of the EHRs may play in decision 
making.  
 
Adverse drug events (ADE) are one outcome of miscommunication in the medication 
management process. The costs of ADEs to the healthcare system are staggering, yet in one U.S. 
study physician reviewers determined that of the 30% of inpatients who experienced at ADE, 
44% were preventable. 229–231 While these medication-related problems are the symptom of a 
complex and disconnect healthcare system, the inclusion of pharmacists in the medication 
management has reduced the rates of ADEs as well as healthcare costs.232 ADEs account for 
somewhere between 1.4–15.4% of hospital admissions in the USA and Canada, accounting for 
an estimated 177,504 emergency department visits with U.S. patients 65 years and older, and 
increasing the mean length of hospital stay from 8 to 20 days.233–235 SDM is known to improve 
communication, lessen ADEs and overall lower healthcare costs.236,237 Through greater 
communication and collaboration between HCPs and patients, IP-SDM provides a platform that 
has significant potential to further lessen ADEs and continue to lower healthcare costs.144  
In most healthcare settings, pharmacists and physicians often do not communicate well because 
they largely work independently in parallel with each other, rather than collaboratively.238 There 
can as well be challenges in communication due to differences of opinion of role, reluctance to 
challenge, different work schedules, and different information priorities.239–241 For example, how 
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physicians and pharmacists communicate and make decisions with each other is based on 
perceptions about the role each one plays in a person’s care, and is tightly tied to ideas about 
pharmacists’ scope of practice. According to Nugus et al., there is a clear acknowledgement in 
healthcare that physicians are the ones with “formal responsibility for patient care” and that they 
are omnipresent in care. 72 As a result, EHRs may reflect the physician’s information or decision-
making needs more than the pharmacist or the patient. The challenge to designing 
multidisciplinary EHRs, is that they need to account for the workflow and communication 
models of different professions. It is important that physicians and pharmacists have strong 
communication because it is essential to go beyond transactional interactions to ensure optimal 
therapeutic outcomes of patients.242 This research is to better foundationally understand how 
pharmacists and physicians communicate, which can be used to lessen medication related errors, 
however healthcare costs, and design and improve EHRs that facilitate collaborate.  
This objective of this exploratory study is to examine how physicians and pharmacists 
understand and communicate patient-focused medication information with each other, and to 
identify barriers to IP-SDM for medication management that should inform designing EHRs that 
support IP-SDM. This research will allow for the design and refinement of EHRs that can be 
designed to facilitate better communication, improve medication management and ultimately 
contribute to improved care.  
4.3 Methods 
4.3.1 Research Design 
This research was part of a larger mixed methods study on shared decision making in the context 
of electronic health records that included observations, interviews, and think-alouds with 
patients, physicians in primary care, and pharmacists. This paper focuses on the qualitative, 
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semi-structured interviews with physician and pharmacists. We have taken a pragmatic stance, 
recognizing that a constructivist view of truth can be tempered with the need to conduct research 
that informs health care decision making.161 Our analysis was guided by a framework analysis 
method that provides both a systemic and flexible approach to multi-disciplinary data analysis.182  
 
We conducted interviews in community pharmacies and primary care clinics across Canada, 
using provinces to represent different levels of primary care integration and adoption of 
electronic health records (Table 4-1). This research received ethics approvals from the University 
of Waterloo, the University of Alberta, Wilfrid Laurier University, Université Laval, the 
University of Toronto, and Dalhousie University.  
Table 4-1 Description of in-place Electronic Health Records (EHRs) and Primary Care 
Models in Alberta, Ontario, Quebec, and Nova Scotia between December 2015 and October 
2016. 
 Alberta Nova Scotia Ontario Quebec 
Electronic Health 










Laboratory Values Yes Yes Yes Yes 
Medical imaging  Yes Yes Yes Yes 































Physician Access to 
EHR 
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Pharmacist Access to 
EHR 
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future) 



















*EHRs are region specific in Ontario; separated into 3 regions 
**Information collected in this table reflects healthcare at the time of the interviews and may 
have changed since. 
 
Recruitment & Participants 
The research team used a purposive sampling approach to identify a broad spectrum of practice 
sites. Recruitment was conducted through several venues including posters, social media, 
snowball sampling from previous and existing contacts of the researcher team. We included 
pharmacists and family physicians practicing in Ontario, Alberta, Quebec and Nova Scotia. 
 
Data Collection 
Three research assistants conducted and audio-recorded the interviews. One of the research 
assistants was a PhD candidate and experienced qualitative researcher (KM), and two were 
PharmD students (KW, JB). The three interviewers jointly conducted three interviews to train the 
student RAs in the semi-structured interview techniques, and they regularly met throughout the 
data collection period to compare interview notes and transcripts. All three interviewed 
participants in Ontario, with KW completing all of the interviews in Quebec and Alberta, and a 
JB completing all of the interviews in Nova Scotia. Field notes recorded during and after the 
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interview documented the environment, external influencers or distractions, and participant; 
specific questions were added to better understand the decision-making approach.  
 
Interviews with HCPs consisted of two parts: (1) medication-focused decision-making, and (2) 
interviewee’s opinion of EHRs. HCPs were interviewed where they practiced, either in the 
pharmacy or the physician’s office. Interviews focused on how the pharmacist or physician 
presented information to patients, how collaboration was approached during care, specifically 
with relation to medication prescribing or problem solving, and how they currently interact with 
EHR’s or Electronic Medical Records (EMR) used in their practice, and finally potential areas 
for developing new EHRs. The interview guide is available in Appendix C.  
 
Data Analysis 
We employed a modified version of the Multidisciplinary Framework Method to analyze the 
data.24 A multidisciplinary team, including engineers, clinicians, health researchers, business and 
communication researchers, patients and a patient navigator were involved with data analysis . 
The steps followed were: (1) interviews were transcribed verbatim; (2) core research team 
members read transcripts and listened to the audio recording to familiarize themselves with the 
interviews; (3) core team members thematically coded the data; (4) the entire team thematically 
coded a subset of five interviews; (5) the team codes were used to develop a working analytic 
framework; (6) two team members re-coded the data (KM, KW); and finally (7) the data were 
presented to the entire team for discussion and refinement. Data were stored, organized and 
reported using NVIVO 11 Software (QSR, 2016). Any names and identifiers were in made 
anonymous in the transcription process. Multiple triangulation of the data was achieved through 
 
76 
the use of a variety of geographic sources, multiple coders, and a multi-disciplinary team of 
researchers interpreting the results.169  
4.4 Results 
In total, we interviewed 21 pharmacists and 10 family physicians (Table 4-2). On average, the 
HCPs had been with their current clinic eight years, and had been practicing for 15 years. 
Compared to physicians, a larger sample of pharmacists was recruited to account for variability 
in practice setting including five pharmacists who worked in chain pharmacies, 12 in 
independently owned pharmacies, and four in team-based medical clinics. 
Table 4-2 Participant demographics collected at time of interview (n=34) 
 Family Physicians 
(N=9)** 
Pharmacists (N=25) 
Province   
Nova Scotia 0 4 
Quebec 2 2 
Ontario 6 15 
Alberta 1 4 
Total Participants 10 25 
 Team Environment 10 4 
 Independent Practice 0 21 
Years in Practice* 12.6 16.2 
Average time in current practice (years) 9.9 7.1 
Average Age (years)* 43.4  39.8  
 25-35 years old 2 7 
 36-45 years old 4 12 
 46-55 years old 2 4 
 55+ years old 1 2 
Gender 
 Male 4 11 
 Female 7 14 






Initial coding conducted by the core research team led to the identification of 46 codes, which 
were then developed into five themes describing the different elements of how pharmacists and 
physicians make medication decisions with patients: workflow, communication, accuracy, 
decision-making, and computer systems.  
 
As part of the multidisciplinary framework, we held a two-day research meeting where the entire 
multidisciplinary team participated in the analysis. Research group members came to the meeting 
having individually coded the same five interviews. Through a process of negotiation, individual 
codes were rearranged into 81 subthemes and six major themes as outlined below (Table 4-3). 
KM & KW re-coded the remaining interviews using the new framework with no additional 
themes arising. The new coding framework placed a more significant focus on how pharmacist-
physician relationships and scopes of practice affect medication decisions (Table 4-3). We found 
that decision-making was influenced by the information, processes, and communication factors 
related to EHRs, which in turn were influenced by the physician-pharmacist relationships and 
scopes of practice.  
Table 4-3 Themes related to inter-professional medication decision making between 
physicians and pharmacists 
Theme Subthemes Description 
Inter-professional Shared 
Decision Making 
 IP-SDM Intentions 
 Decision Point 
 Making the decision 
 Assumptions about 
patients 
 Patient communication 
 IP SDM 
 
Pharmacists and physicians did 
not describe IP-SDM in their 
practices, and acted as 
unintentional gatekeepers to 
medication information. 
Professionals make decisions 
based on their individual 
understanding of the patient’s 
situation and educate the patient 






 Reasons for HCPs to 
communicate with 
patients 
 Reasons for HCPs to 
communicate with 
each other 
 Flow of information 
 Communication work-
arounds 
 Method of 
communication 
 Availability 
 How to document in 
the medical or 
pharmacy chart 
 Risk communication 
 Patient as messenger 
Pharmacists and physicians 
often communicate with each 
indirectly through patients, 
faxes, or receptionists. Yet, both 
groups are cautious about the 
expansion of EHRs, and how 
EHRs influence ability to do 
their work.  
Information exchange 
between physicians and 
pharmacists 
 Important information 
for patient care 
 Information detectives 
 Data collection and 
entry 
 Multiple Users 
 Place of access 
 Context of data entry 
 Adherence 
 Information scarcity 
limits roles 
 Design features 
 Timeliness 
Pharmacists and physicians 
require information not 
accessible through current 
online health platforms to 
provide patient care. Even in 
situations where the information 
was available it was clear that 
relationships drove information 
sharing. Most critically, 
physicians required access to 
information about medication 
adherence while pharmacists 
require clear access to 
medications indication. 
Process of Care   System design (fill and 
bill) 
 Identifying patients in 
need of care 
 Stages of care 
 Technology limits 
practice 
 Decision making 
 Workarounds 
 Documentation of 
process 
 Workflow bottlenecks 
 Prioritization 
Pharmacists and physicians find 
that current systems do not 
typically align with their 
decision-making processes and 
do not support collaboration in 
daily workflow.  
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Scope of Practice   Responsibility to 
diagnose 





 Mentorship & role 
modeling 
 Monitoring 
The workplace and professional 
boundaries for pharmacists and 
physicians are both internally 
and externally imposed. This 
includes how each group 
negotiates the boundaries of 
their job, how each group 
negotiates their interactions 
with each other and with 
patients, and how relationships, 
or lack of relationships, impact 
their ability to carry out their 
roles and responsibilities. 
Physician/pharmacist 
relationship 
 Physical distance 
 Community vs. 
primary-care 
pharmacist 
 5Ws of shared 
understanding 
 Filling the 
gap/Tailoring 




Relationships were strongly 
influenced by physician 
location, nature of the task and 
a power imbalance.  
 
  
4.4.1 Inter-professional Decision Making 
In the interviews, we asked about how different treatment options were presented, how patients’ 
values were taken into account, and if the participant knew about IP-SDM. We observed that IP-
SDM was not an active part of the typical decision-making process. Rather, we identified a 
spectrum of decision-making, where the most common approaches to decision making included 
paternalism and informed decision making, as outlined below, rather than IP-SDM. 
 
In the paternalistic decisions that were both described and witnessed, the physician or pharmacist 
made a decision because they “assumed”, “understood”, or “knew” it was “best” and then they 
 
80 
“informed” the patient and what the patient should do. In other words, the physician or 
pharmacist “shared” their final decision rather than sharing the decision-making process: 
``I really do consider also the patient's preference or pre-knowledge or 
understanding. Have I considered all the factors; the patient factors, cost 
factors? That kind of thing I try to make it so it's sort of like rational 
prescribing, thinking is there a reason to give it to them?”  
Physician 1205, Family Health Team, Ontario 
 
During informed decision-making, pharmacists and physicians focus on educating patients well 
enough to allow the patient to make a decision. The goal is to offer recommendations, to help the 
patient understand why the HCP offered the recommendation, and to allow the patient to choose 
if they want to pursue the recommended course of action:  
 “I want them to make an informed decision. I want them to understand 
what's going on with their health. I want them to understand what the 
options are and why we're pursuing those options. I want them to make an 
informed decision about whether they want to move forward with a 
particular treatment course or not and understand the rationale for that.” 
Physician 1202, Family Health Team, Ontario 
 
One of the challenges of informed decision-making is the information will “scare” the patient. It 
is unrealistic for all patients to become as well educated as a HCP about a medical decision: 
“I don’t want to give more information than necessary, especially if I see 
that a patient is more anxious during the beginning of the counselling, and 
even more so if the patient doesn't want to take the medication or is scared 
to take the medication.”  
Pharmacist 1121, Quebec, Independent Pharmacy 
 
Pharmacists who worked in teams talked of making decisions with physicians rather than 
patients: 
 
It was last Wednesday, was the last day that I worked there, and it was more 
I help the physician choose the medication. Not so much the patient 
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themselves. It was a very complex case and the physician had asked me to 
meet with the patient first to do a medication review appointment.  
Pharmacists 1124 Family Health Team Ontario 
 
4.4.2 Communication between pharmacists and physicians 
Communication between pharmacists and physicians is heavily dependent on the fax machine. 
Unlike a phone, faxed documents provide a written record of an encounter. However, fax 
machines are not connected with pharmacist and physician information systems, reducing the 
efficiency of their use. 
“We almost prefer a fax than phone a physician. We phone if it's an 
immediate thing, but faxing gives us, again, the detailed paper, dated and 
detailed work that we can keep track of. That's what we try to do” 
Pharmacist 1109, Independent Clinic, Nova Scotia 
 
A common complaint amongst participants was that the standard processes to request 
information from another HCP are flawed. Pharmacists felt that they were limited by having to 
wait for a reply to a fax, and physicians had to wait until they had time where they could track 
down a pharmacist they trusted. The notion of a centralized way to communicate information 
was met with positive reactions. Being able to access key information without actively 
asynchronously communicating with another HCP was identified as a way to streamline the 
sharing of basic medical information (e.g., diagnosis, prescriptions, and lab results). 
Communication might then be around sharing meaningful information, such as patient histories 
or complex care regimens. Participants were concerned that information is not properly being 
communicated, and may be missing or incorrectly documented. Pharmacists reported rarely 
being able to get past gatekeepers such as office staff. 
 “There's the ward clerk who won't let you through to the doctor. It's really 
difficult to get a doctor on the phone unless if they're calling you”  
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Pharmacist 1102, Independent Pharmacy, Ontario. 
 
In instances where pharmacists are co-located with physicians, face-to-face interactions have the 
potential to foster the development of a trusted relationship. However, even when pharmacists 
and physicians are co-located, pharmacists still negotiate the power differential by modulating 
communication. 
“I don't go to a physician and say, ‘You must do this.’ I say, ‘This is the 
problem that this patient is having on these medications. Here are our 
options. The options are A, B, and C. I like A because this, this, and this. I 
like B because of this, this, and this. What do you think we should do?’ I 
never try and tell them what to do.” Pharmacist 1125, Family Health Team, 
Ontario 
 
4.4.3 Information exchange between pharmacists and physicians 
Pharmacists and physicians use different pieces of information to provide patient care. 
Physicians record diagnostic information, including physical evaluations and tests, while 
pharmacists keep detailed records of medications provided. Most community pharmacists 
interviewed did not have access to the reason a medication was prescribed, or diagnostic test 
and/or laboratory results. They assessed appropriateness and dispensed medications using the 
limited information contained on a prescription or patient recall. Additional or clarifying 
information needed to be requested from the physician. Even in situations where pharmacists had 
access to information through an EHR, issues relating to missing information, and the 
consequent need to contact a physician to gain access to it, were mentioned. 
 “Maybe there's some piece of information that we're missing and that's 
where you ask questions. If they're asking for refills too soon then it may be, 
‘Why are you needing this more than what has been prescribed? Are you 
taking more than what was on the instructions that we have? Has someone 
told you to take more?”  




Pharmacists often were missing information on the reason medications were prescribed. Not 
knowing why or how a prescriber decided on a medication not only limited their ability to 
properly educate patients about their medications, but also limited their ability to participate in 
decisions to start, change, or stop a medication.  
“I would just say that getting information on the indication would be one. 
Trying to find out what they're taking the medication for and what they're 
hoping it's going to do for them would be two of the first questions.”  
Pharmacist 1107, Nova Scotia, Independent Practice 
 
Physicians were also concerned that pharmacists do not have sufficient patient information to 
effectively prescribe, de-prescribe or assess a patient’s medications. Physicians were missing 
information about how a medication is taken after it was prescribed. Occasionally, there were 
plans in place to confirm prescription pick up and adherence, but the absence of adherence data 
was a clear gap in information. Both groups cited the benefit of an EHR being able to improve 
communication and improve patient care overall. 
“We've got a system [to help us keep track of] adherence. It's a really 
difficult point, and it's a really important point that I think we need to look 
because it's not good right now.”  
Physician 1201, Ontario, Family Health Team 
 
4.4.4 Process of Care  
Pharmacists and physicians have different processes for providing care, which are reflected in 
different information systems used in their daily workflow. Physicians use clinical data from 
physical assessment, lab values, and diagnostic imaging to make treatment decisions. Their 
office-based EMRs support documentation of their patient encounters, assessments of the 
information, and prescribing history. In community pharmacies, the pharmacy practice 
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management systems (PPMSs) support dispensing, and provide patient information sheets, 
auxiliary warning labels, warnings about adherence, and drug interaction alerts. Even in Alberta 
and Quebec, where there are province-wide EHRs that include lab values and dispensing 
information, the dispensing information is not integrated into the physician EMR and the clinical 
information is not incorporated into the pharmacist’s PPMS. 
“My goal is to get my EMR and the pharmacist's EMR exactly the same and 
up to date”  
Physician 1206, Family Health Team, Alberta 
 
The lack of overlap between physician and pharmacist information systems reinforces the siloed 
workflows of the two professions, and lack of interoperability between privately-owned 
electronic medical records. However, even when pharmacists and physicians work on the same 
system, it can be difficult to mesh the two decision-making processes. The resulting hybrid can 
be inefficient, requiring back-and-forth between the patient and different HCPs.  
“I made some recommendations to the physician and patient, which then the 
physician discussed with the patient in her appointment with the patient. We 
also discussed, the doctor and I, after, to confirm, yes, this is what we did, 
and just to follow-up on the whole discussion.”  
Pharmacist 1124, Family Health Team, Ontario 
 
Many participants lacked awareness of the decision-making processes of other HCPs, which left 
them guessing about why certain decisions were made. Guesswork thus becomes the de facto 
process, rather than an open and collaborative process. Finally, even though Alberta pharmacists 
are able to prescribe and use a provincial EHR used by physicians their experiences were 





4.4.5 Scope of Practice  
Scope of practice refers to the internal and external boundaries placed on pharmacists and 
physicians. In many provinces, the scope of pharmacist practice has expanded to include 
prescribing, which has traditionally been the physician’s role. This can result in role friction.  
It's been good, all the changes, for sure. [..]You just learn [which 
physicians] who you can do it with and who you can't, and then you go with 
that.  
Pharmacist 1114, Independent Pharmacy, Alberta  
 
In rural areas, pharmacists have more latitude to practice their full scope of practice as there are 
fewer options for care and they are more likely to know other local HCPs. Scarcity of services 
provides situations that encourage greater collaboration and partnerships due to availability as 
well as familiarity with colleagues.  
“There’s no full time physician in town… A lot of the local doctors are very 
open to our input and actually will seek it. Nearby doctors are a group who 
will cover for each other, and we know them”  
Pharmacist 1110, Independent Pharmacy, Nova Scotia  
 
Ideally, a team-based practice means that the different professions are more easily able to 
understand each other’s roles, including how one profession’s skills can complement another’s. 
Physicians generally did not consider pharmacists as partners in care, and rarely mentioned 
active collaboration.  
 
“Yeah. Things are good with my pharmacist and I. We're still trying to work 
on enhancing our relationship but definitely the trust exists there and then 
now it's just kind of more a matter of allowing some pharmacists to feel like 
they can do more.”  




 Even in cases where active collaboration was spoken of in a meaningful and positive way, it was 
still clear that there were underlying restrictions; for example, in the above quote while the 
physician spoke about collaboration, the comments qualified that only some pharmacists should 
be allowed to feel like they could do more. Similarly, the physician referred the pharmacist team 
member as “my pharmacist” creating in and out groups of pharmacists, and reinforcing 
traditional power archetypes.  
4.4.6 Relationships between pharmacists and physicians 
Physician-pharmacist relationships were often influenced by physical location and institutional 
context. When pharmacists and physicians were co-located, particularly when there is a common 
institutional governance such as a family health team in Ontario, they were able to share a 
common system of health records. The face-to-face interactions also allowed the pharmacists and 
physicians to establish personal relationships with each other. Building trusted relationships 
allowed for informal collaboration about patient care. Pharmacists often spoke of feeling like 
they an outsider to care or that they were “… not wanting to bother” the physicians (Pharmacist 
1107, 1108, 1109, 1121). The limited opportunity for face-to-face collaboration artificially 
restricted the pharmacist’s ability to support the patient.  
 
Pharmacists also often felt that they had to navigate the authority of physicians when assessing 
medication, and that, due to their perceived role in health, they were not able to influence care to 
the best of their abilities.  
“I notified a patient’s physician to a contraindicated drug given by a 
patient’s psychiatrist. The physician didn’t feel comfortable changing the 
drug, and the psychiatrist said, well, I'm not changing mine, I have him on 
what I want him to be on. The neurologist, I couldn't get in touch with him, 
and then the group home, they were almost a little bit, ‘we wish you hadn't 
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put your hands in the pot, there's too many people trying to mess things up’. 
It was really frustrating because there's this clear thing that could cause 
harm to the patient, and you almost felt like you were doing more harm than 
good by alerting everyone to it.”  
Pharmacist 1102, Independent Pharmacy, Ontario.  
 
Finally, it became clear through the interviews that pharmacists’ processes for working with 
physicians are not designed to facilitate collaboration. Rather, they may have evolved as work-
arounds that compensate for the strained relationship with the physician.  
“Most physicians do like subtle language of requesting as to, "Can you give 
me the thought behind prescribing this because we're just not sure, we want 
to make sure the patient understands it well or providing 
recommendations."  
Pharmacist 1116, Alberta, Chain Pharmacy 
 
4.5 Discussion 
This project examines how physicians and pharmacists communicate patient-focused medication 
information with each other to inform the designed for EHRs for IP-SDM. There is limited 
research on how EHRs currently impact IP-SDM, and the potential they have for improving 
collaboration. We can see that the limited communication between physicians and pharmacists, 
is strongly dependent on relationship. Sub-optimal management and use of medication is already 
well-documented, and suggests that we may not be optimally positioned to provide accessible, 
effective and affordable medication management as patient need rises over the coming decade.243 
Before pharmacists and physicians can share medication decisions with patients, they themselves 
need access to comprehensive information. Furthermore, they must be prepared to share 
information about decision making, and to develop strategies for inter-professional collaboration 
that do not rely on co-location or a common institutional electronic medical/health record. The 
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findings of this study point to a status quo where integrated provider medication management 
and IP-SDM is the exception rather than the rule in community settings. 
 
Workable solutions to how information is shared are both social and technical. Most electronic 
health information systems are capable of semantic interoperability, where a receiving 
information system is able to clearly interpret information in exactly the same way as the sending 
information system. Using vocabularies including RxNorm, and structured documents such as 
the CDA and FHIR® support interoperability.244 As beneficial as these may be competitive 
market forces the costs rarely support this option, despite its popularity amongst providers. 
Despite pharmacists having played an integral role in delivering high quality clinical care in 
hospitals for decades, this study highlights the slow progress towards integration and IP-SDM 
acceptance in the community. Our research supports the idea that social factors such as 
professional acceptance, institutional structures and trusted versus not-trusted relationships are 
significant barriers to the adoption of EHRs into the care patients rather than the technical 
challenges. 
 
Kannampalli, Schauer, Cohen and Patel note “complex systems can appear very different, 
depending on aspects, granularity, and circumstances that the researcher chooses to focus on.” 245 
By focusing on the relationship between physician and pharmacists in this study, we saw that 
each healthcare profession has access to critical information that the other profession does not 
(e.g., pharmacists do not have access to information about a medication’s reason for use, 
physicians do not have access to adherence information). These reasons relate both to inadequate 
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systems for health information exchange, as well missing professional standards that encourage 
comprehensive medication information exchange.  
 
Our findings on communication, information and process mirrored Bardet et al. meta-model on 
physician and community pharmacist collaboration.246 Bardet et. al. identified that early on in a 
collaboration, key elements include trustworthiness and clarity around roles. Physicians and 
pharmacists also need to develop an interdependence, and establish the interest, skills and 
positive perceptions, have clear expectations, and a relationship that is grounded in trust.247,248 
Open and bi-directional communication is also important.246 Our findings add to the work by 
Bardet et al. by highlighting how the disconnected computer systems and decisions processes 
limit collaboration between pharmacists and physicians. All participants were enthusiastic about 
the potential for provincial EHRs to improve information sharing and communication.12 A well-
designed EHR could also facilitate many of the components of a successful collaboration, 
specifically it has the potential to foster IP-SDM and level the playing field for understanding 
around information, process, and communication.  
 
According to a review of IP-SDM by Dogba et al, safe and high-quality healthcare depends on 
increased levels of collaboration among HCPs and better engagement with patients. 205 In our 
study, all participants voiced their support of IP-SDM in general. However, when it came time to 
give examples, only one physician was able to describe an instance of IP-SDM in practice, and 
no pharmacists or physicians were able to clearly articulate a shared a vision for IP-SDM. 
Moreover, participants had reservations about their patients’ abilities to make decisions. They 
referenced the notion that HCP training and experience enables them to know what is “best for 
 
90 
the patients”. Patel, Bakken, and Ruland refer to this as a “cautious willingness” to participate in 
IP-SDM due to fears over patient competence, motivations, and dishonesty about adherence. 249  
 
The notion of “cautious willingness” also applies to HCP collaboration. 250 Physicians are 
cautious about giving up a perceived ownership of a patient’s care, and pharmacists are equally 
cautious about making physicians feel like they are trying to take over care. The reluctance of 
pharmacists to embrace a full scope of practice also reflects serious concerns about missing 
information. In the interviews, it was clear that pharmacists perceive themselves as the last 
gatekeeper of a patient’s wellbeing, yet are unable to perform that function. 
 
Elwyn et al. noted that HCPs often miss the second half of a consultation, where IP-SDM 
occurs.251 We would argue that the second half of the medication-related consultation is where 
IP-SDM and the pharmacist belong. Physicians have the unique expertise to focus on the 
diagnoses in the first half of the consultation. Pharmacists, however, have the expertise required 
to help the patients understand and choose a treatment option that is consistent with their needs 
and preferences. However, pharmacists cannot act until they have access to the right information 
at the right time, and have a bi-directional communication with the physician. Ultimately 
research should evaluate the link between all interactions in the healthcare process that impact 
patient and clinician decision making.  
 
4.6 Strengths and Limitations 
As part of a larger mixed methods study, the insights presented here are derived solely from 
interviews of pharmacists and physicians. Although these analyses reveal perceptions about and 
 
91 
barriers to IP-SDM and collaboration, they do not reflect a complete analysis of all data 
collected, specifically the data collected from patients. However, in the context of building a 
deep understanding of physician-pharmacist communications and relationships, this analysis is a 
critical step in building a holistic model of IP-SDM related to medication management. In 
addition, while the sample includes pharmacists across all four provinces, recruitment challenges 
limited the participation of physicians in each of the four provinces, especially in Nova Scotia. 
Given the similarities in policies and practice between Canadian provinces and the inclusion of a 
variety of physician perspectives we believe this has had little to no impact on our results. 
Finally, differences in interviewers’ approaches to semi-structured interviews may have led to 
differing emphasis on IP-SDM and collaboration. While the benefits of a multidisciplinary 
research team is stronger objectivity stemming from a variety of research, professional, and 
patient backgrounds, this study might have been strengthened if the research team had employed 
prolonged engagement. While important, due to interview time constraints, we did not explore 
physicians’ perceptions of pharmacists prescribing, adapting, or cancelling medications; the 
influence of these perceptions is suggested for future research. 
4.7 Conclusion 
Our study shows that until pharmacists can see the reason a medication is prescribed and 
physicians can gain insight into adherence, neither group will be fully able to work together to 
make medication decisions collaboratively. The major barriers to collaboration include poor 
communication systems with minimal inter-institutional information exchange, and even when 
an EHR exists there are most often competing decision-making processes. We identified the 
potential to build EHRs that not only better facilitate access to information, but also allow for 
processes that better accommodate collaborative care, and enable better understanding of the 
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pharmacist’s scope of practice. Future research should focus on alignment of EHRs with the 
inter-professional decision making process, that can foster both intra- and inter-institutional 





“My Pharmacist”: Creating and Maintaining Relationship between 
Physicians and Pharmacists in Primary Care Settings. 






This paper examines how pharmacists and primary care physicians communicate with each 
other, specifically when there is or is not an established relationship.  
 
Methods 
Analyzing data from semi-structured interviews with nine primary care physicians and 25 
pharmacists, we examined how pharmacists and physicians talk about their roles and 
responsibilities in primary care and how they build relationships with each other.  
 
Results 
We found that both groups of professionals communicated with each other in relation to the 
perceived scope of their practice and roles. Trust and collaboration was perceived to be driven by 
a healthcare professional’s confidence in another specific healthcare professional (i.e., an 
individual, not a profession). Physicians and pharmacists both described communication and 
trust as being closely tied with having a prior relationship. Pharmacists were also responsible for 
initiating the relationship as they relied on it more than the physicians. The presence or absence 
of a personal connection dramatically impacts how comfortable healthcare professionals are with 
collaboration around care. 
 
Conclusion 
The findings support and extend the existing literature on pharmacist-physician collaboration, as 
it relates to trust, relationship, and role. The importance of strong communication is noted, as is 
the necessity of improving ways to build relationships to ensure strong interprofessional 
collaboration.  
 




Communication between healthcare professionals on a healthcare team is foundational to patient 
care; however, often the only communication occurring is through fax, or other non-collaborative 
tools. Physician and pharmacists share a similar training history, as well as shared values and 
norms, but each profession has unique sub-cultures and characteristics.238,252 There is strong 
research on the benefits of pharmacist-physician collaboration, such as enhanced quality of care, 
increased patient engagement, improved patient safety, as well as staff satisfaction and retention, 
and greater staff perceptions of empowerment and recognition all of which fall under the practice 
of interprofessional collaboration.58,253–255 Strong working relationships between physicians and 
pharmacists are foundational to providing good patient care.239,256,257 The implication of robust 
communication between physicians and pharmacists is an important foundation upon which to 
base interprofessional trust.  
 
The ways in which pharmacist-physician relationships influence communication have not been 
widely explored. Existing research emphasizes the community pharmacist’s roles of drug 
dispensing, medication therapy management, chronic disease management, and patient 
education.258,259 The degree of collaboration between individual physicians and pharmacists 
varies greatly, and is dependent on a number of influential factors such as shared values, 
relationships, role definition, and trust.253,260 For patients, an effective collaboration by their 
healthcare team can lead to improved coordination with healthcare professionals (HCPs), 
increased opportunity to participate in decision-making, improved satisfaction and better use of 
resources.77,210,247,261 Challenges to collaboration are the lack of compensation for teamwork, 
limited time, and the necessity to coordinate care across many different practitioners.252  
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Traditionally, community pharmacists and physicians have worked in separate locations with 
little face-to-face contact. Team-based primary care, also known as the medical home or family 
health team, is one of the models for providing more integrated community health care, where 
the physician works in a co-located setting with other HCPs such as nurse practitioners, nurses, 
and pharmacists.262 Notably, the pharmacist role is not typically affiliated with a separate drug 
dispensary. These expanded roles for pharmacists improve patient outcomes and reduce 
healthcare spending.263,264 As new models emerge, more research is needed to understand the 
influence of co-location on collaboration.  
 
Our paper begins to address the gap in understanding of how pharmacists and physicians 
describe their relationships, both in team-based and traditional settings. Analyzing qualitative 
semi-structured interviews with 9 physicians and 25 pharmacists who are and are not co-located, 
we examined (a) how and when physicians and pharmacists communicate, (b) how and if 
pharmacists and physicians discuss personal relationships, (c) what are the barriers to 
communication between them, and (d) how and if co-location changes their relationship.  
5.3 Methods 
5.3.1 Study Design 
This research is based on thematic qualitative analysis of semi-structured interviews. The 
investigators were gathering the subjective experiences of pharmacists and physicians to better 
understand the meaning they attach to their experiences interacting with each other. This paper is 
part of a larger study of how physicians, pharmacists, and patients understand and communicate 
patient-focused medication information to each other.90,147 We chose a qualitative Focused 
Ethnographic approach to capture experiences in the socio-cultural context in which participants 
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interact with each other.265 Focused ethnography is an evolving method used primarily in 
practice-based disciplines to, as Hall describes, “…capture specific cultural perspectives and to 
make practical use of that understanding.”266 Focused ethnography most commonly uses 
purposive sampling techniques and allows for a holistic exploration of a research question that 
may adapt as the research occurs.265  
 
Ethics approval was received from the University of Waterloo, University of Alberta, Wilfrid 
Laurier University, Université Laval, University of Toronto, and Dalhousie University. A 
qualitative methodological approach of semi-structured interviews, talk-alouds, and observations 
was carried out with nine primary care physicians (PCP) and 25 pharmacists across Canada, 
allowing for open sharing of views on how medication-related decisions are made and 
communicated both across professions and to patients.  
5.3.2 Participants & data collection 
Recruitment was conducted through advertisement in public venues (e.g., libraries, community 
centers) and posting on social media sites (Facebook, Twitter), and through snowball sampling 
from previous and existing contacts of the research team, professional outreach, and suggestions 
from participants resulting in a convenience sample. Participants were included if they were: (1) 
a licensed and practicing pharmacist or physician; (2) spoke English or French; (3) lived and 
worked in Nova Scotia, Quebec, Ontario, or Alberta. Participants were recruited to include a 
range of perspectives, experiences, years of practice, and geographical location, with our sample 
providing a good balance of team and independence practice pharmacists and physicians (Table 
5-1). Identified participants fell into two categories (1) team-based, where pharmacists and 
physicians were co-located and practicing together; (2) independent practice, which may include 
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both clinics as well as corporate practices, where they were not co-located but may work closely 
depending on environmental factors including size of community and established working 
relationships. Participants were diverse and included different years in practice, age, and gender. 
All participants were provided with a letter of information and gave their consent to voluntarily 
take part in the study. 
 
In total, three research assistants conducted and audio recorded the interviews. Initial interviews 
were jointly conducted to train student research assistants in semi-structured interviewing 
techniques, and regular meetings were scheduled to compare notes, go over interviews and 
discuss emerging results. Field notes were recorded during and after the interviews. 
5.3.3 Data Analysis 
Although the interviews primarily explored how physicians and pharmacists make medication 
related decisions, insights into how relationships influence the ways in which physicians and 
pharmacists communicate emerged. Analysis was largely inductive, and used a modified form of 
constant comparative analysis the data was analyzed until theoretical saturation was reached. 
162,185,191 The majority of the analysis came from the interview transcripts with some 
triangulation coming from talk-alouds, observations, and field notes. Initially the coding was 
done in two parts – first with a small group analyzing the interviews using “free” unstructured 
coding and largely descriptive codes, and then, during a two-day meeting, the Framework 
Method was used to bring together the larger research team comprised of engineers (2), 
clinicians (3), healthcare researchers (5), business and communication researcher (1), patients 
(2), and a patient navigator (2) to develop the codes used for the analysis of the two prior 
papers.182,189 From the initial analysis two papers emerged, one about patient medication 
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decision-making, and another on pharmacists and physician decision-making.147 After these two 
papers were completed, the authors determined the value of further analyzing the interviews to 
specifically. Initial re-analysis of the data was completed by KM, who listened again to the 
interviews, coded the data, and defined preliminary themes. Next the authors completed a 
secondary analysis of the collected interview data (KM, LG, KG), who participated in all phases 
of the original coding and analysis, and one member who was brought in as a final coder (EN). 
Data were stored, organized, and reported using QSR NVIVO 11 Software (QSR International 
Pty Ltd. Version 11, 2017).  
 
In what follows, we examine the process of how personal relationships between pharmacists and 
physicians impact how they discuss collaboration and professional interaction. Comparing the 
accounts of physicians, and pharmacists allows us to explore the interactions, what was and was 
not said, and how each professional understands the role of the other. Multiple triangulation of 
the data was achieved through a multi-disciplinary team of researchers interpreting the results, 
multiple coders, and by conducting interviews across Canada in a variety of different settings.169 
5.4 Results 
In total, 34 semi-structured interviews were conducted with physicians and pharmacists across 
Canada using an interview guide (see Appendix C). The interviews were conducted at a place of 
the participants choosing, most commonly their place of work, and took between 30 minutes and 
one hour to complete, depending on participant availability. Table 5-1 summarizes individual 
and contextual characteristics of pharmacists and physicians obtained from the demographic 
survey. The participants represented both urban and rural environments from across Canada, 




Table 5-1 Participant demographics collected at the time of interview (n=34)147 
 Family Physicians 
(N=9) 
Pharmacists (N=25) 
Total Participants 9 25 
 Team Environment 5 4 
 Independent Practice 4 21 
Urban  9 18 
Rural 0 7 
Years in Practice 12.6 16.2 
Average time in current practice (years) 9.9 7.1 
Average Age (years) 43.4  39.8  
 25-35 years old 2 7 
 36-45 years old 4 12 
 46-55 years old 2 4 
 55+ years old 1 2 
Gender 
 Male 4 11 
 Female 5 14 
 
The results of this secondary analysis are presented in this paper. The secondary analysis resulted 
in three new thematic areas, different from the original paper focused on understanding how 
relationships and collaborations are discussed.147 “My pharmacist” examines when physicians 
discuss different ways they communicate with pharmacists they know, or provided specific 
examples of when they sought out a pharmacist with whom they had a relationship. “Can’t get 
through to them” gives data on barriers discussed by pharmacists, namely the different 
perceptions of gatekeepers and modes of easy communication. Finally, “It took a little bit of 
time” discusses when relationships have been built, positively or negatively, and how this shapes 
collaboration and interactions. 
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5.4.1 “My pharmacist” 
During the interviews, physicians and pharmacists were asked how and when they 
communicated with each other. All physician respondents spoke about pharmacists affirmatively, 
but there was a marked difference in how physicians spoke about their communication with 
pharmacists in general and those with whom they have a confident working relationship or 
worked with as part of a team. The participating physicians attributed positive relationships with 
pharmacists to being located close by, or to co-location as part of a team based clinic, and 
separated pharmacists they knew from pharmacists they did not know: 
“I called the pharmacy because I wasn’t sure how to prescribe some 
medication… In fact, a pharmacist answered and I asked if [D] was there 
because I know him, and I spoke to him.” [Physician 1201, Team 
Environment, Ontario] 
 
When responding to an interview question about what sort of interactions the physician has with 
pharmacists, Physician 1207 stated, “That’s our pharmacist.” During Physician 1205’s 
interview when discussing if they worked together with pharmacists in patient care, 1205 replied 
that “… Individuals that I feel could benefit from a med reconciliation, I would refer them to B, 
my pharmacist.” Physicians who spoke about ‘their’ pharmacist in this way of ‘knowing them,’ 
thusly identified their pharmacist as smart and reliable.  
 
For physicians who did not work in the same building, or very close to pharmacists, the level of 
collaboration was markedly different.  
“My patients all have different pharmacies… I rarely speak to the same 
pharmacists on a monthly basis, or a regular basis. It is not really a 
constant team work but rather sporadic interactions... We don’t have direct 





Physician 1209 specifically mentioned that they do not want to ‘waste’ time establishing the 
basics of a relationship when they do not know if they will ever speak to that pharmacist again.  
In contrast, when physicians mentioned having a specific pharmacist they talk to, they often 
described having trust or confidence in the pharmacist: 
“With the pharmacist we have in our department, for sure, we are very 
spoiled… I have complete confidence in her skills… So, with my pharmacist, 
everything works very well. And I have no problem with her making 
suggestions.” [Physician 1210, Team Environment, Quebec]  
 
Comparatively, the quote below demonstrates the other way of discussing interactions with 
pharmacists, more common to physicians not actively working in collaborative environments.  
“I would message the front and ask them to call the pharmacy and 
confirm… unless there’s a bigger concern I’m happy for the secretaries to 
do it.” [Physician 1203, Team Environment, Ontario] 
 
For physicians who do wish to develop a relationship with a pharmacist, the evolving corporate 
model of pharmacy can be a barrier to relationship building: 
[I know pharmacists at] maybe a half dozen pharmacies. For the other 28, I 
don’t know who I’m speaking to… [Pharmacist] is like the old-time, 
country, family pharmacists. He knows his patients, and he’s there all the 
time. [Pharmacists at big chains] they just come and go, and you never 
know who’s there next. They don’t know the patients… it’s challenging. 
[Physician 1201, Team Environment, Ontario] 
 
The above physician demonstrates their perception of the difference between pharmacists they 
know and feel comfortable with versus ones they do not know. The idea that the unknown 
pharmacist would also not know the shared patient is key to understanding the difficulties in 
building trust without proper communication. As this physician pointed out, his trust in the 
pharmacist relies on the patient being familiar to the pharmacist. Physician 1205 noted that they 
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appreciated the respectfulness of the pharmacist they work with most often, and was clear that 
part of that respect included the physician having the final say: 
“I found [B] to be extremely respectful, and oftentimes like I said at this 
stage we’re still in the “These are my suggestions,” and I still have the okay 
or not okay” [Physician 1205, Team Environment, Ontario] 
 
This physician’s sense of it being unimportant for them to have an interaction with an unknown 
pharmacist to clarify information directly contradicts Physician 1201, who feels ‘spoiled’ to have 
full confidence in their pharmacist’s skills.  
As a counter to physicians who most often could identify a single pharmacist, the pharmacists 
who are not co-located and by necessity interact with a wider group of physicians as such have to 
navigate unfamiliar physicians as part of their profession. Instead of saying my physician, they 
used phrases such as the doctor, a physician, or our clinic. The difference in the language used to 
describe relationships between physicians and pharmacists also comes through in how both 
pharmacists and physicians discuss interprofessional communication.  
5.4.2  “Can’t get through to them” 
Pharmacists identified that they can be more effective when they have a strong relationship with 
the physician. However, it was very challenging for pharmacists to initiate a relationship with a 
physician. Gatekeepers, often reception staff or nurses, were mentioned as barriers to direct 
communication with physicians, especially in independent pharmacy settings: 
“[Family Doctors], you can’t get through to them. There’s the ward clerk 
who won’t let you through to the doctor. It’s really difficult to get the doctor 
on the phone unless they’re calling you.” [Pharmacist 1102, Independent 




This said, even in situations where there was a dedicated phone line, there were still barriers to 
collaboration:  
“Either it’ll be the secretary running back and forth between me and the 
doctor, if they say that the doctor can’t come to the phone. In that case, 
they’ll just ask me to fax it.” [Pharmacist 1105, Independent Practice, 
Ontario] 
 
The exception was in rural practice, where pharmacists were more likely to meet physicians 
through small social networks, because there were fewer providers in town, or because the clinic 
and pharmacy were closer together. During the interviews, it became clear that co-location 
allows for the same type of informal networking and rapport building as rural environments. 
Pharmacists who identified relationships with specific physicians outside of a co-located 
environment were more likely to mention the ability to call a physician to discuss a patient:  
“If it's urgent, I will call them. I have most of the local doctor's cell phone 
numbers. If I need to get a hold of them, I will get a hold of them.” 
[Pharmacist, 1101, Independent Practice, Ontario] 
 
This pharmacist goes on later to discuss how having a relationship with a physician eases the 
process of communication: “I have an arrangement with the doc to just call him if there’s a 
major issue and we fix it now.” 
In contrast, every physician mentioned it was easy to contact a pharmacist if needed:  
“If the patient’s in the office, I will call the pharmacist right then and 
there… I will talk to the pharmacist and we’ll try and resolve it.” [Physician 
1206, Team Environment, Alberta]  
 
Most physicians interviewed agreed with the pharmacists that fax as the easiest way to 
communicate. While the pharmacists saw fax as a way to have a record of the conversation, less 
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intrusive, or as an easier mode of communication for the physician, physicians said that they 
preferred fax as a way to align patient care, rather than to seek out clarifications or collaborate.  
“I'll usually do a fax just because I feel like it's less intrusive, and so they 
can potentially get back to me quicker without having to call, but if it's 
something that I really want to know, then I might do both.” [Pharmacist 
1107, Independent Practice, Nova Scotia] 
  
The lack of easy communication outside of co-location settings was an issue for both physicians 
and pharmacists. Physician 1201 ended their comment by stating that having direct conversations 
with pharmacists would be more productive than “…waiting for this stuff to sort itself out.” 
Physicians in team-based environments described stronger relationships with community 
pharmacists who were not co-located, suggesting when physicians work closely with pharmacists 
they gain a better understanding of the role pharmacists have in health: 
“We know most of our pharmacists that are in the neighbourhood and we 
have a good rapport with them, and we can phone them up, we’ve met them. 
We talk to them because they’re physically within walking distance” 
[Physician 1208, Team Environment, Ontario] 
  
Having a good rapport with pharmacists based on physical walking distance also implies that the 
physician has a strong community focus and that the physician and pharmacist are working 
together to support patients, the community, and each other.  
5.4.3  “It took a little bit of time” 
As the team-based model grows in popularity and is increasingly seen as an ideal way to care for 
patients, there was a general feeling that collaborating with known colleagues was preferred, 
though it takes time to develop the relationship. 
“It took a little bit of time for the doctors to feel comfortable with me, to be 





Pharmacists noted a stronger sense of agency when working in co-located environments, feeling 
more positive about the overall influence they have over care. Developing relationships between 
practitioners was built around an awareness of role and ability.  
“I was the only pharmacist here so I had to essentially develop my own role, 
which is great because I had a lot of autonomy. It was also challenging too 
because the role was new and [the physicians] didn’t necessarily know how 
to utilize the pharmacist role in a family health team.” [Pharmacist 1118, 
Team Environment, Ontario] 
 
But over time, the pharmacists became a central part of the team, relied upon in the daily 
workflow.  
“I work with a team of family physicians. We are about 24 physicians. We 
have a pharmacist. If ever [the pharmacist] is not there because there is a 
day of the week she is not, then at that moment, if it isn’t urgent, I’ll wait 
until she is back at work the next day.” [Physician 1210, Team 
Environment, Quebec]  
 
Negotiating boundaries around care and role can be difficult. When pharmacists have not worked 
in collaborative partnerships, even in team-based clinics, they identified difficulty articulating 
the boundaries of their role and emphasized they only asserted themselves with physicians they 
knew,  
“[Giving recommendations] is not so much with physicians outside of the 
clinic where I work. It’s specifically with the ones I collaborate with at the 
community health center clinic.” [Pharmacist 1124, Team Environment, 
Ontario] 
 
When relationship building has been successful, the benefit of casual interactions becomes 
apparent. During Pharmacist 1118’s workflow talk-aloud, the process was interrupted by a 
physician interrupting the think-aloud to say hello, seeing if the pharmacist was available to talk 
about shared patients. 
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“Physician: I just wanted to poke in and say Hi, but I will let you guys do 
your thing. 
Pharmacist 1118: Yeah, no problem 
Physician: [After you’re done] we can go over to the café and maybe get 
some tea or coffee or something.” 
 
These informal interactions are only possible when there is a personal relationship between 
practitioners. Later in the think-aloud Pharmacist 1118 discussed how personal relationships 
positively influence their ability to do their jobs “Again, because I work so closely with the 
doctors here, I can just send them a message saying, "Hey, can you do this blood work for me?"” 
Interestingly, this played out in Pharmacist 1118’s perception of the expanded scope of practice 
as well:  
“I don't really need to practice under the expanded scope because I have 
such a good relationship and such close contact that I don't necessarily 
need to write a prescription or extend a prescription because I can just say, 
"Hey, can you just do that for me?"” .” [Pharmacist 1118, Team 
Environment, Ontario] 
 
Physicians who did not work directly with pharmacists in co-located settings discussed that 
while they did interact with pharmacists, in most cases those interactions were limited to 
clarifications. The noted examples of collaboration between physicians and pharmacists only 
occurred in situations when there was an established relationship where they either knew each 
other personally or worked together in a collaborative health environment.  
5.5 Discussion 
The original purpose of gathering this data used for this analysis was to better understand the 
decision-making process by physicians and pharmacists.147 Our analysis identified that co-
location allows relationship building through familiarity and ease of access, both of which allow 
the pharmacist to demonstrate their expertise. This qualitative exploration of how relationships, 
 
108 
trust, and communication are discussed often included mentions and clarifications of role, which 
is reflective from past research into interprofessional collaboration and provides opportunity for 
future study.252,267 
 
During early analysis it emerged that as decisions were being made the influence of personal 
relationships between physicians and pharmacists was present as a factor even when the intent of 
the interviews was not to investigate these relationships explicitly. The question arose about how 
this perception of relationship influences how and when collaboration occurs.  
 
While this study did not measure trust, it is an established factor in building collaborative 
relationships.268 Pharmacists who have built established relationships with physicians have more 
opportunities to demonstrate their clinical knowledge, which allows physicians to develop trust 
in their abilities, as well as gaining a better understanding of a pharmacist’s scope of 
practice.267,269 As trust builds, our research agrees with what Zillich et al. discussed as being 
influential to collaborative relationships: when pharmacists gain confidence to assert themselves 
as true collaborators in care, there is a better understanding the pharmacist’s scope of practice, 
and physicians are more likely to initiate interactions and seek out pharmacist expertise.269  
 
Closely linked to ideas around trust are perceptions of role boundaries, and ideas of who is the 
ultimate authority on care. Brock et.al discuss how collaboration between pharmacists and 
physicians is influenced by what types of exchange occurs between them.268 The pharmacists and 
physicians in this study often identify their role, or their scope of practice, both real and how it is 
perceived, as influencers in the type of exchange that occurs between each group.267,268 Each 
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time role, or scope of practice was discussed there was congruence around how physicians and 
pharmacists perceived these, even when the perception was not tied to the actual scope of 
practice.  
 
Pharmacists discussed being respectful in how they challenged physicians on questions around 
medication management, and physicians who discussed pharmacists positively also cited the idea 
of being respectful as a positive driver of good relationships. Within the specific relationships 
examined from the physician perspective, working in a co-located environment did not 
necessarily result in stronger relationships with pharmacists, however through providing an 
opportunity for better communication, it thusly increased collaboration.  
 
Meaningful collaboration occurred when each practitioner actively sought the other out for more 
than a back-and-forth interaction.144 Research outside of health care, in marketing and sales, 
supports that team cohesiveness is linked to effectiveness, even when it is not connected directly 
to improved productivity.270,271 Our results mirror this, in that when pharmacists and physicians 
are co-located, or work closely together, the way in which they discuss collaboration shifts from 
describing it in more tentative terms, to a more natural interaction. There is very little research 
that compares how collaboration changes between practitioners who are directly in a co-located 
practices or have an established relationship, versus collaborators who are external to the 
practice.  
 
Within the relationships discussed, it was clear that having a personal relationship with a specific 
pharmacist resulted in a physician having more meaningful interactions with that pharmacist due 
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to them having a clearer understanding of the pharmacist role in patient care, and feeling that 
care is shared between them. Similar to Snyder et al.’s study, we found that generally 
pharmacists were the primary initiator or relations, and described their process to building 
relationships with physicians clearly.267 The pharmacists who operated in co-located 
environments or within ‘walking distance’ of a physician were more likely to described 
successfully relationship building, and often describing that there were shared motivators, such 
as improving patient care.269 Still, physicians were the gatekeepers of the relationship.246 
5.6 Limitations 
This study reached saturation, however, there was a relatively low response rate for physicians, 
with less than half the number of physicians responding than pharmacists. Our sample was a 
convenience sample, and the participants who were willing to share their views may have had 
different attitudes and experiences than pharmacists and physicians that were not interested in 
the research. Our data was triangulated through the interviews and talk-alouds, and through 
coding, saturation was reached. Future studies can include participants that identify as high 
collaborators, as well as those who do not collaborate on a regular basis.  
5.7 Conclusions 
Strong pharmacist and physician working relationships not only influence how and when 
collaboration happens but also influence the level to which collaboration occurs. The findings 
from this study demonstrate that while physicians who have an established relationship with a 
specific pharmacist hold positive perceptions around a pharmacist’s role, this does not 
necessarily transfer to other pharmacists as professionals. This analysis focused on identifying 
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the differences physicians and pharmacists discuss in communicating with known, versus 
unknown colleagues, and understanding barriers to successful collaboration 
Understanding of different working environments where each player feels able to best use their 
skills and collaborate to improve patient care is important. Different environments support 
nuanced approaches to collaborative care. The role relationships have in influencing how and 
when interactions occur should be given consideration to best maximize potential for designing 
collaborative care teams. Carefully designing systems that support active collaboration as well as 
ways of communicating is important to ensure strong interprofessional partnerships.  
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A Scoping review of research on presence and impact of including reason for 
use information with prescriptions 





Though pharmacists in North America are obligated to ensure that prescribed medications are 
appropriately administered to the public, information about the reason(s) for why medication is 
prescribed is not a required component of a legal prescription. Although the benefits to 
prescribers of medication—including the reason for use on prescriptions—has been well 
documented, it is not yet standard practice to share this information with pharmacists. 
  
Objective  
To provide healthcare, informatics, and engineering researchers with a cohesive summary and 
scope of literature explaining why documentation of reasons for the use of medication affects the 
workflow and professional responsibilities of pharmacists. 
 
Methods 
We performed an multidisciplinary scoping review, searching literature from healthcare, 
informatics, and engineering. The following databases were searched between December 2017 
and January 2019: PubMed, Institute of Electrical and Electronics Engineers (IEEE), Association 
for Computing Machinery (ACM), International Pharmaceutical Abstracts (IPA), and EMBASE.  
  
Results 
3,912 potentially relevant articles were identified, with nine papers meeting the inclusion criteria. 
The studies used different terminology (e.g., indication, reason for use) and a wide variety of 
study methodologies, including prospective and retrospective observational studies, randomized 
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control trials, and qualitative interviews and focus groups. The results suggest that including the 
reason for use on a prescription can help the pharmacist identify more errors, reduce the need to 
contact prescribers, support patient counseling, and improve patient safety. Reasons that may 
prevent prescribers from adding reason for use information include concerns about workflow and 
patient privacy.  
  
Conclusion 
More research is needed to understand how reason for use information should be provided to 
pharmacists and how it will impact collaboration and communication in daily practice. It is also 
necessary to establish a consistent vocabulary and terminology for accurately describing this area 




Patient safety; Medication safety; Health services research; Review; Reason for Use  
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6.2 Background and Rationale 
Medications are generally prescribed for conditions and illnesses for four reasons: to cure, to 
prevent, to slow progression, or to manage symptoms. Medications can also be prescribed to help 
in diagnosis or to manage the adverse effects caused by another medication or treatment. Expert 
knowledge is necessary to determine the different reasons a medication may be prescribed, and 
there may be no direct connection between a medication’s reason for use and its corresponding 
indication. Sometimes the reason for use is obvious, such as when an antibiotic is used to treat an 
ear infection. Other times the reason for use is less obvious, such as when a hypertension 
medication is used to treat nightmares related to post-traumatic stress disorder.272  
 
To foster collaborative care, it is vital for prescribers to share a medication’s reason for use with 
others on the healthcare team. Providing reason for use information (in addition to official drug 
indication information) with the goal of collaborating and information sharing will contribute to 
ultimately improving patient safety. Currently, pharmacists who do not have access to the reason 
for use for a prescription must ask the patient.273 This is problematic as the accuracy of patient 
self-reported diagnosis varies widely. While the accuracy is quite good with conditions such as 
diabetes, it is very low for conditions such as rheumatoid arthritis, or heart failure.274–276 People 
who have difficulty communicating their diagnoses tend to be older, live with more chronic 
illness, and have a higher risk of death.277 This puts the onus on the patient to correctly share the 
physician’s prescribing rationale. 
 
In patient safety literature, there appears to be consensus that it is safer for pharmacists to have 
access to information about why a medication was prescribed.278 There has also been keen 
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interest in the design of electronic prescribing systems, which arguably make it easier for 
prescribers to share reason for use information with one another. For example, Schiff et al. are 
currently testing an indication-based prescribing system, where prescribers start with a diagnosis 
or problem and then select from a list of recommended treatment options.279 However, there 
appears to be very little information on how reason for use information should be added to 
support pharmacist decision-making.  
 
To date, no systematic or scoping reviews have addressed the value of including the diagnosis, 
reason for use, or indication along with a prescription, nor have they considered how this 
information could influence a pharmacist’s decision making. The objective of this 
multidisciplinary scoping review is to characterize the research on how the addition of the reason 
for use information on a prescription impacts a pharmacists’ ability to practice. Given that this 
topic spans multiple disciplines, the first step is to map relevant literature to identify the potential 
size and scope of research across a variety of disciplinary databases. When literature on a 
particular topic is scattered across different disciplines, there is a real risk that the research will 
be siloed and will not reach those who are in a position to translate the research into practice.  
 
This review was guided by the research question for this study: “How are pharmacists 
professionally affected when the reason for use is included on a prescription, and what are the 
implications for collaboration and patient safety?” Our goals were to describe and summarize 
research on the design, implementation, and evaluation of reason for use information given with 
a prescription to provide healthcare, informatics, and engineering researchers with a cohesive 
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summary of the scope of literature around reason for use of medication to date, as it relates to 
pharmacists.  
6.3 Methods 
We followed the scoping review framework developed by Arksey and O’Malley and was 
conducted the reporting using the PRISMA Extension for Scoping Reviews (PRISMA-ScR) 
Checklist.196,280 We carried out the following five stages of a scoping review: (1) identify the 
research question, (2) identify relevant studies, (3) select articles, (4) chart the data, and (5) 
collate and summarize the data.196 To build the search strategy, we used the SPIDER tool 
(sample, phenomenon of interest, design, evaluation, research type) to identify qualitative and 
mixed-method studies.281 We also used the PICO tool (patient, intervention, comparator, 
outcome) to develop a search strategy for quantitative studies, such as randomized controlled 
trials.282 
6.3.1 Information Sources 
We searched the following databases for journal articles and conference proceedings between 
December 2017- March 2018 and ran an update in January 2019: PubMed, Institute of Electrical 
and Electronics Engineers (IEEE), Association for Computing Machinery (ACM), International 
Pharmaceutical Abstracts (IPA), and EMBASE. We also hand searched reference lists from 
relevant articles. We exported all search results to EndNote reference manager software (V8, 
Clarivate Analytics) and removed duplicates. The EndNote File was exported to Covidence, a 




Three librarians worked together to build a comprehensive search strategy for each database, 
with support from database specialists. We began by familiarizing ourselves with the 
terminology for “reason for use” by conducting a preliminary search on PubMed and by 
searching reference lists of known publications on the topic. Developing a search strategy for 
each database was complex, necessitating as comprehensive a search as possible while still 
limiting the noise caused by the wide-reaching “indication” search term. Databases across 
disciplines were searched to identify the scope of research in a multidisciplinary area of study. 
Detailed search strategies are presented in Appendix F. A sample search strategy for PubMed is 
as follows:  
(("reason for use"[All Fields] OR Indication*[All Fields] OR Off-Label Use[MeSH terms] OR 
(diagnosis[All Fields] OR diagnosis[MeSH terms] AND (pharmacists[MeSH Terms] OR 
pharmacist*[All Fields])) AND (prescription[All Fields] OR drug prescriptions[MeSH Terms] 
OR prescriptions[MeSH Terms]) AND (documentation[MeSH Terms] OR document[All Fields] 
OR record[All Fields] OR communication [MeSH terms] OR communication[All Fields] OR 
Electronic health record[MeSH Terms] OR “electronic medical record” OR labels[All Fields] 
OR off-label[All Fields] OR Off-Label Use[MeSH Terms] OR electronic prescribing[MeSH 
Terms]) AND (collaboration OR intersectoral collaboration[MeSH Terms] OR interprofessional 
relations[MeSH Terms] OR patient care team[MeSH Terms] OR professional role[MeSH Terms] 
OR team[All Fields] OR interprofessional[All Fields] OR “interprofessional collaboration” [All 
Fields] OR patient[All Terms] OR patients[MeSH Terms]))) 
6.3.3 Selection of sources 
Titles and abstracts were imputed into Covidence and two authors independently screened the 
titles, abstracts, and full-text articles according to the eligibility criteria. Studies were eligible for 
inclusion if they included pharmacists as part of the study and examined one of the following: (1) 
the inclusion of reason for use in a prescription; (2) the addition of reason for use to a 
prescription medication label; or (3) why prescribers do or do not include reason for use in 
prescriptions. We did not limit ourselves to a specific type of study or field of study. We did not 
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place any limits on the date or location of publications except that research must be published in 
English. We excluded dissertations and commentaries. 
6.3.4 Data Synthesis 
One researcher used a standardized form to extract data from included full-text articles. Data was 
verified by a second researcher. We recorded the following data: lead author, year of publication, 
geographic location, participants, methods, analysis, research setting, outcomes, and location of 
the reason for use (e.g., electronic health record (EHR), written prescription. We began by 
categorizing the literature according to the methodology, key findings, and setting. As articles 
were reviewed, we added categories as necessary to understand the full extent of themes and 
research currently occurring. We identified gaps and key findings after reviewing the final list of 
included articles.  
6.4 Results 
6.4.1 Study selection  
We identified a total of 4,027 titles from the search with an additional 21 studies identified from 
other sources (Figure 6-1), of which 136 were duplicates. After 3,912 articles were screened, a 
total of 9 remained that met the inclusion criteria as outlined (Table 6-1 Included Studies). 
Examples of reasons papers were excluded included the following: focus on labeling rather than 
prescriptions,283,284 did not include a pharmacist,86,285–288 focused on medication review without 
indication,289,290 monitoring medication treatment,291 and network data mining.292 Five 
overarching themes were found and are summarized below: (1) Importance of Including Reason 
for Use on Prescriptions; (2) Impact of Reason for Use on Decision-Making and Workflow; (3) 
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through other sources 
(n = 21) 
Records after duplicates removed 
(n =3,912) 
Records screened 
(n = 3,912) 
Records excluded 
(n = 3,340) 
Full-text articles assessed 
for eligibility 
(n =  572) 
Full-text articles excluded, 
with reasons 
(n = 563) 
Studies included in 
qualitative synthesis 
(n = 9) 
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Descriptive Characteristics  
 
The nine included studies were published between 1998 and 2018. In total, four studies were 
conducted in the United States, 273,278,293,294two in Europe295,296, one in the Middle East297, and 
two in Australia298,299. Two studies focused on prescribing in hospital295,297, six focused on 
primary care, 273,293,294,296,298,299 and one involved a consultation with experts from different 
settings.278 As per the inclusion criteria, all studies included pharmacists, seven included 
physicians,278,293–295,297–299 four included patients, 278,293–295 and one presented results from a pilot 
with various stakeholders.278 Five studies used a qualitative approach,278,293,294,296,298 and four 
used a quantitative approach273,295,297,299. Three of the included studies were published in health 
research journals,295,298,299 with the remaining six published in pharmacy practice 
journals.273,278,293,294,296,297 We did not identify any studies in the engineering or informatics 
literature. 
 
6.4.2 Importance of Including Reason for Use on Prescriptions 
All included studies identified that reason for use is needed to improve patient safety. Generally, 
research participants had positive reactions toward adding the reason for use to prescriptions. 
The most studied topics related to reason for use included the consequences of missing 
information, how the suboptimal flow of information between health care practitioners impacts 
patient care, and how better systems might be designed to support improved documentation. The 
papers did not always mention how a pharmacist gets access to reason for use without a 
prescription, with Warholak et al, identifying using the patient as an intermediary to get access to 
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information.294 Using semi-structured interviews with pharmacists, physicians, and patients, 
Garada et al. identified that the addition of reason for use information can reduce prescription 
and dispensary errors, and that adding the information to the label supports patient engagement 
and the work of other healthcare professionals (HCPs).298 Garada et al. also identified that 
prescribers were concerned about workflow and privacy, though privacy was not a concern 
shared by patients.298 Liddell et al. specifically identified that including reason for use was the 
most important aspect of new prescription notations.299  
 
6.4.3 Impact of Reason for Use on Decision-Making and Workflow 
Three studies mentioned pharmacists who felt limited in their ability to perform professional 
duties because of missing information such as patient medical conditions, reasons why a 
medication was prescribed, and treatment plans293,294,296; three identified the importance of 
reason for use in identifying prescribing errors and improving safety295,297,298; four recognized the 
potential for reason for use information to improve workflow278,293,294,297; and three discussed 
reason for use as a barrier to patient counselling. 293,294,300 Of the three studies which examined 
workflow: Al-Khani et al. identified the difficulty in getting physicians to comply with including 
reason for use297; Tarn et al. identified the potential benefit that improved collaboration can have 
on efficiency293; and Warholak et al. identified that inclusion of reason for use can reduce 
unnecessary interactions between prescribers and pharmacists.294 Four studies discussed how 
adding reason for use to prescriptions would improve the pharmacist’s ability in clinical 
decision-making. 273,293,294,298 Al-Khani et al.’s study used a hospital’s safety reporting system to 
 
123 
show that 35% of the medication prescribing errors that pharmacists flagged were identified 
using reason for use.297 
 
6.4.4 Reason for Use to Support Collaboration 
Two articles identified that having reason for use information improves collaboration and 
communication.293,296 Six studies examined pharmacists and physicians jointly. 278,293–295,297,298 
Through an extensive stakeholder assessment, Kron et al. discussed how pharmacists often try to 
infer information about why a medication was prescribed from the patients, which is supported 
by Warholak et al.’s findings that after a diagnosis is included on an electronic prescription, 
pharmacists have less confusion and uncertainty in their practice. 278,294 Liddell et al. 
demonstrated a very positive response from physicians about being more collaborative with 
pharmacists—both pharmacists and physicians were positive about tools that would facilitate 
their communication.299  
 
6.4.5 Barriers to Reason for Use Information  
Only one paper examined privacy concerns, concluding that while pharmacists and physicians 
were concerned about privacy, patients were not concerned with the privacy implications of 
documenting reason for use on a prescription.298 
 
Of the five included studies that mentioned technology278,294,295,297,298, four suggested there was a 
need to improve the prescribing software available.7,25,26,29 Four studies examined electronic 
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prescribing. 294,295,298,297,278 Raebel et al. discussed the effectiveness of a computerized pharmacy 
alert system paired with active collaboration between HCPs.300 Raebel’s study’s goal was to 
improve prescribing safety and identified that a barrier to this was that clinical patient data was 
not easily available to many pharmacists.300 Kron et al. specifically examined the difficulties in 
encouraging prescribers to include the reason for the prescription and identified that electronic 
prescribing was laying the foundation for future adoption.278  
6.4.6 Terminology 
Including a reason for use with a prescription was described in a variety of ways. The most 
common terminology is “indication”278,296,298. One study used “indication in prescription”297 and 
“patient diagnosis”294, while the remainder used “medication indication293, “indication for 
treatment”295, “reason for use”273, “purpose of the medication”299 and “clinical patient data.”300 
6.5 Discussion 
We set out to identify and describe the current literature concerned with how reason for use 
information can be shared with a pharmacist through a prescription. One of the most significant 
discoveries of this review is how little research currently examines the importance of providing 
the reason for use to a pharmacist. While databases across disciplines were searched, no papers 
from engineering or computer science were included. The lack of papers that met our criteria for 
inclusion from ACM and IEEE databases is significant as the field itself is multidisciplinary—




We identified nine studies that included the pharmacist as a potential user of reason for use 
information. All nine studies examined patient safety but only one study explored privacy. 
Several studies also examined the impact of reason for use on the pharmacists’ workflow, 
including improving the pharmacists’ ability to identify errors, providing better patient 
counselling, and reducing the need to contact a prescriber to clarify a prescription. The most 
common barrier cited was physician workflow. 
 
For HCPs who are helping patients manage medications, the medication reason for use is a 
foundation of effective patient care—treatment outcomes may improve if these links are 
made.85,301 There is at least one indication listed on the monograph for each medication (on-label 
indications), however there are many situations where medication are used in ways that are not 
explicitly listed on a monograph (off-label indications). Estimations are that roughly 21% of 
medications are prescribed for off-label use.302 Thus, in the current model where the reason for 
use is infrequently shared, pharmacists, physicians, and other HCPs who are tasked with 
assessing prescriptions written by another prescriber are limited to making educated guesses 
about the reason for use.  
 
While there is a significant body of literature on how reason for use information can be tracked 
in EHRs or for pharmacovigilance, most studies have not considered the impact of reason for use 
information on pharmacists.86,285,303 Murphy et al. demonstrated the importance of reason for use 
in their paper titled “Why is your patient sedated?” where they identified that 75% of patients 
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who had been prescribed a sedative hypnotic in a large, tertiary referral hospital had no reason 
for use documented in the chart.285 In a commentary titled “Incorporating Indications into 
Medication Ordering — Time to Enter the Age of Reason” Schiff et al. argued that indications-
based prescribing could improve prescribing, medication use, and patient safety while allowing 
prescribers to maintain autonomy.279 In another commentary, Li and Zhou went further, arguing 
that excluding reason for use in prescriptions is dangerous and that pharmacists need both 
medication information and patient information (diagnosis, history, laboratory results) to care for 
patients.304 
 
Indication was the most common term used in the identified research it should be noted that the 
term ‘indication’ makes identifying relevant ‘reason for use’ research difficult. Indication can 
refer to both the official indication of a mediation in respect to its monograph, as well as the 
reason a medication was prescribed. Indication, reason for use, and diagnosis are often used 
interchangeably; the resulting lack of terminological clarity makes it challenging to easily 
identify publications that can more accurately and efficiently guide prescriptive practice. 
 
Understandably, there are concerns about including the reason for use information in 
prescriptions. In the Netherlands, for example, as of 2012 the Dutch Medicines Act was changed 
and the law now requires prescribers to include the reason for use in the prescriptions for certain 
medications, however, two years after the law passed only 12% of affected prescriptions had a 
reason for use included.288 Providing more information alone is not a panacea. Kennedy et al. 
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identify that in modified prescriptions pharmacists identified more errors, highlighting the 
importance of evaluating patient safety interventions.305 Further, several authors argue that 
simply including more information cannot and should not replace communication between 
physicians, pharmacists, and patients.86,286,287 Pharmacists currently depend on information from 
patients to fill in the gaps of knowledge around reason for use.289  
 
The results of this scoping review identify that more research must be done that includes 
pharmacists in the process of understanding how including the reason for use on a prescription 
can benefit collaboration as well as facilitate information transmission between HCPs. Given the 
growing scope of knowledge around building beneficial EHRs that foster collaboration as well as 
communication, the lack of research discussing the importance of how to best provide 
pharmacists with information about diagnosis or reason for use represents a significant gap in our 
current knowledge, especially across different databases. 
6.5.1 Challenges in searching multidisciplinary research 
Despite a comprehensive search strategy from databases across disciplines, our scoping review 
only identified nine articles. This may be related to the inherent difficulty of identifying common 
and universal search terms across multidisciplinary literature reviews. Reason for use literature 
bridges health, engineering, informatics and other areas, all with different terminologies, 
frameworks, and methods. The papers included in this study were all from healthcare journals, 
primarily pharmacy journals. This may mean that engineering and informatics disciplines are not 
aware of these papers. While the methodology for health-related scoping reviews is well 
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documented9, the search methodology has not yet caught up in other disciplines. For example, 
while PubMed uses the medical subject heading (MeSH) search terms and Embase uses Emtree, 
these are not standard between databases, and the non-medical databases often do not have 
standardized search terms. It is also difficult to identify equivalent terms that work across all 
databases.  
 
Conducting multidisciplinary research will grow more challenging unless emphasis on shared 
terminology can be built into the process. This issue is of particular importance to both 
researchers and practitioners, whose work depends on the translation of research into practice. 
This review emphasizes the scope of awareness around including reason for use on a prescription 
for pharmacists. With regards to the excluded papers, it was clear that by excluding the 
pharmacist in the process, the burden remains on the patient to transmit key information among 
practitioners, and it is difficult for the pharmacist to fulfill their role potential.306–308 
6.6 Significance 
This research advances our understanding of the existing literature on including reason for use 
alongside a prescription, specifically identifying the gap in the literature that includes a 
pharmacist perspective. Future reason for use research should be multidisciplinary, collectively 
including the unique perspectives of prescribers, pharmacists, and patients. Research that 
includes multiple members of the care team focused on improving collaboration will ultimately 
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Table 6-1 Included Studies 
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Discussion and Conclusion 
7.1 Introduction  
Increasingly, the healthcare field is moving towards an interprofessional, patient-centred model. 
In parallel to this, the rapid advancement of technology is enabling the creation of broadly 
accessible tools such as EHRs to facilitate information gathering and sharing. As all participants 
in healthcare respond to these changes, it is becoming clearer that, as knowledge is transmitted 
from person to person, through any medium, it becomes more tailored and, ideally, more useful 
to the users of that knowledge. How people access information and what information each user 
needs changes depending on their role and values. It follows that any tool used to facilitate 
health information sharing, communication, or decision-making must be created in such a way 
that it accounts for the different user needs presented by each participant. This thesis explores 
IP-SDM among physicians, pharmacists, and patients, and begins to understand how EHRs can 
facilitate improved information sharing. Through this exploration, it became clear that there is a 
subjective element to communication among participants in health. Through identifying how 
relationships can influence interactions between physicians and pharmacists — specifically the 
impact relationships have on professional exchanges and information sharing — the need for 
future research to better understand this variable emerged.  
 
This thesis presents emerging research about how people access, use, discuss, and transmit 
information related to health by presenting the results of an multidisciplinary project that seeks 
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to understand how and what health information patients, pharmacists, and physicians are 
sharing, including the types of information typically exchanged, and to begin to understand best 
practices and tools that support communication and collaboration.  
 
The first phase of the project involved contacting, observing, and interviewing patients, 
pharmacists, and physicians. This data collected during this phase was used to develop two 
research papers that examined different aspects of how these groups interacted with each other, 
specifically around medication decision-making, and also explored how EHRs can be used to 
facilitate their interactions. During the coding phase for the two initial papers that described this 
data, a new finding emerged—that physicians’ and pharmacists’ perceptions of communication 
and trust appeared to be closely tied with having a prior relationship with each other. Through 
this secondary analysis, a third paper was developed to explore the ways relationships 
influenced how, what, and when information was communicated, and the potential implications 
this has for understanding collaboration and communication among HCPs. In alignment with 
prior literature, the findings support the notion that communication is necessary for 
collaboration between pharmacists and physicians, and encourages thinking about how their 
communication is influenced within professional boundaries as well as through deeper in 
personal relationships.  
 
Incorporating findings from the papers on physician-pharmacist decision-making and 
relationships, the importance emerged of understanding the scope of information around 
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including the reason for use along with a prescription. Though this topic is currently being 
explored, the majority of the current body of research focuses on the patient-physician 
relationship and does not significantly examine how this impacts pharmacy practice nor does it 
include pharmacists in much of the research. Aligning with best practices of scoping reviews, 
this study identified both gaps and directions for future research.  
7.2 Mixed methods 
Mixed methods and multidisciplinary approaches to understanding how health-focused 
information is collected and shared provide important insight into how people are navigating the 
healthcare system. Currently, much of the research on this topic has been siloed in its approach 
and has generally focused on studying one or two perspectives within a single discipline. 
Developing a theoretical framework to support multidisciplinary research will allow future 
multidisciplinary studies to identify how this research should be conducted and also enhance 
methods and tools used to support the conduct of this research.309 This broader approach would 
help to validate findings and methodologies, which would ultimately further help with the 
adoption of the information presented. The next steps for this area of research—developing a 
theoretical framework for multidisciplinary research in health—would also respond to an 




7.3 Reason for use 
Medication indication, or reason for use information, is a foundational piece of information 
needed to provide effective care and treatment outcomes may improve if this information about 
the reason for prescription, diagnosis, and medication choice is provided.85,301 Estimations are 
that roughly 21% of medications are prescribed for off-label use.302 Understanding medication 
indication is vital for non-prescribers involved in care: it can influence care by considering drug 
interactions and side effects, and by clarifying the need for a patient to take a specific drug. 
Though there is at least one official indication for every approved drug (on-label indications), 
there are many situations where medications are used in ways for which they were not explicitly 
approved (off-label indications). While HCPs are often able to make educated guesses about the 
reason a medication was prescribed based on experience, information gathering, and resources 
that provide information on indication (such as Lexi-Comp and Drugs.com, among others), 
there are clear limitations to this approach, particularly when it comes to off-label prescribing.  
7.4 Challenges in multidisciplinary research 
There are many challenges in conducting multidisciplinary research. For their research to be 
successful, the multidisciplinary research team needs to spend time exchanging discipline-
specific knowledge, including explaining theories and methods that may not easily come 
together. Even though designing multidisciplinary research projects is common today, there is 
not a clear answer to the question of how to conduct multidisciplinary research well. 
Researchers are often trained to approach research in different ways, using different languages. 
Creating a framework where every participant is on the same page can be challenging. 
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Pharmacists, engineers, and sociologists approach and think about their work differently, and 
there is a need to bridge understanding. Multidisciplinary research partners may not feel 
comfortable either critiquing out of their areas of expertise or understanding different evaluation 
methods. There are also difficulties in getting the right feedback to negotiate moving a project 
forward. As projects reach completion, the publishing process itself becomes an inherent 
challenge, not only in regards to where research is published, but also in how it is written. 
Asking ourselves what multidisciplinary research is, and what it should be, is the first step 
needed before researchers can fully work together.  
 
The purpose of multidisciplinary research is to bring together disparate narratives to answer an 
overarching question that is relevant across all these narratives. It is well established that, when 
conducting multidisciplinary research, it is necessary to develop an understanding of each 
discipline’s culture, structure, science, terminology, and expectations around knowledge and the 
research process. An ongoing challenge of this thesis was building a cohesive narrative from the 
data collected. Whose story should be told with the data, when there is no naturally consistent 
narrative that happens across the different disciplines being studied?  
 
Further, the terminology around multidisciplinary research itself is not well defined. The 
inconsistencies in terminology, methods, and theories is reflected in one of the most cited 
definitions of multidisciplinary research, by Aboelela et al.310: 
 
“…any study or group of studies undertaken by scholars from two or more 
distinct scientific disciplines. The research is based upon a conceptual 
model that links or integrates theoretical frameworks from those 
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disciplines, uses study design and methodology that is not limited to any 
one field, and requires the use of perspectives and skills of the involved 
disciplines throughout multiple phases of the research process.” 
 
Aboelela et al.’s definition highlights that multidisciplinary research connects theoretical 
frameworks from different disciplines and uses study design and methodologies that are not 
limited to one field, rather than actively integrating them.310 However, it does not articulate the 
need to develop a new framework that is itself multidisciplinary. The next step to strengthening 
multidisciplinary research is to develop an overarching theoretical process framework that can 
guide collaboration among disciplines.  
 
Developing this shared understanding occurs throughout the research process, from ideation 
through to publication. One study by Grönqvist examined challenges of establishing a 
multidisciplinary research project, and the hazards of not having a shared theoretical 
framework.166 The study described a project in which, while several theories were proposed 
during the process, there ultimately was no agreed-upon overarching theoretical framework, 
given that the different projects occurring concurrently.166 Grönqvist concluded that, while it 
can be most effective to allow each researcher to frame their research in a field-specific way, 
this deficit makes a true multidisciplinary contribution difficult.166 The data presented in 
Chapters 3 and 4 were analyzed using the multidisciplinary framework method, which helped to 
guide the process of data analysis for parts of the resulting papers. The research used in this 
thesis was multi-disciplinary in approach, but the resulting papers published remained more 
discipline-specific. Engineering focused projects,152–154 as well as business focused projects,150 
were published separately from the health-focused projects included in this thesis. While 
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collaborative members from each discipline or perspective were included in all the work, each 
paper focused on a discipline-specific methodology, and to date, none have been written in a 
way that fully combines methodologies. 
 
Currently, there is not an established overarching theory to guide multidisciplinary research. 
When we think about gaining knowledge, we generally think about how knowledge 
progressively develops, for example, new knowledge challenging and then overthrowing old 
paradigms. Thomas Khun identified that it is not cumulative progress, but rather discontinuities 
in a series of phases that drives science forward:311  
 
“For reasons that are both obvious and highly functional, science 
textbooks (and too many of the older histories of science) refer only to that 
part of the work of past scientists that can easily be viewed as contributions 
to the statement and solution of the texts' paradigm problems.” - Thomas 
Khun311 
 
Further, Khun identifies that, if an area remains unresolved for long enough, there will come a 
point where scientists begin to question the model itself, describing: "a proliferation of 
compelling articulations, the willingness to try anything, the expression of explicit discontent, 
the recourse to philosophy and to debate over fundamentals."311 Many areas of science are 
increasingly driven by data, rather than by theories, as Khun argues. Often health research 
reflects a new data-driven approach while adding a practice-driven element. Under Khun’s 
theory, this would align as a paradigm shift, which emphasizes the need for multidisciplinary 
research to establish theoretical frameworks that account for an overarching theory, while 
continuing research into practice-related elements.  
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 Finding potential solutions to some of the identified barriers to improved multidisciplinary 
research is important for driving this important type of research further. In this thesis, I put 
forward that before we can fully realize the benefits of multidisciplinary research, we will need 
to rethink how multidisciplinary research is conceived. While there is a current focus on how to 
do the research and how to find the solutions, there is little clarity on how we see the 
overarching process of conducting and navigating multidisciplinary research. As 
multidisciplinary research grows in popularity, the question of what is multidisciplinary 
research must also be asked. In many successful multidisciplinary research projects, the 
collaborative process is conducted through a divide-and-conquer process. 
 
Multidisciplinary research by nature encourages challenging established scientific ideas and 
collaborating to combine different discipline-specific areas of expertise to find a better solution. 
If multidisciplinary research is to be truly successful, the next step is to work fully together: 
write jointly, use standard terminologies, and use the same methods, all under a 
multidisciplinary theoretical framework. The strength in the findings presented is not only in 
how they begin to build a narrative around how people access, use, and understand health 
information, but also in identifying how they do not come together in a single disciplinary way. 
7.5 Implications and future research 
Today Canada is an emerging market for EHRs and other networked tools that facilitate 
communication in healthcare. This thesis, while exploratory, demonstrates that there is both a 
desire and a need for better communication among HCPs, and between HCPs and patients. This 
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thesis demonstrates that there are still clear knowledge gaps around key questions about 
information sharing, role, and scope of practice. Research clearly demonstrates that other HCPs 
and patients are still not aware of a pharmacist’s full scope of practice.48,90,147,252 To fully 
understand how people are making decisions about health, from both the clinician and patient 
perspectives, it is clear that more research needs to be done into subjective factors, such as how 
relationships can shape and influence the information being used to make these decisions. By 
understanding what information is being used, and improving capabilities to share the 
information in easy and collaborative ways, all aspects of healthcare will benefit.  
 
In the data included in the study, the response to EHRs and their potential for improving 
information access and collaboration was positive. However, it was well recognized that EHR 
information is not a panacea, especially when the information is not delivered in a meaningful 
way.305,312 Well-designed EHRs give healthcare teams and patients a more complete picture of 
patient health, provide information on diagnosis, enable more reliable prescribing, improve 
efficiencies and productivity, facilitate coordinated care, and share health information.313 By 
enhancing communication, EHRs allow clinicians to focus on patient care while improving both 
interactions and communication between HCPs and patients.59 Improved communication and 
collaboration has been demonstrated to improve health outcomes and patient safety, as well as 
improving the overall patient agency. Future research that accounts for different information 




Through the research described in this thesis, it became clear that while stakeholders may value 
different things, there is a commonality, as when, for example, physicians need information 
about adherence and pharmacists need information on reason for use. The process of 
exchanging information about adherence and the reason for use is a potential venue for 
communication; however, there is an identified difference between information exchange and 
meaningful collaboration. Collaboration is not required to share information, but without 
collaboration, that information may not be fully used or understood by both parties. To improve 
patient care and overall engagement, there needs to be acknowledgement that effective 
collaboration is not just a matter of the creation of tools. It requires a better overall 
understanding of systematic differences of values and relationships, and a better understanding 
of tools that can actively improve collaboration and communication. 
 
Continuing to collaborate with different disciplines to conduct patient-engaged research will 
allow the results of this study to be used in developing EHRs across Canada. Further research 
into the diverse perspectives of HCPs and allied health professionals, as well as those designing 
health systems, would help to optimize information sharing, communication, collaboration, and 
ultimately the decision-making process. Future research should be designed to accommodate a 
robust multidisciplinary approach that allows us to examine how sharing and communicating 
health information changes, as the influence of technology and the number of stakeholders 
involved in care increases. Examining how this can happen in part through developing an 
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multidisciplinary model of collaboration and information sharing, based on an understanding of 
roles, priorities, and values can help to direct and frame multidisciplinary research.  
7.6 Strengths and limitations 
In addition to the limitations outlined in the substantive chapters, the most significant limitation, 
as discussed above, is the lack of overarching theoretical frameworks that can guide 
multidisciplinary research.  
 
Currently, there are several issues of equality when it comes to working with patient groups that 
may be more vulnerable, as, for example, those with genetic health issues, such as 
Huntington’s, that may influence willingness to participate in research studies or illnesses with 
social stigmas such as HIV and mental illness. As well, there are overall challenges with 
recruiting a diverse and representative population of research participants. In the three studies 
comprising chapters 3,4 and 5 the core research team members adopted reflexive skills in 
reaching out to various patient advocacy groups as well as traditionally underserved 
populations.24 The research design’s use of mixed methods research and emphasis on patient 
and community-engaged research was helpful. Future studies have an opportunity to be more 
inclusive and diverse, as well as including more vulnerable patient groups.15,314 By 
incorporating a participatory approach, and including patient partners and patient 
representatives on the research team, in addition to reaching out to capture the voices of 
different members of the community, this project attempted to achieve as much participant 
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diversity as possible. Even so, ultimately, there were barriers to reaching several stakeholder 
groups, which may limit the generalizability of this project.  
Similarly, there are challenges in recruiting within the health profession. Future research should 
focus on recruiting a more diverse population of HCPs. While efforts were made to recruit 
physicians, ultimately scheduling conflicts limited their participation. Future research should 
include more HCPs, as well as allied health professions such as nurses, to begin to build a more 
encompassing picture of the scope of health communication in Canada.  
 
The mixed methods and multidisciplinary approach in this thesis is an important strength of this 
project. The participatory methods that were employed ensured that there was an important 
patient focus throughout the research process, from ideation through to publication. Currently, 
there are not many studies that examine patient and multiple HCP perspectives about how and 
what information is transmitted between each party, and even fewer in a Canadian context.  
7.7 Conclusions 
While the findings are exploratory they do present an initial understanding for which future 
research can use to better understand the complexities around communication, information 
sharing, and how relationships can influence collaboration. By answering the objectives, this 
research begins to identify how patients, pharmacists, and physicians find and communicate 
information to make decisions both individually and together, the findings help support future 
research that will support new systems and tools. The lessons learned from the presented studies 
can help direct the development of EHRs and other networked information sources that not only 
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support but also facilitate communication and collaboration. The findings have relevance to 
healthcare organizations, engineers, information specialists, patients, and researchers. To build 
systems that facilitate communication, there is a need for them to be designed with complex 
user needs in mind, and understand the different influencers that go into finding, seeking, and 
communicating information between stakeholders including how relationships influence 
collaboration. Understanding the scope of knowledge around reason for use information will 
help to guide further research into what information is important for active collaboration. By 
understanding that each participant in health care may have different information needs, future 
systems can be designed to not only facilitate information sharing, but better enable Ultimately, 
building EHRs and other tools that take into account the diverse needs of the different users can 
help promote safe medication use and, overall, improve participation in the healthcare process 
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Response: No Date: (mm/dd/yyyy) 
Notes:  
Ethics Clearance (b) (ORE # 20940) 
Dear Researcher: 
 
This is to advise that the ethics review of your application to conduct research: 
 
Title: Playing Telephone: Medication management and integrated electronic health records 
ORE #: 20940 
Principal/Co-Investigator: Kelly Grindrod (kgrindrod@uwaterloo.ca) 
Principal/Co-Investigator: Catherine Burns (c4burns@uwaterloo.ca) 
Principal/Co-Investigator: Jilan Yang (jilan.yang@uwaterloo.ca) 
Principal/Co-Investigator: Josephine McMurray (jmcmurray@wlu.ca) 
Collaborator: Joyce Dogba (joyce-maman.dogba@fmed.ulaval.ca) 
Collaborator: Samina Abidi (samina.abidi@dal.ca) 
 
has been completed through a University of Waterloo Research Ethics Committee. Based on the 
outcome of the ethics review process, I am pleased to advise you that your project has received 
ethics clearance.  
 
Note 1: This ethics clearance from a University of Waterloo Research Ethics Committee is valid 
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for one year from the date shown on the certificate and is renewable annually. Renewal is 
through completion and ethics clearance of the Annual Progress Report for Continuing 
Research (ORE Form 105).  
 
Note 2: This project must be conducted according to the application description and revised 
materials for which ethics clearance has been granted. All subsequent modifications to the 
project also must receive prior ethics clearance (i.e., Request for Ethics Clearance of a 
Modification, ORE Form 104) through the Office of Research Ethics and must not begin until 
notification has been received by the investigators.  
 
Note 3: Researchers must submit a Progress Report on Continuing Human Research Projects 
(ORE Form 105) annually for all ongoing research projects or on the completion of the project. 
The Office of Research Ethics sends the ORE Form 105 for a project to the Principal 
Investigator or Faculty Supervisor for completion. If ethics clearance of an ongoing project is 
not renewed and consequently expires, the Office of Research Ethics may be obliged to notify 
Research Finance for their action in accordance with university and funding agency 
regulations.  
 
Note 4: Any unanticipated event involving a participant that adversely affected the 
participant(s) must be reported immediately (i.e., within 1 business day of becoming aware of 
the event) to the ORE using ORE Form 106. Any unanticipated or unintentional change which 
may impact the research protocol, information-consent document or other study materials, must 
be reported to the ORE within 7 days of the deviation using ORE Form 107.  
 
Best wishes for success with this study. 
 
---------------------------------- 
Julie Joza, MPH  
Senior Manager, Office of Research Ethics  
University of Waterloo ext. 38535  
 
Robert Basso, PhD  
Chair, Research Ethics Board  
Wilfrid Laurier University 
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Figure depicting recruitment and the consent process for each participant 
 
 
Research Team Recruits 
Physicians, Pharmacists, and 
Research assistant obtains 
physicians (and nurse 
practitioners if applicable) 
consent to be audio recorded, 
observed while talking with 
patients and interviewed
Medical office staff notifies 
patient that a research team is 
present. A sign is posted in the 
waiting area.
Research assistant obtains 
patient consent to be 
observed and recorded while 
talking with physician in usual 
course of care
Pharmacists consent to be 
audio recorded, observed 
while talking with patients and 
interviewed
Pharmacy staff notifies patient 
that a research team is 
present. A sign is posted at 
the pharmacy counter.
Research assistant obtains 
patient consent to be 
observed and recorded while 
talking with pharmacist in 
usual course of care
Research assistant obtains 
patient consent to be 
interviewed and audio 
recorded at their home
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Patient e-mail recruitment sample 
Below message is sent out to invite patients to participate a research study on behalf of the 
researchers at University of Waterloo. 
====================================================================
========== 
Hi, everyone:  
 
My name is ***. I am a (research coordinator, Ph.D./Master student, research assistant) at 
School of Pharmacy, University of Waterloo. I am currently working on research project to 
study how integrated electronic health record can support interprofessional shared decision-
making for medication therapy management.  
 
We are looking for health professionals and patients who will help us understand how electronic 
medical records can be better designed for medication management. We are hoping to observe 
medication management in at least four Canadian provinces, including Alberta, Ontario, 
Quebec, and Nova Scotia. This study has been reviewed and received ethics clearance through a 
University of Waterloo Research Ethics Committee and the Research Ethics Board at Wilfrid 
Laurier University. 
 
We would like to invite you participate in our study. If you choose to participate, we will 
schedule a time at your convenience to visit your home and observe how you manage 
medications, including the process used for reviewing medication lists, the results of a 
medication review, how medications are recommended and how patients make decisions around 
taking medications. Through semi-structured interviews, we will also inquire about how each 
participant identifies potential and existing medication review problems and how each 
participant work to solve the problems themselves. The observation will take up to 2 hours and 
the structured interview up to 30 minutes. 
 
If you are interested in participating, or have any questions, please contact:  
 
Jilan Yang, PhD 
Research Coordinator 
School of Pharmacy 
University of Waterloo 
Email: jilan.yang@uwaterloo.ca 




Kelly Grindrod, BScPharm, PharmD, MSc 
Assistant Professor 
School of Pharmacy 
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Tel: (519) 888-4567 ext. 21358  
Email: kgrindrod@uwaterloo.ca.  
 
Thanks very much.  
HCP e-mail recruitment sample  
Below message is sent out to invite healthcare professionals to participate a research study on 
behalf of the researchers at University of Waterloo. 
====================================================================
=========== 
Hi, everyone:  
 
My name is ***. I am a (research coordinator, PH.D./Master student, research assistant) at 
School of Pharmacy, University of Waterloo. I am currently working on research project to 
study how integrated electronic health record can support interprofessional shared decision-
making for medication therapy management.  
 
We are looking for health professionals and patients who will help us understand how electronic 
medical records can be better designed for medication management. We are hoping to observe 
medication management in at least four Canadian provinces, including Alberta, Ontario, 
Quebec, and Nova Scotia. This study has been reviewed and received ethics clearance through a 
University of Waterloo Research Ethics Committee and the Research Ethics Board at Wilfrid 
Laurier University. 
 
We would like to invite you participate in our study. If you choose to participate, we will 
schedule a time at your convenience to visit your workplace and observe how you manage 
medications, including the process used for reviewing medication lists, the results of a 
medication review, how medications are recommended and how patients make decisions around 
taking medications. Through the semi structured interviews, we will also inquire about how 
each participant identifies potential and existing medication review problems and how each 
participant work to solve the problem. The observation will take up to 2 hours and the structured 
interview up to 30 minutes. 
 
If you are interested in participating, or have any questions, please contact: 
 
Jilan Yang, PhD 
Research Coordinator 
School of Pharmacy 
University of Waterloo 
Email: jilan.yang@uwaterloo.ca 
Phone: 519-888-4567 ext. 21377 
Kelly Grindrod, BScPharm, PharmD, MSc 
Assistant Professor 
School of Pharmacy 
Tel: (519) 888-4567 ext. 21358  
Email: kgrindrod@uwaterloo.ca.  
 
 
Thanks very much.  
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Information Letter and Consent- Patients 
PATIENT HOME VISITS 





STUDY TITLE:  
 
Playing Telephone: Medication management and integrated electronic health records 
 
NAME OF PRINCIPAL INVESTIGATORS  
 
Kelly Grindrod, BScPharm, MSc, PharmD 
Assistant Professor, University of Waterloo School of Pharmacy 
200 University Avenue West 
Waterloo, ON N2L 3G1 
Phone: 519.888.4567 x21358 
Email: kgrindrod@uwaterloo.ca 
 
Catherine Burns, PhD 
Professor 
Systems Design Engineering 
University of Waterloo  
Tel: (519) 888-4567 ext. 33903 
Email: c4burns@uwaterloo.ca 
 
NAME OF SPONSORS: 
 




You are being asked to take part in a research study. Please read this explanation about the 
study and its risks and benefits before you decide if you would like to participate. You should 
take as much time as you need to make your decision. You should ask the study staff to explain 
anything that you do not understand and make sure that all of your questions have been 
answered before signing this consent form. Before you make your decision, feel free to talk 






The objective of this project is to look at how patients, family physicians and pharmacists share 
information so they can make decisions about treatment. The goal of this project is to improve 
how we work with medications so we can better prevent errors and side effects. The ultimate 




We are visiting patients, physicians and pharmacists in Alberta, Ontario, Quebec, and Nova 
Scotia. During each visit, we are observing how doctors and pharmacists work, how they use 
their computer systems and how they talk with patients, and how patients make medication 
decisions. You are being asked to participate in a patient home visit. 
At the patient home visits, the research team will collect data in six ways:  
(1) Complete a short demographic survey including information on age, gender, years of 
practice, etc;  
(2) Complete a short health literacy survey; 
(3) Observe how you organize and manage your medications in your home;  
(4) Have you talk-out-loud while using any electronic health records (audio recorded); 
(5) Have you explain a typical encounter with a family physician, nurse practitioner or 
pharmacist (audio recorded); and 
(6) Interview you about your experiences in managing medications and using electronic 
health records (audio recorded). 
 
The home visit will take up to 1-2 hours.  
Please note this study project will not be collecting data on actual medication lists but rather on 
the type of information exchanged between patients, family physicians, nurse practitioners and 
pharmacists, including tools and workflows involved in each step of medication management. 
After each visit, all audio recordings will be transcribed and any identifying information will be 
removed. The audio recording will then be deleted. The de-identified transcripts will be used to 
identify quotations that may be used in research publications and presentations. Quotations will 




Participation in this study is voluntary. You may decline to participate any study components of 
demographic survey, clinical observation and interview. You may also decline to answer any of 
the questions in demographic survey and structured interview. 
 
WITHDRAWAL FROM STUDY: 
 
You may withdraw from this study at any time without any negative consequences by advising 










We do not anticipate any risks to you due to participating in this study. This study consists of 
unobtrusive observations and interviews. We are maintaining participant confidentiality; no 




There are unlikely to be any direct benefits to the participants of this study. The intention of this 
project is to use the information gathered to help Telus Health redesign their electronic medical 
and pharmacy records. The ultimate beneficiaries will be patients and clinicians who will use 




All information study participants provide will be considered confidential. Each study 
participant will be assigned a study ID that will be used for all data collection and data forms. 
You will not be identified in any report or publication. Only the research team will have access 
to individual participant data. Audio recordings will be deleted as soon as they are transcribed. 
Survey questionnaires and transcripts collected during this study will be retained for seven years 
in a secure location at our research offices at the University of Waterloo’s School of Pharmacy 
in Kitchener, Ontario. 
 






This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee and the Research Ethics Board at Wilfrid Laurier University. 
However, the final decision about participation is yours. If you have any comments or concerns 
resulting from your participation in this study, please contact Dr. Maureen Nummelin at 1-519-
888-4567, Ext. 36005 or maureen.nummelin@uwaterloo.ca or Dr. R. Basso, the Chair of the 
REB at WLU at 519-884-0710 ext. 4994 or rbasso@wlu.ca. 




If you have any questions about participation, or would like additional information to assist you 
in reaching a decision about participation, please contact:  
 
 
Kelly Grindrod BScPharm, PharmD, MSc 
Assistant Professor 
School of Pharmacy 
Tel: (519) 888-4567 ext. 21358  
Email: kgrindrod@uwaterloo.ca.  
 
 
Jilan Yang, Ph.D. 
Research Coordinator 
School of Pharmacy 







CONSENT FORM – AGREEMENT TO PARTICIPATE 
By signing this consent form, you are not waiving your legal rights or releasing the 
investigator(s) or involved institution from their legal and professional responsibilities. 
I have read the information presented in the information letter about a study being conducted by 
Kelly Grindrod and Catherine Burns at the University of Waterloo. I have had the opportunity 
to ask any questions related to this study, to receive satisfactory answers to my questions, and 
any additional details I wanted. 
 
I am aware that my interview will be audio recorded to ensure an accurate recording of my 
responses. I am also aware that excerpts from the interview may be included in the thesis, 
publications and/or presentations to come from this research, with the understanding that the 
quotations will be anonymous.  
 
I was informed that I may withdraw my consent at any time without penalty by advising the 
researcher.  
 
This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee and the Research Ethics Board at Wilfrid Laurier University. 
However, the final decision about participation is yours. If you have any comments or concerns 
resulting from your participation in this study, please contact Dr. Maureen Nummelin at 1-519-
888-4567, Ext. 36005 or maureen.nummelin@uwaterloo.ca or Dr. R. Basso, the Chair of the 
REB at WLU at 519-884-0710 ext. 4994 or rbasso@wlu.ca. 
 
With full knowledge of all foregoing, I agree, of my own free will, to participate in this study. 
YES NO  
 
I agree to have my interview audio recorded. 
YES NO  
 




Participant Name: ____________________________ (Please print)  
 
Participant Signature: ____________________________  
 
Witness Name: ________________________________ (Please print) 
 




Information Letter and Consent- Healthcare professionals 
 
HEALTHCARE PROFESSIONAL 






Playing Telephone: Medication management and integrated electronic health records 
 
NAME OF PRINCIPAL INVESTIGATORS 
 
Kelly Grindrod, BScPharm, MSc, PharmD 
Assistant Professor, University of Waterloo School of Pharmacy 200 University Avenue West 
Waterloo, ON N2L 3G1 Phone: 519.888.4567 x21358 
Email: kgrindrod@uwaterloo.ca 
 
Catherine Burns, PhD Professor 
Systems Design Engineering University of Waterloo 
Tel: (519) 888-4567 ext. 33903 
Email: c4burns@uwaterloo.ca 
 
NAME OF SPONSORS: 
 




You are being asked to take part in a research study. Please read this explanation about the 
study and its risks and benefits before you decide if you would like to participate. You should 
take as much time as you need to make your decision. You should ask the study staff to explain 
anything that you do not understand and make sure that all of your questions have been 
answered before signing this consent form. Before you make your decision, feel free to talk 




The objective of this project is to study how electronic health information is shared across 
patients, family physicians, nurse practitioners and pharmacies. This includes the types of 
information typically exchanged, tools that support interprofessional shared medication 
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decision- making and best practices. The goal of this project is to improve the management of 
medications 
  
to save lives and reduce the overwhelming financial burden of medication errors and side 





To better understand how we should be building electronic health records, we are visiting 
patients and healthcare professionals in Alberta, Ontario, Quebec, and Nova Scotia. We chose 
these specific provinces because each has a different way of delivering healthcare in the 
community. 
 
Through our team of co-investigators and collaborators, we are identifying multiple sites in each 
province, including each of the following: a community pharmacy, a team-based primary care 
clinic, an independent-practice family physician clinic and patient homes. 
 
We are visiting each site to collect data on the following: 
(1) The types of information typically exchanged between patients, physicians, nurse 
practitioners and pharmacists about medication management, drug interactions, and side effects 
assessment; 
(2) The types of tools being used by pharmacists, physicians and nurse practitioners during 
decision-making and how are they different; 
(3) How workflow differs for patients, physicians, nurse practitioners and pharmacists; 
(4) How patients, physicians, nurse practitioners and pharmacists assess for medication 
adherence, interactions and side effects; 
(5) How pharmacists, physicians and nurse practitioners make medication 
recommendations; and 
(6) How patients make medication decisions based on their clinical visit experience. 
To answer these questions, the research team would like to collect data at your site in five ways: 
(1) Complete a short demographic survey including information on age, gender, years of 
practice, etc; 
(2) Observe your typical daily workflow over 30-60min; 
(3) Have you talk-out-loud while using electronic health records to explain your workflow 
(audio recorded); 
(4) Observe you while you speak with a patient about medication therapy (audio recorded 
and the patient will also need to provide consent); and 
(5) Interview you about your experiences in managing medications and using electronic 




The clinical observations will take place at pharmacies and medical clinics. The observations 
and interviews will take up to 1-2 hours per health professional and can be coordinated so that 
we interview multiple healthcare professionals over 1 day at a single site. 
  
Please note this study project will not be collecting data on actual medication lists but rather on 
the type of information exchanged between patients, family physicians, nurse practitioners and 
pharmacists, including tools and workflows involved in each step of medication management. 
After each visit, all audio recordings will be transcribed and any identifying information will be 
removed. The audio recording will then be deleted. The de-identified transcripts will be used to 
identify quotations that may be used in research publications and presentations. Quotations will 




Participation in this study is voluntary. You may decline to participate any study components of 
demographic survey, clinical observation and structured study interview. You may also decline 
to answer any of the questions in demographic survey and structured interview. 
 
WITHDRAWAL FROM STUDY: 
 
You may withdraw from this study at any time without any negative consequences by advising 








We do not anticipate any risks to you due to participating in this study. This study consists of 
unobtrusive observations and interviews. We are maintaining participant confidentiality; no 




There are unlikely to be any direct benefits to the participants of this study. The intention of this 
project is to use the information gathered to help TELUS Health and other EMR providers 
redesign their electronic medical and pharmacy records. The ultimate beneficiaries will be 







All information study participants provide will be considered confidential. Each study 
participant will be assigned a study ID that will be used for all data collection and data forms. 
You will not be identified in any report or publication. Only the research team will have access 
to individual participant data. Audio recordings will be deleted as soon as they are transcribed. 
Survey questionnaires and transcripts collected during this study will be retained for seven years 
in a secure location at our research offices at the University of Waterloo’s School of Pharmacy 
in Kitchener, Ontario. 
  






This study has been reviewed through the joint Waterloo-WLU ethics review agreement as 
outlined at https://uwaterloo.ca/research/office-research-ethics/research-human- 
participants/application-process/waterloo-and-wilfrid-laurier-university-co-ordinated-joint. 
 
This study has received ethics clearance from a University of Waterloo Research Ethics 
Committee at University of Waterloo and the research ethics committee at Wilfrid Laurier 
University. However, the final decision to participate is yours. Should you have any comments 
or concerns resulting from your participation in this study, please contact Dr. Maureen 
Nummelin, the Director, University of Waterloo Office of Research Ethics, at 1-519-888-4567, 
Ext. 36005, or Dr. Robert Basso, the Director, Wilfrid Laurier University Research Ethics 
Board, at 519-884-0710 x4994. 
 
QUESTIONS ABOUT THE STUDY 
 
If you have any questions about participation, or would like additional information to assist you 
in reaching a decision about participation, please contact: 
 
Kelly Grindrod BScPharm, PharmD, MSc Assistant Professor 
School of Pharmacy 
Tel: (519) 888-4567 ext. 21358 
Email: kgrindrod@uwaterloo.ca. 
 
Jilan Yang, Ph.D. Research Coordinator School of Pharmacy 
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Thank you for your participation in our study. As a reminder, the purpose of this study is to 
analyze the current state of shared electronic health information across patients, primary care 
clinics and pharmacies, including types of information typically exchanged, best practices and 
tools that support interprofessional shared medication decision-making. 
The information collected from the study will help us to better understand how and when 
patients should be engaged in medication-related decisions, especially when they take multiple 
medications. This study will also help us to understand how medication-related decisions should 
be coordinated across family physicians, nurse practitioners, pharmacists, medical specialists 
and non-regulated care providers. 
Please note that any information pertaining to you as an individual participant will be kept 
confidential. No personal information will be identified in the research findings. Once all of the 
data are collected and analyzed for this project, we plan on sharing this information with the 
research community and Telus Health through seminars, conference presentations and journal 
articles. If you are interested in receiving more information regarding the results of this 
research, or would like a summary of the results, please provide your e-mail address to the 
researchers. When the study is completed, anticipated by September 2016, we will send you the 
information. 
This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee and the Research Ethics Board at Wilfrid Laurier University. If you 
have any comments or concerns in this study, please contact Dr. Maureen Nummelin at 1-519-
888-4567, Ext. 36005 or maureen.nummelin@uwaterloo.ca or Dr. R. Basso, the Chair of the 
REB at WLU at 519-884-0710 ext. 4994 or rbasso@wlu.ca.  
Yours sincerely, 
Kelly Grindrod, BScPharm, PharmD, MSc 
Assistant Professor, School of Pharmacy 
University of Waterloo 
519-888-4567 x21358 
Catherine Burns PhD 
Professor, Systems Design Engineering 
Faculty of Engineering 












1. Gender: ________________________________ 
2. Age: ___________________________________ 
3. Occupation: _____________________________ 
4. Years in practice: ______________________ 
5. Highest degree obtained: __________________   Year graduated: ___________ 
6. What is your place of employment? 
□ Hospital   □ Family Health Team  □ Long Term Care Home  
□ Pharmacy  □ Other (specify) _________________________  
7. Years in current role/position: __________________ 
8. Years in current job/employer:_________________ 
 
Interview Questions for Physicians 
 
Think Aloud 
**Suggestion: Record a task that involves evaluating a medication such as a completing a fax refill request from a 
pharmacy or writing of a new prescription 
1. Imagine you have a student standing next to you. Can you talk through this as if you 
were teaching the student what you are doing?  
2. That’s how we want you do the think-aloud completing the task. 
3. Afterward the talk aloud, ask: How did you know this was indicated? Effective? Safe? 
That the patient is going to take it? 
Patient Encounter 




1. Afterward all the encounters are complete (not after each one), ask: How did you know 
this drug was indicated? Effective? Safe? That the patient is going to take it? 
Decision Making: 
We’re going to start by talking about how you work with patients and pharmacists 
1. Tell me what it’s like in your clinic. 
 
2. Think back to the last time you prescribed a medication, can you tell me about that? 
(Probing questions: Describe to me how you present a patient with different treatment options? 
Tell me how you take into account the values of the patients? How do you decide what 
information to tell them? How do you evaluate their health literacy?) 
 
3. When looking at a medication prescribed by someone else, tell me how you find out the 
indication for the patient’s medication? 
 
4. Can you describe for me how you follow medication adherence in your patients? How 
do you find out a patient decided to stop taking medication? Or that they changed how they take 
a medication? When would you call a pharmacist? 
 
5. We’re going to ask you questions about pharmacists. When I say pharmacist, who 
comes to mind for you? What pharmacists do you work with? 
 
6. Think back to the last time you identified a problem with a medication, can you tell me 
about that? If you had a question about the prescription, what would you do first? When would 
you call a pharmacist? (Probing options: What do you generally need to access? Over the last 
week, when did you need to get in touch with a pharmacist? What have you found to be the best, 
or easiest way? How do you know when a pharmacist got the information you wanted to share? 
Do you think there’s a way to make it easier? How often do you talk to a pharmacist on the 
phone? Through fax? When do you call them? When do you fax them?) 
 
7. When was the last time you disagreed with a pharmacist about a patient’s treatment? 
How was it resolved? 
 
Use of computer systems 
Now we’re going to switch over to a discussion of your computer systems. 
1. What computer system do you use? (Probing options: How long have you had it in 
place? Why did you choose this system? Who purchased it? Have you worked between 
different systems? What system do you prefer and why?) 
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2. Think back to the last patient you saw. Talk me through how you used your [  ] 
system. (Probing options: What information did you look at first? Where did you spend 
most of your time? Would you say this is the standard use of the system ) 
3. Describe how easy or difficult it is to use your [  ] system to review a patient’s 
medications? What about the medical history? 
4. Describe how useful or not useful your [  ] system is for reviewing a patient’s 
medications. What about medical history? 
5. What do you like most about your [ ] system? What do you like least? 
6.  Describe to me how you access other patient records like lab values, x-rays or hospital 
discharge summaries? What do you look for the most? 
7. Tell me how you use electronic health records that are not included in your EMR? (AB: 
Netcare; SW Ontario: ClinicalConnect; NS: SHARE; QC: DSQ) Why do you generally 
need to access them? 
8.  Describe an ideal computer system for your clinic. Do you foresee any barriers to using 
even an ideal system – even in an ideal world? How would you fix those barriers? 
9. Now we’ve talked about your practice and your computer systems. What is your take 
home message for us?  
 
Interview Questions for Pharmacists 
 
Decision Making: 
Interviewer: Okay, we’re going to start by talking about how you work with patients and 
physicians. 
1.  Tell me what it’s like in your pharmacy. 
2. Think back to the last time a patient asked you to help them make a choice about a 
medication, can you tell me about that? (Probing questions: Describe to me how you present a 
patient with different treatment options? Tell me how you take into account the values of the 
patients? How do you decide what information to tell them? How do you evaluate their health 
literacy?) 
3. Tell me how you find out the indication for a patient’s medication? 
4. How do you follow medication adherence in your patients? How do you find out a patient 
decided to stop taking medication? Or that they changed how they take a medication? 
5. We’re going to ask you questions about physicians. When I say physician, who comes to 
mind for you? What physicians do you work with? 
6. Think back to the last time you identified a side effect or drug interaction, can you tell me 
about that? If you had a question about the prescription, what would you do first? Why? 
Describe to me what you do when you need to get in touch with a physician? Describe to me 
how you present a physician with different treatment options? (Probing options: What have you 
found to be the best, or easiest way? How often do you talk to a physician on the phone? 
Through fax? When do you call them? When do you fax them? How do you know when a 





Use of computer systems 
Now we’re going to switch over to a discussion of your computer systems. 
1. What computer system do you use? (Probing options: How long have you had it in place? Why 
did you choose this system? Who purchased it? Have you worked between different systems? 
What system do you prefer and why?) 
 
2. Think back to the last patient you saw. Talk me through how you used your [      ] system. 
(Probing options: What information did you look at first? Where did you spend most of your 
time? Would you say this is the standard use of the system ) 
 
3. Describe how easy or difficult it is to use your [     ] system to review a patient’s medications? 
What about the medical history? 
 
4. Describe how useful or not useful your [     ] system is for reviewing a patient’s medications. 
What about medical history? 
 
5. What do you like most about your [   ] system? What do you like least? 
 
6.  Describe to me how you access other patient records like lab values, x-rays or hospital discharge 
summaries? What do you look for the most? 
 
7. Tell me how you use electronic health records that are not included in your EMR? (AB: Netcare; 
SW Ontario: ClinicalConnect; NS: SHARE; QC: DSQ) Why do you generally need to access 
them? 
 
8.  Describe an ideal computer system for your clinic. Do you foresee any barriers to using even an 
ideal system – even in an ideal world? How would you fix those barriers? 
 
9. Now we’ve talked about your practice and your computer systems. What is your take home 










Trust Questions for Healthcare Professionals 
 
Think back over the last week of work and the people who were involved in your patients’ 
medication management including family physicians, nurse practitioners and/or community 
pharmacists. Thinking of all those people, rate your opinion of the following questions. 
On a scale of 1 to 10, rate how much you agree with each question (1=highly disagree; 10=highly 
agree). 
  MDs NPs RPhs 
1 My patients are generally treated well by the other primary care 
providers. 
   
2 Other primary care providers put my patient’s interests above all other 
considerations. 
   
3 Other primary care providers took my patient seriously. 
 
   
4 Other primary care providers’ judgement about my patient’s 
medication therapy was trustworthy. 
   
5 Other primary care providers were honest in dealing with my patient. 
 
   
6 I would be willing to let my patient’s medication be managed again by 
other healthcare providers in the future. 
   
7 The treatment my patient received from other primary care providers 
improved his/her condition. 
   
8 I had confidence in other primary care providers who looked after my 
patient in the community. 
   
9 In general, other primary care providers could have been more 
compassionate with my patients. 
   
10 Other primary care providers appeared willing to help my patients.    
11 Other primary care providers should have shown more respect to my 
patients. 
   
12 Other primary care providers were too busy to spend meaningful time 
looking after my patient. 
   
13 If mistakes were made with my patients’ medications, other primary 
care providers would have admitted to them. 
   
14 Other primary care providers kept me informed about my patient’s 
medications, including relevant tests and circumstances that could have 
affected my patient’s medication therapy. 
   
15 Other primary care providers were concerned for my patient’s comfort.    
16 Other primary care providers were insensitive to my patient’s needs.    
17 Other primary care providers discussed with my patient all available 
treatment options. 
   




Healthcare professional Memos 
MEMO #1: Decision Making.  
Definition 
Gatekeeping and Understanding: Pharmacists and physicians did not describe 
SDM in their practice and acted as gatekeepers to medication information. 
Professionals make decision based on their understanding of the patient situation 
and educate the patient on that decision.  
 
Codes 
SDM intentions; decision point; making the decision; assumptions about 
patients; patient communication; IP SDM  
Summary of data  
 Barriers to IP-SDM 
Participants view making decisions through whatever framework they exist most 
comfortably in. In settings where they is no co-location of participants, usually 
decisions happen in silos, in what is perceived as necessity: care has to happen as 
quickly as possible. Established roles and process’ result in gatekeepers, human or 
technological: “You can't get through to them. There's the ward clerk who won't 
let you through to the doctor” (Pharmacist 1102, Ontario, Independent Practice). 
There is an established emphasis on authority and historical roles meaning 
decisions will happen without having all of the necessary information. Does this 
mean that in theory participants support collaborative decision making, but not in 
practice? 
 
When participants were asked specifically about how they make health decisions, 
usually they described contacting other players only as they saw necessary. The 
overall assumption that prescribers and dispensers have completely separate roles 
was a clear one. Pharmacists felt that their job was to ‘warn’ and ‘advise’ but not to 
challenge. Similarly, when physicians were working with other prescriptions there 
was a clear hesitancy to get involved in other practitioners decisions “I can't think 
of one right now. I guess I've had some disagreements, but if they are the 
ultimate prescriber, I might not "win," in brackets, that discussion. I may just be 
able to get my concerns put across, and I might want to document my concerns if 
I have strong disagreements or strong feelings” (Pharmacist 1107 Independent 
Practice, Nova Scotia).  
 
 Decision making reality 
Participants view of decision making was thought of as inherently desirable to the 
care process, however the concept was not brought up without interviewer 
prompting. In addition, the goal was in all but two cases to get patients to 
understand why a HCP was suggesting a treatment, or offering a diagnosis, not to 
actively participate in any decision making process. “It's not what product you 
pick, it's how you sell it. If they want a decongestant, ultimately they're all [pain 
medication] and [decongestant medication]. It's doesn't really matter. How are 
you going to sell that” (Pharmacist 1101, Ontario, Chain Pharmacy). The 
education offered to a patient similarly reflected this – the goal was to get the patient 
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on board, not to discuss the process. “I don’t want to give more information than 
necessary, especially if I see that a patient is more anxious during the beginning 
of the counseling, and even more so if the patient doesn't want to take the 
medication or is scared to take the medication.” (Pharmacist 1121, Quebec, 
Independent Pharmacy). 
Tailoring care to what a patient is perceived to need contrasts with the philosophical 
ideals of patient-centred care, something that every participants focused on as a 
value. So, although patient centred care is acknowledged as a core value, the process 




Pharmacists and Physicians working in Family Health Teams in Ontario spoke 
differently about both how they engage with patients, and colleagues in decision-
focused setting.“In terms of deciding which medication to use with a patient, we go 
through the options we have available, usually with the physician based on what the 
patient is presenting with” (Pharmacist 1125, Ontario, Family Health Team). “I 
want them to make an informed decision. I want them to understand what's 
going on with their health. I want them to understand what the options are 
and why we're pursuing those options. I want them to make an informed 
decision about whether they want to move forward with a particular 
treatment course or not and understand the rationale for that.” (Physician 
1202, Ontario, Family Health Team). 
 
Points for further 
consideration  
 What tools and technology can support IP-SDM 
 What cultural shift needs to happen to support IP-SDM 






MEMO #2: Communication.  
Definition 
Timing and access: Pharmacists and physicians often communicate with each 
indirectly through patients, faxes, or receptionists. Yet, both groups are 
cautious about the expansion of infrastructure that could help, or hinder.  
Codes 
Reasons for HCPs to communicate with patients; Reasons for HCPs to 
communicate with each other; flow of information; communication work-
arounds; methods of communication; availability; how to document in the 
medical or pharmacy chart; risk communication; patient as messenger 
Summary of 
data  
 Myth of Collaborative Care.  
Participants viewed care as generally siloed, physicians prescribed a 
medication or treatment, and pharmacists dispensed and discussed a 
medication. While closely linked to communication Pharmacists tended to 
focus on what they could do without access to a physicians go ahead, while 
generally keeping the physician in the loop “I adjust all the doses, and I do 
everything, he doesn't have to know, but it's important that he does actually 
know what his INR is, just for the file in case the patient shows up in a week 
from now with some weird thing” (Pharmacist 1101, Ontario, Chain 
Pharmacy). Additionally, Pharmacists emphasized the goal of being 
unobtrusive when it comes to care, not wanting to bother a physician with 
questions, even if it delayed the response time to care. “I'll usually do a fax 
just because I feel like it's less intrusive, and so they can potentially get back 
to me quicker without having to call, but if it's something that I really want 
to know, then I might do both.” (Pharmacist 1107, Nova Scotia, Independent 
Pharmacy).  
“Usually when you have issues, first way we are going to try to reach them is 
the fax. We try to put that as short as possible, the less they read, the better it 
is, the more the chances that we have an answer.” (Pharmacist 1120, 
Independent, Ontario).  
The ideology is that providing the best care to patients is directly linked with 
the pharmacists constraints of how, and when they can have access to a 
physician, within the practical barriers of lacking active collaboration. “My 
interactions with pharmacists are more with local pharmacists, by phone. We 
don’t have direct contact to create therapeutic plans.” (Physician 1209, 
Quebec, Family Health Team). While philosophically pharmacists were 
considering interactions with doctors, and encouraging a back and forth 
between patients, physicians and pharmacists the reality of patient-centred 
collaboration remained generally unattainable. “I'll give them what 
information I can and then it's up to them to discuss further with the doctor 
based on what I told them.” (Pharmacist 1117, Ontario, Chain).  
 Direct access in communication 
This could mean that participants support collaboration in theory, but in 
reality, is not built into the normal process of care. The reluctance of 
pharmacists to interact with physicians beyond fax was met with a desire for 
easier communication, and more potential for collaboration. “There're a few 
doctors you can call and talk to, and that's awesome, but it's next to never. 
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Most of them want you to fax.” (Pharmacist 1114, Alberta, Independent 
Pharmacy)”.  
 
While almost all of the pharmacists outside of clinics and family health teams 
cited barriers such as faxes, or gatekeepers such as receptionists, physicians 
never mentioned barriers to accessing pharmacists. The barriers with 
physicians were with regards to if the pharmacists were known, or unknown 
to them. Physicians spoke about collaborating even when electronic health 
records, or faxes were used. “Unless there's a bigger concern, I'm happy for 
the secretaries to do it. Sometimes they'll message them and they'll call me 
in the room when the pharmacist is on the line and I'll go and talk to them. 
They can send a message when they have free time so we both can just do 
our work as long as it doesn't result in unnecessary messages.” (Physician 
1203, Ontario, Clinic).  
 
 Infrastructure to support communication 
Participants viewed barriers to communication as generally an annoyance. 
Lacking the ability for quick turnarounds in getting information was a 
constant complaint among participants. The idea of having a centralized way 
of communicating information, which was not dependent on fax was met as 
philosophically unproblematic. This said, the process of actively setting up, 
maintaining, and building the infrastructure was met with hesitancy. “Yes, if 
we had an electronic health record, it would be very helpful. We have a 
system in the hospital but we still don’t have access to the provincial one 
where we could see the patient’s complete profile.” (Physician 1210, 
Quebec, Family Health Team). Could this mean that the reluctance of 
participants to actively engage in collaborative communication stems not only 
from a lack of awareness of scope of practice, but more simply, a lack of 
ability to have the same information? “My goal is to get my EMR and the 




Regardless of what type of clinical setting, when physicians and pharmacists 
had a personal relationship with each other, communication was easier. Having 
personal cell phones of other practitioners was cited in three cases as a way to 
direct communication. Additionally, when participants were in a rural setting, 
there was always a more significant mention of knowing other practitioners 





 What are participants motivations from improving communication 
 How to build EHR’s to better facilitate care  
 How communication can improve across all care settings, not just where 






MEMO #3: Information.  
Definition 
Indication and Adherence: Pharmacists and physicians require information to provide 
patient care that is accessible through current EHRs. Most critically, physicians required 
access to information about medication adherence while pharmacists require clear access 
to medications indication. 
Codes 
Important information for patient care; information detectives; data collection and 
entry; multiple users; place of access; context of data entry; adherence; information 




 What information is necessary for care 
Participants view access to health information as fundamentally desirable, and were all 
very aware of what information they were missing, that was central to limiting their 
ability to do their job: Pharmacists were keenly aware that they had to participate in 
significant information gathering, usually done from talking to a patient rather than 
‘bothering’ the prescriber. “I would just say that getting information on the indication 
would be one. Trying to find out what they're taking the medication for and what 
they're hoping it's going to do for them would be two of the first questions that I would 
want to ask.” (Pharmacist, 1107, Nova Scotia, Independent Practice ). In addition, 
Physicians were aware of the gap that came after they prescribed a medication. There 
were occasionally plans in place to confirm prescription pick up, and adherence but the 
lack of a formalized information point was a clear gap in care. “We've got a system about 
adherence. It's a really difficult point, and it's a really important point that I think we 
need to look because it's not good right now.” (Physician 1201, Ontario, Family Health 
Team).  
 What information is being communicated between healthcare professionals 
Participants communicated the majority of their communication revolved around 
information that was known to be missing, or assumed to be incorrect. “If the doctors 
don't make these errors or prescribe the individual prescription of the patients.. Yeah, 
we spend a lot of time faxing, clarifying what we think are errors.” (Pharmacist 1112, 
Ontario, Independent Pharmacy). Discussing what and why participants are 
communicating proved to leave the study with more questions. A clear takeaway was the 
necessity for the ability to be aware of indication and adherence was a core takeaway. 
Participants also suggested that often communication between healthcare professionals 
themselves was limited, and often was based on whatever information they could gather 
from ‘Googling’, discussions with the patient or caregiver, or ‘best guess’ assumptions. 
“Taking everything with a grain of salt, I guess, because the diagnosis the patient has 
given me may not exactly match the diagnosis that the physician gave.” (Pharmacist 
1107, Nova Scotia, Independent Practice).  
There is an ideology of providing patient centred care, however all too often the patient 
themselves was central to providing health care practitioners the information needed to 
provide care. This is philosophically problematic, because it emphasizes an undercurrent 
of mistrust, both between practitioners and patients. This may be due to lack of 
knowledge, or wilfully withholding information; which highlights lacking a centralized 
source of information has a direct negative impact on a patient’s health. “Mostly, it will 
have a direct effect and impact on patient's healthcare because like we said, right now, 
unfortunately we're guessing, and we're assuming that patients are taking the medicines 
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we're giving them, that the medicines are the way we think they are” (Physician 1201, 
Ontario, Family Health Team).  
Interestingly, along with a lack of cohesion in finding and sharing information, there was 
additionally a hesitation to actively include patients in health information sharing. 
Participants discussed having to use patients to get information, but when it came to 
making them equal partners feelings of patients being unwilling or unable to understand 
health information: “We haven't explained it to the patient yet. I will explain tomorrow 
because I'm actually going to be delivering the medication myself to the patient, so I'll 
get the answer first from the doctor and then I'll let the patient know because they'll be 
so confused.” Pharmacist 1112, Ontario, Independent Pharmacy).  
 
 Where information is coming from.  
All too commonly, the solution to finding missing information is not solved through 
discussion between practitioners. Most often health care practitioners mentioned asking 
patients for clarity, or even going to in search of information on their own: “I may have to 
Google it. The patient will often tell me. It might be in a note from the specialist, but if 
for some reason is not in the specialist note or the patient doesn’t know, I may have to 
Google it.” (Physician 1208, Quebec, Family Health Team). There was a clear moral 
obligation for practitioners to work with the best information they would find; there was 
also an inherent disconnect about the best place to find, and the best way to share 
information necessary for patient care. “We have a pretty incomplete medical history. We 
don't have labs. We don't have diagnoses, usually, unless we ask. Even then, you don't 
know if it's accurate.” (Pharmacist 1117, Ontario, Chain Pharmacy) 
 
Deviant cases 
One physician spoke about how they worked with the pharmacists who were part of their 
family health team, and actively collaborated for care. This may emphasize that it is a 




 How knowing adherence and indication can help with improving care 
 How can information be best transmitted without leaning on the patient to be a 
sold carrier between practitioners.  
 
 
MEMO #4: Process and Collaboration.  
Definition 
Systems and Understanding: Pharmacists and physicians find that current systems do 
not typically align with their decision-making processes and do not support collaboration 
in daily workflow. 
Codes 
System Design (fill and bill); identifying patients in need of care; stages of care; 
technology limits practice; decision making; workarounds; documentation of 




Outsider to care 
Physicians and pharmacists both develop personal processes that work best for them 
internally in their practice, and externally through collaboration. Participants suggested 
that there is an imbalance in information available to them, and that to a large extent care 
stops when the patient leaves them. Perhaps the reluctance to challenge any medication 
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decisions in an active way comes from this lack of awareness of unknown processes of 
prescribing and diagnosing. “I would try to think of it from a physician's perspective, 
and think of why they might be prescribing this particular medication. Taking 
everything with a grain of salt, I guess, because the diagnosis the patient has given me 
may not exactly match the diagnosis that the physician thought it was for.” 
(Pharmacist 1107, Nova Scotia, Independent Pharmacy). This can translate down to 
unspoken ethical concerns of doing what is right, protecting the patient, as well as 
protecting your practice with a undercurrent of not wanting to step on other practitioners 
expertise. Perhaps the reluctance to challenge any medication decisions in an active way 
comes from this lack of awareness of unknown processes of prescribing and diagnosing. 
This can translate down to unspoken ethical concerns of doing what is right, protecting 
the patient, as well as protecting your practice with a undercurrent of not wanting to step 
on other practitioners expertise. “He basically said, well, that's not my problem, because 
I'm not the one prescribing the seizure medication.” (Pharmacist 1102, Ontario, 
Independent practice).  
 
Information gatekeeping 
There was a keenness to convey support for patient centred care, and collaborative 
agenda. When other practitioners were included, they were brought up as advisors, to 
give insight into one particular aspect, or to clarify the necessity of a treatment. “Most 
physicians do like subtle language of requesting as to, "Can you give me the thought 
behind prescribing this because we're just not sure, we want to make sure the patient 
understands it well or providing recommendations." (Pharmacist 1116, Alberta, Chain 
Pharmacy). So, although the ideology of collaborating care and working with other 
practitioners the reality of working within implicit barriers to access results in 
information necessary for IP-SDM remaining in silos.  
 
Conversely to discussions around decision making with other practitioners, where care is 
siloed, it was second nature for participants to talk about including patients in the 
decision process. This emphasized a contrast with the consistent underlying assumptions 
of how they perceive other people understand, need, and use health information. “I don’t 
want to give more information than necessary, especially if I see that a patient is more 
anxious during the beginning of the counseling, and even more so if the patient 
doesn't want to take the medication or is scared to take the medication.” (Pharmacist 
1121, Quebec, Independent Pharmacy,).  
 
Many participants spoke about conversation, and collaboration both with colleagues and 
patients so it may be that far from the desired outcome of IP-SDM, there is a basic lack of 
awareness and confidence in other players abilities to be knowledgeable enough to 
participate in care in a truly collaborative way: “I'm not asking. It's implied. However, 




One pharmacist working in a Family Health Team in Ontario spoke about IP-SDM in a 
patient care situation. Two physicians spoke about the benefits of working in Family 






 How can an EHR be built to facilitate collaborative processes of care, including 
medication management and diagnosis 
 Building a better understanding be built about perceived roles in care, and how 




MEMO #5: Role/ Scope of Practice/ Relationship & Identity.  
Definition 
Internally and externally imposed boundaries: The perceived workplace and professional 
boundaries for pharmacists and physicians stem from how each group negotiates the boundaries of 
their job, how each group negotiates their interactions with each other and with patients, and how 
relationships, or lack of relationships impact their ability to carry out their roles and 
responsibilities. 
Codes 
Responsibility to diagnose; negotiating role boundaries; accountability; medication 
management; mentorship & role modeling; monitoring; physical distance; community vs 
primary-care pharmacist; 5Ws of shared understanding; filling the gap/tailoring; building 




 Role Boundaries.  
Participants viewed care as generally siloed, physicians prescribed a medication or treatment, and 
pharmacists dispensed and discussed a medication. Philosophically linked to communication, the 
differences arises in the perceptions of how roles are self-limited, and externally limited as they 
relate to care. Pharmacists tended to focus on what they could do without access to a physicians 
go ahead, while generally keeping the physician in the loop “I adjust all the doses, and I do 
everything, he doesn't have to know.” (Pharmacist 1101, Ontario, Chain Pharmacy). 
Additionally, pharmacists emphasized the goal of being unobtrusive when it comes to care, and 
when it came time to actively collaborate to make a change there was a feeling that the physician 
authority had to be convinced: “I contacted the doctor right away to say, I don't think this is 
going to be an appropriate combination, can we change things? Unfortunately, the physicians 
weren't overly receptive to it… They were almost a little bit, we wish you hadn't put your hands 
in the pot. It was really frustrating because there's this clear thing that could cause harm to the 
patient, and you almost felt like you were doing more harm than good by alerting everyone to 
it.” (Pharmacist 1102, Ontario, Independent Pharmacy).  
 
 
Scope of Practice 
Given that interviews spanned from independent clinics, pharmacies, family health teams, and 
chain stores it was clear that the political context of what was allowed to be done was clearly 
present in participants views, in a way that it was clear many did not question in their daily 
practice. Physicians led the care, and often took ownership of guiding the next directions that 
patients should take: “I request that the patient sees the pharmacists. And the pharmacist sees the 
patients, checks adherence and comes to discuss it with me.” (Physician 1210, ? ?). Pharmacist 
interviews brought up the whole picture of a patient’s health, not just specific to a diagnosis or 
treatment plan, but would bring up relationships outside the traditional ideas of authority “It's 
kind of interesting in community, because people will ask you a lot of questions that are not 
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medication-related. Sometimes they just want someone to talk to for a little bit.” (Pharmacist 
1102, Ontario, Independent Pharmacy) 
 
This could mean that due to training, pharmacists understand the boundaries of their role, and 
believe themselves to be more limited in care, or training. “I Try to keep in mind is they may 
also have different sources of information than I do for why they may have chosen a particular 
treatment option versus what I would have chosen, just because of different sources a 
physician might have, or where they get their evidence versus where I might get mine.” 
(Pharmacist 1107, Nova Scotia, Independent Pharmacy). It could be that the reluctance of the 
pharmacists to fully commit to changing scopes of practice could be because of their commitment 
to the whole picture of a patient, while understanding that they are missing information that gives 
them the ability to be internal to decisions to care. “I'll give them what information I can and 
then it's up to them to discuss further with the doctor based on what I told them. Usually when 
I don't have the indication, we can .. Most drugs you can pretty much figure it out.” 
(Pharmacist 1117, Ontario, Chain Pharmacy). 
  
Practice of Care 
Pharmacists perceive themselves as the last gatekeeper to a patients health. The ideology that 
providing care to patients that understands the full picture of what is best for a patient was mixed 
in with the boundaries of the scope of practice that a pharmacist had – both in working with a 
physician, but also what they perceived their role to be, and what they felt they could, and should 
do. “I really did think about the situation quite thoroughly, to see, should I have just let the 
drug interaction happen? Should I have just filled it and said to the doctors, hey, this could 
happen, should we just monitor? And I don't think I would've done that. I don't think that 
would've been in the patient's best interests.” (Pharmacist 1102, Ontario, Independent 
practice)”.  
 
Tailoring care outside the traditional boundaries is something that comes easier to physicians: “I 
think doctors are less worried than pharmacists to prescribe something even if the indication 
and the clinical use differs. Pharmacists will be more by the book.” (Physician 1209, Family 
Health Team, Quebec). Participants suggested that there was significant gaps in knowledge 
around adherence for physicians, and around indications for pharmacists. Physicians generally did 
not consider pharmacists as a partner in care, and rarely brought up active collaboration. Even 
when pharmacists are members of Family Health Teams, the language used to describe their role 
implies a significant amount scope of practice implications: “Definitely the trust exists there and 
then now it's just kind of more a matter of allowing some pharmacists to feel like they can do 
more” Physician 1205, Family Health Team, Ontario). The Physician ‘allowing’ the pharmacist 
to ‘feel’ that they can do more is not language used to describe collaboration, but instead again 
implies the physician holds ultimate authority over care.  
 
Deviant cases 
The pharmacists that were part of family health teams, or family health clinics, regardless of the 
provinces were more confident in their having all of the information to make more active clinical 
decisions. “Here, I have all the same information that they do. You can be a lot more 
confident in what you're recommending because you have all the information that you need 







 What motivations are there for people pushing boundaries of their scope of practice, or for 
understanding other roles scopes of practice 
 How does having access to core data (adherence, indication) change how practitioners 
interact with each other, and patients. 
 How can there be better understanding of scopes of practice, especially given a rapidly 











1. Gender: ________________________________ 
2. Age: ___________________________________ 
3. Occupation: _____________________________ 
4. Highest degree obtained: __________________ 
5. Please outline any health conditions you have been diagnosed with: 
☐ Prefer not to disclose ☐ High Blood Pressure ☐ Type 1 Diabetes ☐ Type 2  
Diabetes ☐ Arthritis ☐ Osteoporosis ☐ Hypertension ☐ Cardiovascular disease  
☐ Cancer (please specify) _________________________ 
☐ Other (please specify) _________________________ 
 
6. How many prescription medications have you been taking in the past three months?: 
____________ 
 
7. How many supplements or alternative medications have you been taking in the past three 
months?: ____________ 
 
8. How many times did you visit a physician or nurse practitioner in the past three months: 
______ Reason:___________________________________________________ 
 
9. How many times did you visit a specialist in the past three months: 
_______Reason:___________________________________________________ 
 
10.How many times did you visit the pharmacy in the past three months: 
_______ Reason:___________________________________________________ 
 





Interview Questions for Patients 
 
1. Think the last time you went to your doctor. Can you describe it to me? When we’re 
seeing doctors we often have a decision to make, when you think back on your 
appointment, can you describe a decision you had to make? A decision can be starting or 
stopping a drug, going to physio, or a specialist. When you were discussing making that 
decision, who led the conversation? 
2. When you first have a health concern, how do you decide what to do? 
3. When I say ‘primary care physician’, who do you think of? 
4. What do you talk about at the beginning of your appointment? How would you describe 
a normal interaction with your GP? Your Pharmacist? Your specialist? 
5. Would you say generally speaking, your physician gives information to you, or that you 
give information to them? Think about after a decision is made, do you talk to anyone 
else, like a pharmacist? Have you heard of Shared Decision making?  
6. Can you talk about how your doctor informs you about an illness?  
7. Do they tell you about treatment options? How does the discussion on which would best 
fit for you go? 
8. If you are curious, do you ask for more information about your diagnosis from your 
doctor? Your specialist? Your pharmacist? Friends? 
9. Do you bring someone with you to health appointments? 
10. Have you ever thought about how much information you want from your health team? 
11. Think of the last time your were prescribed a medication. What is the most important 
thing on your mind when you’re making the choice to take, or to not take that 
medication 
12. Have you ever disagreed with your doctor about a suggested treatment? How was it 
resolved?  
13. How do you think your health care team works together when making a decision about a 
medication or treatment? Do you think your doctor and pharmacist work together? 
14. How do you know when you are working with a really good pharmacist or physician or 
nurse practitioner?  
15. Is there anything else you want to say about how you make decisions? 
------------ 
16. Have you heard of electronic health records?  
17. How do you think electronic health records can help you? 
18. When do you think electronic health records could get in the way? How? 
19. Have you ever thought about what health data your doctor has on you? Would you like 
to access it? Do you think having access to it would change how you think about your 
health? 
20. In an ideal world, how much of your health data would you like to see? Where would 
you like to see it? What do you think you could do with it? 
21. Have you ever worried that your health information wasn’t being properly 
communicated to you, or between your various health care providers? 
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22. Have you ever had access to your own records? Have you ever tried to access your own 
records? Would you want access? 
23. Have you ever accessed any of your own lab reports? Did you find it helpful to see 
them? Did you talk to anyone about them? 
24. What do you do that makes to make your time with a doctor/pharmacist/nurse 
practitioner easier?  
25. How have you seen your care change in the last five years? 
26. What further changes do you hope to see? 
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 Trust Questions for Patients 
 
On a scale of 1 to 10, rate how much you agree with each question (1=highly disagree; 10=highly agree) 
 





1. During my latest visit, I was treated like an individual, not 
a case number  
    
2. During my last visit, I feel my interests are put above all 
other considerations 
    
3. During my last appointment I feel I was taken seriously     
4. Generally speaking I trust their judgement about my 
medical care. 
    
5. Generally speaking, I feel they are honest with me     
6. I want to continue going to my current     
7. I feel treatment I am prescribed generally improves my 
condition  
    
8. I felt I could go to them to discuss any concerns I have 
about treatment (side-effects) 
    
9. I have confidence in my current     
10. I trust my current     
11. I feel that my current practitioner is compassionate      
12. I feel a willingness to help me from my current      
13. I feel my current practitioner respects me     
14. During my last visit, they spent meaningful time looking 
after me 
    
15. If a mistake is made in my treatment, I trust it would have 
been admitted to by my current 
    
16. Generally speaking, I am kept informed of my tests and 
treatments 
    
17. Generally speaking, they are concerned for my comfort     
18. Generally speaking they are sensitive to my needs     
19. They generally discuss all available treatment options 
and worked to find the one best suited to me 
    
20. Generally speaking, I feel I can go to them with questions 
about changing or stopping treatment 
    








(("reason for use"[All Fields] OR Indication*[All Fields] OR Off-Label Use[MeSH terms] OR 
(diagnosis[All Fields] OR diagnosis[MeSH terms] AND (pharmacists[MeSH Terms] OR 
pharmacist*[All Fields])) AND (prescription[All Fields] OR drug prescriptions[MeSH Terms] 
OR prescriptions[MeSH Terms]) AND (documentation[MeSH Terms] OR document[All 
Fields] OR record[All Fields] OR communication [MeSH terms] OR communication[All 
Fields] OR Electronic health record[MeSH Terms] OR “electronic medical record” OR 
labels[All Fields] OR off-label[All Fields] OR Off-Label Use[MeSH Terms] OR electronic 
prescribing[MeSH Terms]) AND (collaboration OR intersectoral collaboration[MeSH Terms] 
OR interprofessional relations[MeSH Terms] OR patient care team[MeSH Terms] OR 
professional role[MeSH Terms] OR team[All Fields] OR interprofessional[All Fields] OR 




(("reason for use" OR Indication) AND (document OR documentation OR record OR label) 
AND (prescription OR drug OR medic*)) 195 
 
IEEE:  
(("reason for use" OR Indication OR (diagnosis AND pharmacist)) AND (prescription OR 
pharmaceutical OR drug OR medic*) AND (documentation OR document OR record OR 
communication OR labels OR off-label OR electronic prescribing)) (218) 
 
IPA 
1 ("reason for use" or Indication or indications).mp.  
2 (diagnosis and (pharmacists or pharmacist)).mp.  
3 (prescription or drug prescriptions or pharmaceutical preparation).mp.  
4 (documentation or document or record or communication or Electronic health record or 
electronic medical record or labels or off-label or electronic prescribing).mp.  
5 (collaboration or interprofessional relations or professional role or team or 
interprofessional or interprofessional collaboration or patient).mp.  
6 1 or 2 
7 3 and 4 and 5 and 6 







1 exp treatment indication/ or exp drug indication/ 
2 "reason for use".mp. 
3 exp diagnosis/ae [Adverse Drug Reaction] 
4 exp non prescription drug/ or exp prescription/ or exp prescription drug/ 
5 exp empowerment/ or exp follow up/ or exp document delivery/ 
6 information processing/ae [Adverse Drug Reaction] 
7 exp hospital information system/ or exp medical record/ or exp information system/ or 
exp electronic medical record/ or exp "organization and management"/ or exp computer 
system/ or exp computer/ 
8 exp prescription/ or exp "off label drug use"/ or exp "drug use"/ or exp drug indication/ 
or exp drug labeling/ 
9 exp patient care/ or collaboration.mp. or exp cooperation/ or exp intersectoral 
collaboration/ 
10 exp health care personnel/ or exp professional practice/ or interprofessional.mp. 
11 1 or 2 
12 5 or 6 or 7 
13 3 or 4 or 8 
14 9 or 10  
15 11 and 12 and 13 and 14 
1513 
 
 
